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Abstract
The Wnt signalling pathway is involved in stem cell maintenance, differentiation and tissue develop-
ment, and in so doing plays a key role in controlling the homeostasis of colorectal crypts. In response
to an external Wnt stimulus, the intracellular levels of the protein β-catenin are regulated by the
proteins which make up the Wnt signalling pathway. Abnormalities in the Wnt signalling pathway
have been implicated in the initiation of colorectal and other cancers.
In this thesis we analyse and simplify existing models of the Wnt signalling pathway, formulate
models for Wnt’s control of the cell cycle in a single cell, and incorporate these into a multiscale
model to describe how Wnt may control the patterns of proliferation in a colorectal crypt.
A systematic asymptotic analysis of an existing ODE-based model of the Wnt signalling path-
way is undertaken, highlighting the operation of different pathway components over three different
timescales. Guided by this analysis we derive a simplified model which is shown to retain the essen-
tial behaviour of the Wnt pathway, recreating the accumulation and degradation of β-catenin. We
utilise our simple model by coupling it to a model of the cell cycle. Our findings agree well with the
observed patterns of proliferation in healthy colon crypts. Furthermore, the model clarifies a mech-
anism by which common colorectal cancer mutations may cause elevated β-catenin and Cyclin D
levels, leading to uncontrolled cell proliferation and thereby initiating colorectal cancer.
A second model for the influence of the Wnt pathway on the cell cycle is constructed to incorporate
the results of a recent set of knockout experiments. This model reproduces the healthy proliferation
observed in crypts and additionally recreates the results of knockout experiments by additionally
including the influence of Myc and CDK4 on the cell cycle. Analysis of this model leads us to suggest
novel drug targets that may reverse the effects of an early mutation in the Wnt pathway.
We have helped to build a flexible software environment for cell-based simulations of healthy and
cancerous tissues. We discuss the software engineering approach that we have used to develop
this environment, and its suitability for scientific computing. We then use this software to perform
multiscale simulations with subcellular Wnt signalling models inside individual cells, the cells forming
an epithelial crypt tissue. We have used the multiscale model to compare the effect of different
subcellular models on crypt dynamics and predicting the distribution of β-catenin throughout the
crypt. We assess the extent to which a common experiment reveals the actual dynamics of a crypt
and finally explain some recent mitochondrial-DNA experiments in terms of cell dynamics.
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Chapter1
Literature Review
1.1 Introduction
C
olorectal cancer or bowel cancer (CRC) is one of the most widespread malignancies in
the western world and is rapidly becoming a leading cause of cancer mortality worldwide.
In 2004 CRC accounted for 13% of cancers in the UK, making it second only to lung
cancer in terms of mortality rate1 and the most common cancer to cause death in non-smokers. The
lifetime risk of developing CRC in the UK population is 5%, and the risk rises dramatically with
age. Incidence rates also vary by a factor of 20 times across the world, suggesting that there is a
strong link with environmental and dietary factors (Fodde et al., 2001).
The intestine contains a series of pits or crypts, lined by a monolayer of epithelial cells (see Fig-
ure 1.1). The earliest signs of cancer are aberrant crypt foci, these growths affecting only a few
crypts. The next stage in tumour progression is abnormal and disordered growth, or dysplasia.
Dysplastic aberrant crypt foci may develop into polyps — benign tumour masses that protrude
from the epithelium. Some polyps retain normal cell architecture and morphology, whereas others
have abnormalities in inter- and intra-cellular organisation. Abnormal polyps are called adenoma-
tous polyps or adenomas. Most people aged 70 or above will have developed at least one colorectal
adenoma, but it will usually be asymptomatic. The next stage of cancer progression is when adeno-
mas develop into adenocarcinomas, aggressive tumours (Fodde et al., 2001).
Metastasis is the process by which cancer cells break away from a tumour and spread around
the body, usually in the bloodstream, to cause secondary tumours elsewhere. CRC is usually only
diagnosed when adenocarcinomas have developed, but there is an excellent prognosis for cases caught
before metastasis, surgery and chemo/radiotherapy being quite effective. However the likelihood of
1http://info.cancerresearchuk.org/cancerstats/
2
1.2 Colorectal Crypts Chapter 1: Literature Review
successful treatment following metastases is much lower. For this reason, the detection of CRC is as
important a research area as its treatment. Fearon & Vogelstein (1990) proposed that accumulation
of mutations in certain genes corresponded to the stages in development of colorectal cancer, as the
early mutations were almost always in components of the Wnt signalling pathway.
In this thesis we investigate the link between Wnt signalling and cell proliferation, by building
mathematical models of the Wnt signalling pathway and its influence on the cell cycle. We introduce
such subcellular models into a cell-based model of a colorectal crypt to establish whether Wnt
signalling is sufficient to cause the observed patterns of proliferation in the intestine, and further
establish how populations harbouring mutations might establish themselves.
In section 1.2 of this literature review we introduce the physiology of colorectal crypts, describing
how they function under normal circumstances and introducing the cells involved. In section 1.3 we
describe the cell cycle, the process by which cells replicate, and review mathematical models of the
cell cycle. In section 1.4 we focus on the Wnt signalling pathway and explain its intimate involvement
in CRC. Finally, in section 1.5, we consider the effect of mutations on the crypts, explaining how
they are thought to lead to CRC initiation.
1.2 Colorectal Crypts
The intestine is characterised by a large number of regularly spaced crypts which provide a large
surface area for absorption of water and nutrients. These crypts were first identified in 1688 by
Marcello Malpighi but are named after Johann Nathanael Lieberku¨hn who described them in 1745.
In this thesis the crypts of Lieberku¨hn will be referred to simply as crypts. Figure 1.1 shows the
crypts in the small and large intestine. In the small intestine small crypts are surrounded by larger
villi — finger-like protrusions out from the surface of the epithelium. In the large intestine (colon
and rectum) crypts are larger and there are no villi present; in this thesis we focus on the crypts of
the large intestine which are more prone to cancer. The crypts are usually non-branching, tightly
packed cylindrical tubes which are evenly distributed and parallel.
1.2.1 Cell Types
In the intestine epithelial stem cells, located at the base of each crypt, generate four cell lineages
(Moore & Lemischka, 2006):
• enterocytes, which secrete hydrolases (enzymes for hydrolysis reactions) and absorb nutrients;
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Figure 1.1: A. The small intestine crypts and villi. B. The colorectal crypts. Proliferating cells
are stained brown. From Fig. 2a) and 2b) Radtke & Clevers, SCIENCE 307:1904-
1909 (3/25/2005). Reprinted with permission from AAAS.
• goblet cells (most abundant), which secrete a protective mucous lining;
• enteroendocrine cells (rare), which secrete hormones including serotonine and secretin;
• Paneth cells (found only at the bottom of small intestinal crypts), which secrete antimicrobial
peptides and enzymes (Porter et al., 2002).
The first three cell types are generated throughout both the small and large intestines, whilst Paneth
cells are present only in the small intestine. The proliferating epithelial cells sit on a bed of fibrob-
lasts and mesenchyme (connective tissue). Studying the interactions between epithelial cells and
fibroblasts is becoming more of a focus for research as there is increasing evidence that mutations in
fibroblasts can precede crypt carcinoma development (Bhowmick & Neilson, 2004): epithelial cells
are certainly dependent on fibroblasts for growth and differentiation signals.
1.2.2 Crypt Dynamics
It is thought that the base of each colonic crypt contains a number of stem cells that divide and
differentiate; proliferating transit or progenitor cells are found in the lower two-thirds of the crypt and
quiescent (non-dividing) differentiated cells in the upper third (Sancho et al., 2004), see Figure 1.1.
Despite the crucial importance of stem cells in the dynamics of colorectal crypts the precise number
of stem cells is unknown. Estimates range between 4 and 16, with up to 40 cells retaining the ability
to become stem cells if needed (Marshman et al., 2002).
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Under normal physiological colonic conditions, the epithelial cells differentiate as they migrate from
the base to the top of the crypt. Once at the top, they are thought to undergo apoptosis before
being shed into the gut lumen. The number of dividing cells is balanced by the number being shed
into the lumen at the top of the crypt and, in this way, the whole of the intestinal epithelium is
renewed (over a period of 3–6 days in mice (Potten & Loeﬄer, 1987) and around 6 days in humans
(Ross et al., 2003)).
Only the ‘immortal’ stem cells (and, in the small intestine, Paneth cells which live for 20 days) escape
the flow of cells from the bottom to the top of the crypts. There is a balance that the body must strike
between renewing the epithelium before it is damaged by the contents of the gut (leading to infection)
and renewing the epithelium too fast (using lots of energy and predisposing the crypts to hyper-
proliferation). It is the mechanisms that regulate rapid cell proliferation and apoptosis (homoeostatic
mechanisms) that are prone to causing cancer when mutations occur (Radtke & Clevers, 2005).
The earliest mutations which occur in CRC are almost always in components of the Wnt signalling
pathway (Powell et al., 1992), which is involved in the control of cell proliferation, differentiation
and adhesion. The level of Wnt-pathway-target gene expression in a colorectal crypt is observed to
be highest at the base of a crypt, where the stem cells are located, and to decrease towards the top
(Gaspar & Fodde, 2004; Larsson, 2006). Before we discuss how the Wnt pathway influences the cell
cycle we first describe the cell cycle itself.
1.3 Cell Cycle
The repeating sequence of events involved in cell-division is known as the cell cycle and is commonly
split into four phases. During the S phase a copy of the cell’s DNA is synthesised. There follows a
gap phase (G2) during which the cell grows. During the mitosis (M) phase the cell splits and forms
two ‘daughter’ cells, which then enter a long gap phase (G1) during which they grow sufficiently to
synthesise their DNA and repeat the process (Figure 1.2). There is large variation in the duration
of the G1 phase between different tissues and cell types. While the durations of the different phases
in human colorectal tissue are not known, they are on the order of hours. The full cell cycle lasts
approximately 12 hours in the highly proliferating cells near the base of a crypt in the mouse small
intestine (Meineke et al., 2001).
In most tissues at any given time not all cells are actively proliferating: many appear to be quiescent.
A new phase of the cell cycle, G0, has been introduced to account for this behaviour. Whether
G0 is distinct from G1 or simply a name for cells ‘stuck’ in G1 is still under debate, but in any
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case it provides a useful way of describing cells which do not appear to be proliferating. Under
suitable external signals quiescent cells may return to G1 after hours, days, months or even years
(Alberts et al., 2002), or they may undergo apoptosis (programmed cell death). Cells enter G0 for a
number of reasons, including lack of available materials or energy for replication, but usually because
they are terminally-differentiated (Hutchinson & Glover, 1995), such as an epithelial cell at the top
of a crypt.
Figure 1.2: The phases of the cell cycle. G0 Quiescence, G1 Gap 1, S DNA Synthesis, G2 Gap
2, M mitosis (DNA and cell division).
While progress through the cell cycle is known to be regulated by at least thirty different proteins,
a small number of distinct ‘checkpoints’ have been identified. In order to pass through these check-
points certain proteins must exceed threshold levels. For instance, the concentrations of the Cyclin
family of proteins rise and fall as the cell cycle progresses. A map of all the known protein inter-
actions involved in the cell cycle was created by Kohn (1999), which spanned four journal pages in
fine print; many more interactions have now been identified and it is thought that still more remain
to be documented. Any description of the cell cycle, in words or equations, therefore represents a
dramatic simplification of the true events leading to replication of a cell.
1.3.1 Regulation by Cyclins
The role of cyclins in the cell cycle is of particular interest for us as Cyclin D has been identified
as one of the targets of β-catenin promoted transcription in colorectal tissue (Tetsu & McCormick,
1999; Wang et al., 2002a; Shtutman et al., 1999). Cell-cycle control is regulated by interactions
between cyclins, cyclin-dependent kinases (CDKs) and cyclin-dependent kinase inhibitors (CDKIs)
(Kitazono et al., 2005). Individual cyclins act by binding to their CDK partners at different stages
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in the cell cycle. Of the many cyclins found to date, the following four have been identified as
principal components of the cell cycle: Cyclins D and E are fundamental to G1 and to the G1/S
transition, Cyclin A is active in the S phase and Cyclin B drives the G2/M transition.
Cyclin D proteins are regulators of the G1 phase of the cell cycle, binding to either CDK4 or CDK6
in response to mitogenic stimulation. A transcription factor E2F1 leads to the expression of proteins
involved in the S phase of the cell cycle (Bracken et al., 2004). It is degraded by retinoblastoma
protein pRb. The Cyclin D/CDK complexes phosphorylate the retinoblastoma protein pRb, which
is hyperphosphorylated by Cyclin E/CDK2, preventing its downregulation of E2F1 (Swat et al.,
2004); this leads to the accumulation of active E2F1 and the transcription of more Cyclin E and
genes involved in S phase, such as Cyclin A (Sherr & Roberts, 1999). E2F1 is also a transcription
factor for itself (Takahashi et al., 2000).
The D-type cyclins (D1, D2 and D3) are generally expressed in response to extracellular growth
factors (such as Wnt), resulting in cell proliferation under favourable conditions. The different D-
type cyclins have structures which appear to be optimised for different tissue types, but each can
form a complex with either CDK4 or CDK6. Recent findings in mice by Yang et al. (2006) suggest
that Cyclin D2 is restricted to highly-proliferating areas of the crypt, whereas Cyclin D1 is expressed
more widely throughout the crypt. The findings in Sansom et al. (2007) suggest that this is because
Cyclin D2 is a transcriptional-target of β-catenin whilst Cyclin D1 is not (nuclear levels of β-catenin
are high in highly-proliferating areas). While cell-cycle progression can occur in some tissues in
the absence of Cyclin D (Kozar & Sicinski, 2005), the bulk of reports suggest that D-type cyclins
are vital to the healthy operation of colorectal crypts (Tetsu & McCormick, 1999; Shtutman et al.,
1999; Rimerman et al., 2000). Our use of the general term ‘Cyclin D’ represents all of the D-type
cyclins present in the crypt.
In addition to the obvious role of Cyclin D in the G1/S transition more subtle effects have been
observed: Cyclin D1 can induce the differentiation of colon epithelial cells in mice (Hulit et al.,
2004), and E2F1 (whose levels are affected by Cyclin D) is important in epithelial morphogenesis
(Ivanova et al., 2005).
In section 1.3.3 we review existing mathematical models of the cell cycle, focussing on those that
include Cyclin D. We are particularly interested in models that feature Cyclin D (so that they can
easily be coupled to a model of the Wnt pathway) and which can reproduce two specific phenomena
observed in the crypts: firstly, lack of Cyclin D can induce quiescence (Gemin et al., 2005) and,
secondly, reduction of Cyclin D levels can slow the onset of the G1/S transition (Han et al., 1999).
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1.3.2 Regulation by c-Myc
c-Myc is an important target of the Wnt/β-catenin pathway (He et al., 1998), which is responsible for
many of Wnt’s downstream effects. Sansom et al. (2005) showed that Cyclin D1 is not an immediate
target of β-catenin following APC loss in the intestine, and suggested instead that the upregulation
of Cyclin D2 and c-Myc is responsible for proliferation under a Wnt stimulus. Sansom et al. later
showed that deletion of c-Myc and APC results in healthy colonic epithelium in mice (Sansom et al.,
2007), suggesting that c-Myc is an important target of β-catenin/TCF4 following a mutation in the
Wnt pathway.
c-Myc is a protein which is heavily involved in deciding whether a cell should proliferate, dif-
ferentiate or undergo apoptosis (Grandori et al., 2000; Murphy et al., 2005). c-Myc is almost al-
ways found in heterodimers with members of the Mad-Max family of proteins. Myc/Max proteins
stimulate the transcription of many different genes, whilst Myc/Mad complexes repress transcrip-
tion (Dang et al., 1999). c-Myc is a known transcription factor for Cyclin D1, Cyclin D2, CDK4
and E2F1 (Hermeking et al., 2000; Bouchard et al., 1999; Adhikary & Eilers, 2005; ODonnell et al.,
2005). Miliani de Marval et al. (2004) showed that overexpression of c-Myc deregulates epithelial
cells only when CDK4 is present.
c-Myc is a transcriptional repressor of p21 (a cyclin-dependent kinase inhibitor) (Wanzel et al.,
2003), and Liu et al. (2006b) showed that repressing p21 transcription is necessary for c-Myc to
cause increased proliferation in the intestinal epithelium. c-Myc can also repress p21 by binding
directly to it, preventing p21 from interacting with cyclins.
p21 forms a complex with Cyclin E/CDK2 and inhibits its function (Sherr & Roberts, 1999). In a
role contradictory to its classification as a CDKI, p21 also forms a complex with Cyclin D/CDK4,6
activating it and allowing Cyclin D dependent phosphorylation of pRb (Weinberg & Denning, 2002).
In addition, p21 can bind directly to E2F1 inhibiting its transcriptional activity (Dotto, 2000).
1.3.3 Mathematical Models of the Cell Cycle
There has been considerable effort invested in describing the proliferation of cells mathematically.
Many different approaches have been taken; here we review some of these approaches.
Gyllenberg & Webb (1990) created a deterministic age-structured PDE model for a population of
cells, in which the rate of cell division was age-dependent. Proliferating cells may become quiescent
(and vice-versa), whilst only proliferating cells can grow and divide. In this way the evolution of a
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population is tracked over time.
Pettet et al. (2001) formulated a spatially-structured PDE model of cell density, decomposing the
tumour into populations of proliferating and quiescent cells whose densities could vary at different
spatial positions in the tumour. The concentration of a diffusible nutrient governed the tumour’s
development since, as in Gyllenberg & Webb (1990), cells are segregated into proliferating and qui-
escent classes which respond differently to this nutrient. The proliferating cells divide and cause a
population increase; this effect, and the directed movement of cells up spatial gradients of the nu-
trient, cause the tumour to grow. Assuming that quiescent cells are more motile than proliferating
ones, a steady state is reached with an outer layer of quiescent cells (moving towards an external
nutrient) followed by a layer of proliferating cells and another layer of quiescent cells forming a core.
This model provides a possible explanation of tumours’ internalisation of labelled cells and inert
microspheres (Dorie et al., 1982, 1986).
Basse et al. (2003) derived a DNA-content structured PDE model for the different phases of the
cell cycle. A time delay was introduced into the governing equations as cells leave the G1 phase,
grow to double their DNA content (S phase) and enter G2 a finite time later. The DNA content
of a population of cells was determined numerically and favourably compared to flow cytometry
experiments.
In each of the above models PDEs were used to model progress through the cell cycle in a large
number of cells. Since we are interested in subcellular phenomena we will focus on models describing
the protein interactions that drive a single cell through the cell cycle. These models are characterised
by ODEs for the concentration of each of the proteins of interest and are formulated using the laws
of mass-action and Michaelis-Menten kinetics.
Progress through the cell cycle is marked by changes in protein levels, and it is the interactions
between different proteins that can form biochemical switches (Legewie et al., 2005). Cell cycle
‘checkpoints’ are best explained as mathematical bifurcations: once a certain parameter (protein
level) reaches a threshold value the system exhibits a new qualitative behaviour (passes through a
checkpoint or bifurcates) (Csikasz-Nagy et al., 2006).
Many cell-cycle models that account for the action of Cyclin D focus on the G1/S transition, as it
is believed that the durations of the S, G2 and M phases are largely independent of Cyclin D, and
their durations remain fairly constant throughout a tissue. Studying the G1/S transition should
therefore be sufficient to study the influence of Cyclin D on cell proliferation in the colon.
Some of the earliest cell-cycle models to incorporate Cyclin D were developed by Obeyesekere and
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co-workers (Obeyesekere et al., 1997; Obeyesekere & Zimmerman, 1999) and made predictions con-
sistent with the observation that a cell becomes quiescent when growth-factor levels (Cyclin D
transcription factors) are reduced. Aguda & Tang (1999) focussed their model on the G1/S tran-
sition; simulations can complete the G1/S transition in the absence of Cyclin D expression, so the
model does not exhibit quiescence due to a lack of Cyclin D that we require.
Probably the best known protein-interaction model for the cell cycle is due to Tyson & Novak (2001),
a more recent extension (Novak & Tyson, 2004) being tailored to mammalian cells. To stimulate
production of Cyclin D and start the cell cycle Novak & Tyson included an early starter protein,
whose concentration increases until it triggers the production of a delayed starter protein (DRG)
which stimulates the production of Cyclin D. The concentration of DRG, denoted by [DRG], quickly
reaches a stable level which it retains throughout further cell cycles.
In order to investigate the effect of reducing Cyclin D levels we have used a MatLab ODE solver
(ode15s) to simulate the Novak & Tyson (2004) model, reducing the value of [DRG] in successive
simulations. This leads to longer cell-cycle durations, with the undesirable side effect of cells growing
to much greater, physically unrealistic, sizes (see Figure 1.3).
In the simulation presented in Figure 1.3 the size of the cells when they divide is much larger (by
a factor of about 25) than that at which they normally divide. Figure 1.3 shows how each of the
model variables evolve over five cell cycles. There are so many interactions being considered that
it is extremely difficult to establish the precise relationship between Cyclin D expression and other
cell-cycle variables. Removing Cyclin D from the system increased the cycle time but did not lead to
quiescence. Because of its complexity and inability to reproduce the quiescence seen by Gemin et al.
(2005), we have not utilised the Novak & Tyson (2004) model.
In chapter 3 we examine a deterministic ODE model developed by Swat et al. (2004) which focusses
only on Cyclin D’s role in the G1/S transition, rather than all Cyclins and all phases of the cell
cycle. The central components are the concentration of E2F1 (an indicator of the S phase), pRb
(retinoblastoma protein), and Cyclin D; the model can exhibit both quiescence and slowing of the
cell cycle in response to changes in Cyclin D levels.
1.4 Wnt Signalling
The components of the Wnt signalling pathway show a high degree of evolutionary conservation
from Drosophila through to mammals (Nelson & Nusse, 2004), suggesting it is an important and
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Figure 1.3: A simulation of the cell-cycle model developed by Novak & Tyson (2004) using
the solver ode15s in MatLab, with the same equations and parameter values as
Novak & Tyson (2004, Figure 2), subject to [DRG]=0.42. Novak & Tyson did not
investigate such dependencies
fundamental pathway. Wnt signalling has long been implicated in colorectal cancer and is there-
fore thought to be important in maintaining the healthy crypt, with mutations leading to cancer
initiation. We will describe the Wnt signalling pathway in some detail in this section. The roles of
Wnt signalling are discussed in section 1.4.1; the action of the pathway’s main downstream target,
β-catenin, in section 1.4.2; the way in which β-catenin levels are regulated by Wnt in section 1.4.3;
other downstream effects of Wnt in section 1.4.4; the way in which the Wnt pathway has been
implicated in cancer in section 1.4.5; and mathematical models of Wnt signalling in section 1.4.6.
1.4.1 Functions of Wnt Signalling
The Wnt pathway is known to play a key role in stem cell maintenance (Reya & Clevers, 2005;
Pinto & Clevers, 2005), cell-cell adhesion (Hinck et al., 1994), cell-fate specification (cell differenti-
ation) (Logan & Nusse, 2004), central-nervous-system patterning (Hall et al., 2000) and tissue de-
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velopment (Church & Francis-West, 2002; Nelson & Nusse, 2004). There are many different Wnt
factor variants, 7 in Drosophila and at least 19 in humans, and these are numbered according to the
order in which they were discovered, e.g. Wnt1, Wnt2 (Nusse, 2007).
A cell’s response to Wnt signalling is believed to be mediated predominantly through β-catenin.
The ‘output’ of the Wnt pathway is therefore considered to be the concentration and location of
β-catenin (Fodde & Brabletz, 2007). When this protein forms a complex with T-Cell Factor (TCF)
in the nucleus it activates the transcription of around 100 genes2 which execute manifold functions.
In the next section we discuss the different roles that β-catenin performs within the cell in more
detail.
1.4.2 β-catenin
β-catenin is produced constitutively3, encoded in humans by the gene CTNNB1, and is found as
a monomer in the cytoplasm. Its levels are controlled by recruitment to a large multi-protein
complex (referred to from now on as the destruction complex ) which includes, amongst others, the
proteins APC, Axin and GSK3β. The destruction complex phosphorylates β-catenin, labelling it for
ubiquitination and hence for destruction by proteosomes (we examine this process more thoroughly
in section 1.4.3). β-catenin cannot affect a cell’s behaviour whilst remaining a monomer in the
cytoplasm; the main sites at which β-catenin is thought to exert its influence are in the nucleus and
at the cell membrane (Gavert & Ben-Zee´v, 2007).
β-catenin in the nucleus
In the absence of β-catenin, T-cell factor (TCF)/lymphoid enhancer factor (LEF) DNA-bound tran-
scription factors bind to transcriptional repressors such as Groucho and Carboxy-terminal binding
protein (CtBP). When β-catenin enters the nucleus it dimerizes with TCFs to remove the repressors
and activate the expression of Wnt target genes, such as Cyclin D (see section 1.3.1).
By preventing β-catenin from entering the nucleus, expression of target genes can be switched
off (Cong et al., 2003). Conversely, forcing β-catenin into the nucleus can activate target genes
(Townsley et al., 2004). Wnt signalling activity is therefore believed to be controlled by the amount
of β-catenin in the nucleus. These levels, in turn, depend on the amount of β-catenin in the cytoplasm
and its rates of nuclear import and export (Sta¨deli et al., 2006). A suprising number of Wnt pathway
2http://www.stanford.edu/~rnusse/pathways/targets.html
3i.e. continuously in all cells, under normal physiological conditions.
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components appear in the nucleus (such as APC and Axin). APC has been shown to counteract
β-catenin activation and methylation of Wnt target genes (Willert & Jones, 2006).
It is still unclear how β-catenin levels in the nucleus are regulated and how they relate to cytoplasmic
levels. However, it is known that β-catenin levels in the nucleus are often much higher than those in
the cytoplasm. Henderson (2000) states that APC acts as a nuclear chaperone for β-catenin, since
APC contains two active nuclear export sequences and moves β-catenin from the nucleus to the
cytoplasm. Xiong & Kotake (2006) agree that APC regulates β-catenin levels in the nucleus, but
suggest that the mechanism is mainly due to APC binding to C-terminal Binding Protein (CtBP)
on DNA promoter regions and preventing β-catenin’s access to the sites. Krieghoff et al. (2006)
suggest that TCF4 and BCL9 recruit β-catenin to the nucleus, but that there is no active export.
They propose that the distribution of β-catenin is governed by the fact that it complexes with APC
or Axin (which are large and move slowly) and therefore β-catenin is retained wherever they are
present, creating a non-uniform distribution.
The level of β-catenin in cell nuclei has been observed to vary throughout the crypt, with the
strongest presence in the cells near the base of the crypts. β-catenin and TCF have been shown
to control the expression of EphB receptors in the crypt (Batlle et al., 2002), and this could be
one of the mechanisms by which β-catenin controls proliferation and differentiation patterns in the
crypt (Gregorieff et al., 2005). Interestingly, Kim et al. (2000) and Larsson (2006) showed that
overexpression of β-catenin induces apoptosis independent of the involvement of major G1 cell-cycle
regulators. However most research suggests that an excess of nuclear β-catenin leads to proliferation,
whilst a deficit causes differentiation and cell-cycle arrest.
β-catenin at the cell membrane
At the cell membrane E-cadherin transmembrane proteins form dimers, the extra-cellular portions
of which bind to other such dimers protruding from the surface of nearby cells to form adherens
junctions at a rate which is Ca2+ dependent. On the inside of the cell membrane β-catenin and
p120 bind to the cytoplasmic tail of E-cadherin (Hinck et al., 1994; Lugli et al., 2007). Once there,
β-catenin forms a bridge to α-catenin, which in turn binds to the actin filaments of the cytoskeleton
as shown in Figure 1.4.
Whilst sequestered at the cell membrane, β-catenin is unavailable for transcriptional activation of
target genes in the nucleus (Harris & Peifer, 2005). Sta¨deli et al. (2006) showed that the same (or
at least overlapping) ‘Arm repeats’ within β-catenin are used to bind to the APC/Axin destruction
complex (leading to β-catenin destruction), to TCF (leading to gene transcription) and to E-cadherin
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Figure 1.4: The role of β-catenin at an adherens junction. Bridging between E-cadherin
and α-catenin, β-catenin is an essential component of the junction. In colorectal
crypts these tight junctions form along the side of each cell, sealing them together.
Reprinted from van Leeuwen et al. (2007), with permission from Elsevier.
(leading to adhesion). These are mutually exclusive binding partners, indicating that β-catenin must
choose between degradation, transcription or adhesion. The overlapping binding regions are shown
in Figure 1.5.
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Figure 1.5: Human β-catenin (encoded by CTNNB1 ) is 781aa. Binding sites for the three main
types of interaction are shown — adhesion, degradation and transcription. Binding of
α-catenin and E-cadherin can be prevented by phosphorylation of Tyr142 and Tyr654
respectively. Ser45 must be phosphorylated by CKIα for canonical degradation to
occur. Reprinted from van Leeuwen et al. (2007), with permission from Elsevier.
Kuphal & Behrens (2006) suggest that E-cadherin may modulate Wnt-dependent gene expression by
regulating the availability of β-catenin. It is thought that Wnt signalling regulates both transcription
and adhesion; a number of mechanisms have been suggested for these interactions. It is possible
that the different Wnt proteins have different intracellular effects, for example Wnt11 seems to
control adhesion of progenitor cells in crypt development (Ulrich et al., 2005). Additionally β-
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catenin is structurally altered only in the presence of Wnt (by an as yet unknown mechanism), so
that its affinities for different binding partners change, altering the balance between transcription and
adhesion (Harris & Peifer, 2005). This ‘balance’ has been modelled by van Leeuwen et al. (2007),
and is discussed in section 1.4.6.
It is becoming clear that cell adhesion, motility and transcriptional Wnt signalling are inter-related,
together forming a complex signalling pathway (Nelson & Nusse, 2004).
1.4.3 The Canonical or Wnt/β-catenin Pathway
Wnt proteins are released from cells into the extracellular space, and act as ligands which bind to
receptors on the cell membrane, thereby stimulating the Wnt pathway of another cell. There are large
numbers of extracellularWnt inhibitors, for example Frps, WIFs, Dickkopf (Dkk), Kremen andWise,
as reviewed by Logan & Nusse (2004). Recently Ching & Nusse (2006) showed that Wntless/Evi
is a transmembrane protein in Wnt-producing cells that facilitates Wnt secretion; knocking out
Wntless/Evi halts Wnt secretion.
Of the large number of Wnt signalling pathway interactions, the ‘canonical’ pathway is widely
accepted as the most important one for CRC (Ilyas, 2005) and a simplified version is presented in
Figure 1.6. The canonical pathway can be described as either ‘On’ (with Wnt stimulation), or ‘Off’
(in its absence).
In this section we discuss the regulation of the canonical pathway (how it is turned ‘On’ and ‘Off’)
and describe the roles of the various components.
Regulation
The destruction complex consists of the scaffold proteins4 Axin and adenomatous polyposis coli
(APC), the catalysts glycogen synthase kinase 3β (GSK3β) and casein kinase Iα (CKIα) which, along
with several other proteins, phosphorylate β-catenin (Na¨thke, 2004). Phosphorylated β-catenin is
ubiquitinated by β-transducin repeat containing protein (β-TrCP) and is subsequently destroyed by
proteosomes: this is the main mechanism for controlling cytoplasmic levels of β-catenin.
To a lesser extent, β-catenin is degraded by a retinoid-X-receptor mechanism (Xiao et al., 2003).
Another novel pathway responds to p53 stimulation and involves a protein called Siah, which (with
4Scaffold proteins bind to both the substrate (in this case β-catenin) and enzymes (such as GSK3β), providing the
correct binding and orientation for a reaction to take place.
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Figure 1.6: A simplified version of the canonical Wnt pathway. LEFT: In the absence of Wnt,
β-catenin levels are regulated by a complex containing APC, Axin and GSK3β. Tran-
scription of TCF target genes is suppressed by the presence of co-repressors. RIGHT:
Wnt binds to Frizzled receptors and activates LRP, which subsequently binds to the
Axin in the degradation complex. Dishevelled destabilises the degradation complex,
allowing β-catenin to accumulate in the nucleus where it complexes with TCF and
activates transcription.
APC) regulates β-catenin stability independently of GSK3β or Axin (Matsuzawa & Reed, 2001;
Liu et al., 2001): the role of APC in this pathway could be important when considering APC
mutations.
Receptors
The first Wnt receptor was identified by Bhanot et al. (1996) as Frizzled (Fz), a seven-pass trans-
membrane protein (Fz passes across the membrane seven times, in a ‘zig-zag’ fashion). The human
genome encodes 10 different Fz proteins. The canonical pathway also requires low-density-lipoprotein
receptor related proteins 5 or 6 (LRP5 or LRP6) (Tamai et al., 2000).
It is thought that Fz and LRP act as co-receptors for Wnt proteins. Wnt activates the pathway by
physically joining, or facilitating the physical joining of, the two receptors on the outside of the cell.
Reports suggest that physical interaction between Fz and LRP is sufficient to activate the canonical
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pathway in the absence of Wnt (Cong et al., 2004; Holmen et al., 2005). Some of the non-canonical
Wnt pathways (see section 1.4.4) do not require both Fz and LRP, for example the planar cell
polarity pathway seems to depend only on Fz receptors (Wehrli et al., 2000; Strutt, 2003).
Several Ser/Thr motifs in the cytoplasmic domain of LRP are phosphorylated: GSK3β has been
shown to phosphorylate part of each motif, followed by CKIγ which phosphorylates the rest of the
motif (Mao et al., 2001; Nusse, 2005; Cadigan & Liu, 2006); Wnt stimulation promotes phosphoryla-
tion at these sites within 10-15 minutes (Davidson et al., 2005; Zeng et al., 2005). Axin is inactivated
(perhaps simply by being attached to LRP, or perhaps by being labelled for degradation) and can
no longer form part of an active destruction complex, leading to activation of the Wnt pathway.
Interestingly, here GSK3β switches the Wnt pathway ‘On’, whereas further downstream, as part of
the destruction complex, GSK3β maintains the ‘Off’ state (see Figure 1.6).
LRP levels are regulated by the Dickkopf (Dkk) and Wise families of proteins (He et al., 2004).
Dkk proteins are thought to prevent the formation of Fz/LRP complexes, and therefore regulate
only the canonical Wnt pathway. Other extracellular factors (sFRP (Jones & Jomary, 2002), Wif
(Hsieh et al., 1999), Cerberus (Piccolo et al., 1999), Coco (Bell et al., 2003)) can inhibit all Wnt
pathways.
Upon Wnt stimulation, Dishevelled (Dvl1, 2 and 3 in mammals) is recruited from the cytoplasm to
Fz receptors and phosphorylated by PAR-1 and CKIε. The action of phosphorylated Dishevelled is
unclear, although it appears to bind to Axin (Kishida et al., 2001) and, in addition, forms a complex
with (or facilitates the formation of a complex between) Frat1 and GSK3β, thereby inhibiting
the activity of GSK3β (Reya & Clevers, 2005). Before the function of GSK3β in phosphorylating
LRP was known, it was observed that GSK3β was localised to the Fz receptor area when a Wnt
stimulus was present. Initially this was thought to be due to Dishevelled removing GSK3β from
the destruction complex and sequestering it to the membrane; more recent results suggest that this
behaviour could be explained by its role in LRP-phosphorylation (He et al., 2004).
It is now thought that the main role of Dishevelled is to recruit Axin to the cell membrane. He et al.
(2004) proposed three hypotheses to explain this. The first theory is that Fz recruits Dsh and LRP
recruits Axin, bringing them into close proximity for inhibition or degradation. The second explana-
tion is that Dishevelled and Axin interact in the cytoplasm, and vesicles transport them to Fz/LRP
together. The third scenario is that Dishevelled inhibits Axin at the Fz receptor, and LRP indepen-
dently inhibits Axin, both processes being necessary for downregulation of the canonical pathway.
However, Zeng et al. (2008) have recently demonstrated that Dishevelled recruits an Axin/GSK3β
complex to the membrane and hence to close proximity to LRP; GSK3β phosphorylates LRP, which
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in turn sequesters further Axin/GSK3β complexes, preventing the formation of destruction com-
plexes. Again we observe both a positive and a negative role for regulatory components of the Wnt
pathway, suggesting an ‘On’ and ‘Off’ state may be overly simplistic.
CKIα and GSK3β
In addition to phosphorylating LRP, GSK3β’s classical role is as the phosphorylatory subunit of the
destruction complex. The first action of GSK3β in the destruction complex is to bind to Axin, then
to stabilise the complex by phosphorylating both Axin and APC. GSK3β only has binding sites for
Axin and cannot physically associate with either APC or β-catenin (Sakanaka et al., 1998).
CKIα physically binds to β-catenin (Bustos et al., 2006) and phosphorylates β-catenin at Ser45,
GSK3β can then sequentially phosphorylate the remaining target residues of Thr41, Ser37 and Ser33.
β-catenin is then released back into the cytoplasm and ubiquitinated by β-TrCP and ubiquitin
enzymes, labelling it for destruction by the proteosomes. All four residues must be successfully
phosphorylated for ubiquitination to occur. For example, a mutation altering the amino acid at β-
catenin residue 45 could leave β-catenin immune to degradation via the destruction complex, whilst,
in all probability, maintaining its ability to promote transcription in the nucleus.
Upon stimulation of the canonical pathway, phosphorylated Dishevelled causes the formation of a
Frat1/GSK3β complex which inhibits the activity of GSK3β (Kishida et al., 2001). Surprisingly
Sierra et al. (2006) found GSK3β in the nucleus acting as a co-repressor with β-TrCP on the c-Myc
promoter region (one of the β-catenin target genes); until recently these proteins were thought to
act only in the cytoplasm. Inoki et al. (2006) found that Wnt controls cell growth by activating
the mTOR pathway, via inhibition of GSK3β; this could lead to regulation of translation through
mTOR and regulation of transcription through β-catenin.
Another suprising finding is the involvement of GSK3β with Cyclin D1. Diehl et al. (1998) show
that GSK3β phosphorylates Cyclin D1 at Thr286 significantly increasing its degradation rate. They
also showed that GSK3β localises to the nucleus during S phase and causes the nuclear export of
Cyclin D1. Salinas (2007) has recently reviewed the roles of GSK3β in the canonical Wnt pathway,
and its influence on the microtubule skeleton in the cell.
Axin
Axin was identified by Zeng et al. (1997) and named because it is an axis negative regulator of
embryonic axis formation, i.e. overexpression of Axin inhibits axis formation in embryos. It is still
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not understood how Wnt and Axin are involved in establishing a tissue axis.
Axin forms the central scaffold of the destruction complex, binding to β-catenin, APC, GSK3β, CKIα
and protein phosphatase 2A (PP2A). Axin has recently been recognised as the chief regulator of
the canonical pathway (Tolwinski & Wieschaus, 2004), being present in a much lower concentration
than other components of the destruction complex (Lee et al., 2003).
As discussed above, upon Wnt stimulation Axin is recruited to the cell membrane by Dishevelled and
inactivated by LRP and/or Dishevelled (Schwarz-Romond et al., 2007); this prevents the formation
of the destruction complex in the cytoplasm, as the active unit GSK3β must bind to both APC and
Axin in order to phosphorylate β-catenin (Sakanaka et al., 1998).
Jho et al. (2002), Leung et al. (2002) and Lustig et al. (2002) found that the Axin paralog5 Axin2
is a Wnt target gene, whereas Axin is expressed constitutively. Axin2 is believed to have the same
binding sites and behaviour as Axin (Behrens et al., 1998), and could therefore act as part of a
negative feedback loop, limiting the intensity of a Wnt signal response.
Adenomatous Polyposis Coli (APC)
APC is a large scaffold protein (APC 2843aa, APC2 2303aa) which forms a scaffold for the destruc-
tion complex. APC was identified as a part of the Wnt signalling pathway by Papkoff et al. (1996),
and plays a key role in regulating crypt fission (Wasan et al., 1998). It is commonly held that APC
binds to Axin and β-catenin, facilitating the formation of the destruction complex which phosphory-
lates β-catenin (Na¨thke, 2004; Senda et al., 2007). However Takacs et al. (2008) have observed that
APC can also reduce Axin levels (through an as yet unknown mechanism), this process upregulates
β-catenin levels, so APC is another component which could both positively and negatively regulate
the pathway.
The central region of APC is responsible for binding β-catenin through seven 20aa repeats (ac-
tivated by phosphorylation of APC by GSK3β) and three 15aa repeats (constitutively active)
(Rubinfeld et al., 1993). The third 20aa repeat is the tightest binding site for β-catenin (Liu et al.,
2006a), and indeed most APC mutants in CRC have lost this repeat. The central region also includes
three Ser-Ala-Met-Pro (SAMP) repeats which bind Axin. APC cannot form an active destruction
complex in the absence of Axin as the conformation of the complex is not correct (Bienz & Clevers,
2000). Phosphatase 2A (PP2A) is a regulatory subunit of the destruction complex which also binds
5A paralog is a duplicated gene in a genome, which may have occurred due to replication errors. Paralogs can often
mutate without changing the behaviour of the original gene and therefore usually exhibit similar but not identical
behaviour (such as the Cyclin D family discussed in section 1.3.1).
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Figure 1.7: The many functions of APC. Schematic representation of the APC protein, showing
regions that interact with other proteins, and the proposed functional significance of
these interactions. Reprinted from Fodde et al. (2003) by permission from Macmillan
Publishers Ltd: Nature Cell Biology 5:190-192, copyright (2003).
APC in this central region.
Penman et al. (2005) showed that full-length APC exists in two distinct soluble complexes, the fully
assembled destruction complex, which cannot interact with microtubules, and a smaller complex
(possibly APC monomers) which can. Before folding, proteins are linear chains of ordered amino
acids with an N-terminal and a C-terminal end. The N-terminal and central regions of APC are
highly conserved between species; there is more variation in the C-terminal end where new bind-
ing partners have been discovered (Na¨thke, 2005). The last 170 amino acids can bind to EB1, a
small microtubule-tip-binding protein. This enables APC to bind to the ‘plus’ (advancing) ends of
microtubules, tubes made up of proteins that provide a supportive cytoskeleton for the cell (and a
network for active transport) (Aoki & Taketo, 2007).
APC is often found at the leading edge of migrating cells, perhaps stabilising microtubules; this
recruitment also involves GSK3β (Mogensen et al., 2002; Etienne-Manneville et al., 2003) which
may be regulating the action of APC. Zumbrunn et al. (2001) suggest that binding of APC to
microtubules is decreased under GSK3β phosphorylation, in contrast to phosphorylation in the
destruction complex which facilitates β-catenin binding.
During mitosis, APC localises to kinetochores (protein structures which assemble on chromosomes
in order to separate the copies), which is consistent with its localisation to microtubule plus ends. In
addition, APC has been detected at centrosomes (the main microtubule organising centres, usually
found at the nuclear membrane) and mitotic spindles (fibres linking kinetochores to centrosomes
during cell division — the ‘ropes’ pulling chromosome pairs apart) (Kaplan et al., 2001). APC is
therefore very important in the M phase of the cell cycle and APC mutations are often associated
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with aneuploidy6 in human gut tissue, suggesting that healthy APC is necessary to ensure the
separation of the chromosomes works smoothly and chromosomes are not lost (a cell undergoing
anaphase can be seen in Figure 1.8).
Figure 1.8: The separation of the chromosomes during anaphase. Chromosomes are
stained blue, mitotic spindles are green, and the cell membrane is red.
The centrosomes (where APC has been detected) are where the mi-
totic spindles converge and kinetochores (again containing APC) are where
the spindles attach to the chromosomes (C.L. Rieder, public domain
http://www.wadsworth.org/bms/SCBlinks/web_mit2/HOME.HTM ).
APC-stimulated guanine nucleotide exchange factor (Asef) also binds to this busy central region of
APC (see Figure 1.7). Asef stimulates actin polymerisation through the action of Rho proteins and F-
actin. Actin fibres are the other main components of the cytoskeleton, binding to cadherins and again
providing an active transport network. Overexpression of APC can lead to long cellular protrusions,
as actin fibres over-polymerise and extend the cell membrane (Na¨thke, 2005). In addition KAP3
binds to APC in the same region as Asef. Since KAP3 is a linker protein for kinesins (motor proteins
that travel along the microtubules), this may facilitate active transport of APC around the cell.
To add further intricacy, Chen et al. (2006) showed that the microtubule-actin cross linking factor
(MACF1) is associated with the destruction complex in the absence of Wnt stimulation, and may
aid the movement of Axin to the LRP receptors upon Wnt stimulation.
We have seen that cytoskeletal regulation is involved in intestinal cell migration, proliferation and
differentiation; the role of APC in these mechanisms is yet another method by which the Wnt
pathway can influence the behaviour of the cell (Hanson & Miller, 2005).
There is certainly shuttling of APC between the nucleus and the cytoplasm. In one study, APC
was even reported to be concentrated in the nucleus (Zhang et al., 2001), although most colorectal
cell line studies find little APC in cell nuclei. As discussed earlier, APC contains nuclear export
6Aneuploidy is a condition in which the number of chromosomes is abnormal due to extra or missing chromosomes.
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sequences (NESs), suggesting the need for nuclear-import activity. Nuclear import appears to be
mediated by the Arm repeats, possibly in the same way that β-importin (which also contains Arm
repeats) binds to nucleoporins to access the nucleus (Bienz, 2002).
Xiong & Kotake (2006) showed that one method of APC nuclear-export was via the CRM1 receptor
on the nuclear membrane. APC possesses CRM1 nuclear export sequences, with at least two at the
N-terminal and three at the C-terminal end. There is also evidence that APC acts as a chaperone,
binding to β-catenin and carrying it in and out of the nucleus (Xiong & Kotake, 2006). APC-
independent β-catenin shuttling also occurs, but it is not known whether this is influenced by Wnt
signalling (Eleftheriou et al., 2001).
APC and C-terminal Binding Protein (CtBP) act as repressors on TCF activation sites, providing
another function for APC in the nucleus (Hamada & Bienz, 2004). Sierra et al. (2006) showed that
APC, β-TrCP and CtBP transiently bind to β-catenin/TCF promoted genes as repressors, before
stable binding of TLE-1 and HDAC1 corepressors. Nuclear CtBP binds to wild-type APC but
not some CRC mutants, suggesting a mechanism for increased Wnt target gene expression that is
independent of β-catenin levels. Thus, in healthy cells, APC directly represses activation of Wnt
target genes and facilitates the degradation of β-catenin; APC performs neither of these functions
in CRC cells.
Other components
As we saw in section 1.4.2, β-catenin interacts with TCF inside the nucleus. TCF is normally present
in the nucleus, bound to DNA promoter regions7 with other proteins which inhibit its activity (co-
repressors). When β-catenin accumulates in the nucleus (in response to a Wnt signal) it displaces
the co-repressors and acts as a co-factor with TCF and the transcription of TCF target-genes takes
place. When the proteins ICAT and Duplin are present target gene expression is inhibited, as these
proteins bind directly to β-catenin, in competition with TCF (Tago et al., 2000; Kobayashi et al.,
2002).
TCF is modified in many different ways: phosphorylation of TCF inhibits its binding to β-catenin,
as does acetylation; while sumoylation8 of TCF activates transcription (Kikuchi et al., 2006). How
these modifications are regulated, and whether they are Wnt-dependent, is not clear; however the
7TCF has a high affinity for the DNA sequence (A/T)(A/T)CAA(A/T)GG and is found on promoter regions with
this sequence.
8Addition of a Small Ubiquitin related Modifier protein, which usually extends the lifetime of a protein and may
also target it for active transport
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phosphorylation of TCF may occur in response to Wnt5a (Ca2+) signalling (Ishitani et al., 2003).
In this review of the canonical pathway we have focused only on the major components. RNAi
screens suggest that over 200 genes are involved in Wnt signalling (Fearon & Cadigan, 2005;
DasGupta et al., 2005) and have established it as one of the most intricate signalling pathways.
1.4.4 Non-Canonical Wnt Pathways
Wnt research has traditionally been concerned with the canonical pathway. However much research
is now directed at non-canonical pathways — those that do not involve β-catenin (for a review, see
Veeman et al. (2003)). Few, if any, pathways are completely independent; it is almost inevitable
that pathways share components, or are at least influenced by the downstream gene expression
associated with other pathways; this suggests that Wnt signalling will have far reaching effects on a
cell’s behaviour.
Wnts are believed to be involved in pathways as diverse as: calcium (Ca2+) signalling, via the
action of Dishevelled (Sheldahl et al., 2003); the Drosophila planar cell polarity (PCP) pathway,
also via the action of Dishevelled (Axelrod et al., 1998); tissue separation between the germ layers
in embryonic development, via the action of Frizzled (Winklbauer et al., 2001); the fibroblast growth
factor (FGF) Snail pathway leading to E-cadherin regulation, via the action of GSK3β (Katoh &
Katoh, in press); and cardiogenesis in the case of Wnt11 (Eisenberg & Eisenberg, 1999).
Wnt shares some of its components with the Hedgehog signalling pathway, namely CKIs and GSK3β
(Taipale & Beachy, 2001) , and with the Notch signalling pathway (Nakamura et al., 2007). Correct
operation of both pathways is thought to be essential for stem-cell maintenance, normal epithelial
renewal and patterning in the crypts (van den Brink & Hardwick, 2006). Akiyoshi et al. (2006)
provide evidence that activation of the Hedgehog pathway antagonises the Wnt pathway in colorectal
cancer cells, although the reason for this is not clear. There is growing evidence that non-canonical
Wnt pathways can play an important role in colorectal cancer initiation (Kikuchi & Yamamoto,
2008).
Non-canonical Wnt pathways can also antagonise the canonical pathway (Topol et al., 2003), and
different Wnt factors may activate different Wnt pathways. For example, Wnt11 represses the
canonical pathway (Wnt1, Wnt3, Wnt3a but not Wnt7 or Wnt7b) possibly due to competition for
Frizzled receptors (Maye et al., 2004). Similarly Wnt5a inhibits the canonical pathway, possibly by
causing the phosphorylation of TCF (Weidinger & Moon, 2003).
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1.4.5 Wnt Pathway in tumourigenesis
By linking mutations with stages in the progression of colorectal cancer, Fearon & Vogelstein (1990)
suggested a genetic model for colorectal cancer progression. As more was discovered about the
action of the various proteins it became clear that the first mutation in colorectal cancer was almost
always in one of the components of the canonical Wnt pathway (Powell et al., 1992; Morin et al.,
1997; Giles et al., 2003). There are many reviews devoted to the role of Wnt signalling in cancer
initiation, such as Behrens et al. (1996), Polakis (2000), Logan & Nusse (2004), Sancho et al. (2004),
Bafico et al. (2004) and Reya & Clevers (2005). Before discussing the most common mutations in
CRC we will first explain how mutations can occur.
Mutations
Each time the DNA in a cell is replicated (during the S phase of the cell cycle) mistakes can be
made. DNA repair mechanisms are in place so most of these mistakes are rectified before S phase
ends. For example, mismatch repair proteins look for nucleotides that do not conform to the usual
A-T/C-G pairings and then use the original DNA strand as a template to repair the damage. But
there are still mistakes, leading to a basic-level ‘background’ mutation rate. This mutation rate can
increase if a random mutation occurs in critical genes, for example a mismatch repair gene. However,
this is not believed to be the case in the majority of cancers (Tomlinson & Bodmer, 1999).
Mutations which occur during the lifespan of an organism and are not inherited are called somatic
mutations. Their effect is varied. Most DNA does not encode genes, and is referred to as ‘junk’
DNA; this is useful at the end of chromosomes and in other vulnerable regions of the DNA, because
mutations here have no effect. Even inside a coding region of DNA most mutations result in a
harmless change of a nucleotide. Because of the way codons translate to amino acids this may not
change the amino acid residue in question. On the other hand if a ‘stop’ codon is accidentally encoded
this leads to premature truncation of the protein, which generally means it loses some binding sites
and functions (a truncation mutation). Insertion and deletion mutations can also occur, usually in
large repeated regions of the DNA as the replication machinery can easily ‘slip’. The mutation rates
for cancerous colorectal crypt cells are usually the same as the rates in healthy cells (Wang et al.,
2002b; Araten et al., 2005), suggesting that DNA repair mechanisms are not usually mutated and
the high turnover of cells in a crypt is the main reason for the prevalence of cancers here.
Approximately 20% of colorectal cancer cases arise as a result of inherited gene mutations
(Lynch & de la Chapelle, 2003). One of the best defined cancer syndromes is familial adenoma-
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tous polyposis (FAP). FAP causes large numbers of benign adenomatous polyps (precursor lesions
of colorectal cancer) to arise in the colon and rectum (Bienz & Clevers, 2000), with some invariably
progressing into invasive and eventually metastatic cancers. APC is the gene which, when mutated,
causes FAP. Additionally most sporadic (non-hereditary) colorectal tumours arise due to APC muta-
tions (Nagase & Nakamura, 1993). Another familial syndrome is hereditary non-polyposis colorectal
cancer (HNPCC). HNPCC is associated with mutations in mismatch repair (MMR) genes and can
cause colorectal cancer at the age of 40–45, without the usual warning of polyps lining the gut.
Microsatellites are genomic regions where short DNA sequences or single nucleotides are repeated,
and replication machinery is prone to mistakes; MMR genes ensure that these repeated sections of
DNA are carefully lined up and repaired. Microsatellite instability occurs when these sections are
not controlled carefully and can elongate or contract during DNA replication, leading to mutations
in proteins such as β-catenin (Mirabelli-Primdahl et al., 1999).
We will use a model of Wnt signalling to study the impact of both APC and β-catenin mutations
in chapter 3; here we examine the effect of these mutations on the proteins’ interactions.
APC Mutations
FAP patients have a mutation in one of their two APC alleles (a ‘single-hit’ or APC+/−); the
progression to colorectal cancer coincides with a mutation in the other allele (a ‘double-hit’ or
APC−/−). Models of cancerous crypts already exist (Komarova & Wang, 2004) and are reviewed
in section 1.5.2. Since none of these models provides a direct explanation of why APC mutations
cause uncontrolled proliferation, we now examine the effect of a mutation in APC more closely.
Aberrant Wnt signalling is fundamental to the initiation of CRC — around 80% of human CRC
tumours possess an APC−/− mutation (Rowan et al., 2000). These mutations render APC un-
able to bind to the other components, preventing the formation of an active destruction complex
(Rowan et al., 2000; Albuquerque et al., 2002) and so β-catenin levels rise. Roughly a further 12%
of CRC tumours possess a single-hit β-catenin mutation (Samowitz et al., 1999; Ilyas, 2005): the
β-cateninmutation is in one copy of the gene only (β-catenin+/−). Half of the β-catenin produced is
immune to degradation by the destruction complex, and retains its ability to promote transcription
of target genes in the nucleus.
Knocking out Cyclin D1 in ‘Min mice’ (Multiple intestinal neoplasia — i.e. mice with FAP) results
in fewer tumours (Hulit et al., 2004), indicating that at least some of the tumourigenic effects of an
APC+/− mutation are dependent on the presence of Cyclin D1.
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There are mutation hotspots in APC, areas of the gene in which mutations are regularly observed.
As it is thought that mutations occur randomly throughout the genome, there must be selec-
tion for cells that harbour mutations in the hotspot region of APC (Nagase & Nakamura, 1993).
Lu¨chtenborg et al. (2004) detected mutations in the main APC hotspot, between codons 1286 –
1513, in 72% of CRC patients, truncating APC mutations accounting for just over half of these.
Albuquerque et al. (2002) have suggested that there is a minimum level of APC required for tu-
mour initiation and β-catenin levels should not be too high. Cells completely devoid of APC can
replicate but do not persist in a population indefinitely. Albuquerque et al. (2002) also observed
an interdependence between the two hits (as did Rowan et al. (2000)): if the first hit knocked out
APC completely then the second was usually a truncating mutation, and vice-versa. The truncation
mutations commonly lead to the loss of most of the ARM repeats, removing APC’s ability to bind to
β-catenin and some of the components of the destruction complex. Most truncating mutations have
lost the third 20aa repeat (see Figure 1.7), which is the tightest binding site for β-catenin (Liu et al.,
2006a). Thus the functional effect of APC mutations is to lose the ability to bind β-catenin; APC
cannot disappear altogether or the cell becomes inviable in the long-term.
Kawasaki et al. (2003) showed that truncated APC, through the Asef pathway, leads to increased
cell migration. It has also been shown that truncated APC can form a destruction complex that does
not bind Axin and therefore cannot phosphorylate β-catenin (Penman et al., 2005). Schneikert et al.
(2007) recently showed that truncated APC regulates the transcriptional activity of β-catenin in a
cell-cycle-dependent manner, which may lead to important feedback in future models of aberrant
Wnt signalling. Whilst Bortl´ık et al. (2006) suggest that not as many mutations are truncating as
was previously thought. It is possible to have double APC mutations, where neither is truncating,
yet still form an adenoma.
Further intricacies in the behaviour of APC are emerging continually. For example, Yang et al.
(2006) suggest that mutant APC acts to halt the ubiquitination or degradation of β-catenin, rather
than its phosphorylation. Expression of full length (wild-type) APC in APC−/− colon cancer cells
causes β-catenin to translocate from the nucleus and cytoplasm to the cell periphery, leading to
an increase in E-cadherin expression and hence causing stronger cell-cell adhesion. Putting these
formerly cancerous cells back into mice does not lead to tumour formation (Faux et al., 2004).
β-catenin Mutations
Up to 12% of small adenomas possess β-catenin mutations instead of APC−/− mutations
(Samowitz et al., 1999). These mutations are commonly in the residues that would ordinarily
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be phosphorylated by the destruction complex, and regulate β-catenin levels (e.g. Ser45). How-
ever only 2.4% of large adenomas, and 1.4% of invasive cancers, carry such β-catenin mutations
(Samowitz et al., 1999). These findings suggest that adenoma development is promoted more
strongly by APC mutations than by β-catenin mutations, even though mutations in both lead
to an accumulation of β-catenin in the nucleus. This suggests that APC must have additional
tumourigenic effects, perhaps through its action on the cytoskeleton, in cell adhesion and/or in
mitosis.
Other Mutations
Of tumours exhibiting mismatch repair mutations, almost a quarter have mutations in Axin2 rather
than APC or β-catenin. However, this still accounts for only a small percentage of all tumours
(Liu et al., 2000) and few colorectal cancers are initiated by a mutation in a gene other than APC
or β-catenin. Hadjihannas et al. (2006) showed that overexpression of Axin2 could lead to chromo-
somal instability. Axin2 could be upregulated as it is a target of Wnt signalling (Jho et al., 2002;
Leung et al., 2002) or because it has a mutation which prevents its interaction with LRP.
Mutations that are associated with the progression of CRC are shown in Figure 1.9. All of the
mutations discussed above are acquired during the earliest stages of colorectal cancer initiation, and
further mutations must occur for progression to clinical cancer. Figure 1.9 shows the progression
for the two forms of genetic instability that commonly contribute to CRC: chromosomal instability
(CIN) and microsatellite instability (MIN). The familial syndrome FAP and APC mutations tend to
cause CIN tumours, whilst HNPCC and β-catenin mutations usually lead to MIN tumours. CIN is
characterised by losing chromosomes — reasons that APC mutations could cause this are discussed
above. Approximately 15% of sporadic tumours are characterised by MIN and approximately 85%
by CIN (Sancho et al., 2004).
Despite the likelihood of a double-hit in APC being much lower than the likelihood of a single-hit
in β-catenin we observe far more colorectal cancers with the double-hit in APC. For this reason a
cell harbouring the APC mutations must be more likely to form a cancer than a cell with a single
β-catenin mutation. We will see in our model of chapter 3 that this discrepancy cannot be due to
the effect of the mutation on β-catenin levels, but APC mutations must be selected due to some of
their other effects on the cell, such as their role in regulation of division as discussed in section 1.4.3.
The direction of our work is to link models of subcellular processes, such as Wnt signalling and the
cell cycle, with models of an entire crypt and, in the future, tissues made up of many crypts. We
will now discuss some of the existing models of Wnt signalling.
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Figure 1.9: Correlation between CRC progression and the accumulation of genetic alterations
according to Fearon & Vogelstein (1990). The genetic alterations frequently found
in CIN tumors are depicted in black; genetic alterations more common in MIN
tumours are depicted in red. Reprinted, with permission, from the Annual Re-
view of Cell and Developmental Biology, Volume 20, c©2004 by Annual Reviews
www.annualreviews.org.
1.4.6 Mathematical Models of Wnt Signalling
The Wnt pathway has been the subject of little mathematical modelling to date, due in part to
its complexity and a lack of quantitative experimental data. However in 2003 Lee et al. published
a detailed ODE-based model which replicated experimental results extremely well and significantly
changed the way in which the Wnt pathway was thought to operate (Tolwinski & Wieschaus, 2004).
The model accounts for Wnt’s control over the formation of the destruction complex and the subse-
quent phosphorylation of β-catenin. One of its major strengths was the first-hand gathering of the
necessary kinetic data. Lee’s coworkers have expanded on the mathematical methods they originally
presented in a further paper (Kruger & Heinrich, 2004). An asymptotic analysis of this model is
presented in Chapter 2.
Van Leeuwen et al. (2007) developed a different model to investigate the interaction between β-
catenin’s roles in adhesion and transcription. There are two main hypotheses — either β-catenin’s
fate is determined by competition for binding partners or it undergoes a conformational change
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which favours transcription. The authors formulated an ODE-based model distinguishing between
the different pools of β-catenin, before presenting model simulations. The results of most of the in
silico experiments suggest that the second hypothesis (β-catenin undergoes a conformational change)
better explains some of the experimental data.
Cho et al. (2006) studied the effect of APC mutations on the Wnt pathway by extending the
Lee et al. (2003) model to incorporate APC mutants with varying affinity for β-catenin. They
suggest that APC mutants are selected because of the effect they have on β-catenin levels. They
assume more β-catenin degradation sites are lost in more highly truncated APC mutants, and sim-
ulate the level of β-catenin that therefore accumulates. Cho et al. incorporated the Axin2 feedback
loop into their model, a feature not included in the Lee et al. (2003) model. Weaknesses of the
Cho et al. (2006) model include the fact that the probability of the different mutants occurring was
not taken into account, neither was the fact that cancers carry two different mutated copies of the
APC gene and therefore two different mutant ‘versions’ of the APC protein. As we saw in section
1.4.5, it is highly unlikely that both mutations are functionally the same. Cho et al. conclude that
mutations are not selected on the basis of maximal levels of β-catenin expression, but rather on an
‘optimal’ level of β-catenin expression. We explain in more detail how the Cho et al. (2006) model
differs from the Lee et al. (2003) model in Chapter 2.
Recently two articles have used the Cho et al. model to investigate further features of the Wnt/β-
catenin pathway. In Kim et al. (2007), Cho et al.’s Wnt signalling model is coupled to a model of the
ERK pathway and crosstalk between the two pathways was found to create a positive feedback loop,
increasing the levels of β-catenin/TCF transcription factor. Wawra et al. (2007) have introduced a
time-delay into Cho et al.’s model to account for the time taken to transcribe and translate Axin2;
they also introduced a new source of negative feedback, assuming that one of the β-catenin/TCF
target genes has a product which inhibits the action of Dishevelled. The authors showed that
oscillations in β-catenin levels may arise as a result of the time delays involved.
1.5 Cancerous Crypt Dynamics
Gene mutations can cause the rate of cell proliferation in the crypts to exceed the rate of cell loss,
leading to a net increase in cell number. We term a crypt exhibiting this behaviour (as a result
of mutations rather than healthy growth) a cancerous crypt. We may also term an individual cell
cancerous if the usual controls on, for example, cell proliferation and apoptosis are not functioning
normally. Aberrant dysplastic crypts can be seen in Figure 1.10.
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1.5.1 Observed Dynamics
The location in the crypt where the first mutation occurred is not usually known; cases can be
made for “bottom-up” (a mutation occurs in the stem cell pool and propagates up the crypt) and
“top-down” (a mutation occurs in a cell above the base and spreads down the crypt) expansion of
the cancerous cells (Shih et al., 2001; Leedham & Wright, 2007). The series of panels presented in
Figure 1.10 show mutant cells which are proliferating throughout the crypt, whereas their healthy
counterparts stop proliferating at some distance up the crypt.
Figure 1.10: Cells stained for β-catenin expression in small adenomas (A and B) and healthy
colonic epithelium (C). In A and B, dysplasia can be seen, with crypts beginning
to branch and buckle. β-catenin is highly expressed and distributed throughout
the top of the crypts, where it is found in the nucleus, cytoplasm and membrane.
Staining for β-catenin is less intense in the normal-appearing epithelium at the
bottom of the crypts of both A and B, where it is confined to the membranes.
The staining pattern at the bottom of these adenomatous crypts is similar to that
observed in normal colonic epithelium (C). Reproduced from Shih et al. (2001).
Copyright (2001) National Academy of Sciences, U.S.A.
Once homeostasis in the crypt is lost, cells increase in number and an adenoma, or small polyp,
forms. Crypts undergo increased crypt fission (splitting to form a new crypt), perhaps as a result
of mechanical ‘buckling’ of the tissue. Further mutations (see Figure 1.9), can cause the forma-
tion of adenomas (polyps protruding into the gut) and, later, carcinomas — aggressive tumours
(Bienz & Clevers, 2000).
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1.5.2 Mathematical Models of Colorectal Crypts and Cancer
Mathematical modelling of tumour growth and mutations began in the 1970s, and was instru-
mental in explaining how cancer initiates (Knudson, 1971) and tumours grow (Greenspan, 1972).
Van Leeuwen et al. (2006) provide a comprehensive review of models for normal colorectal physiol-
ogy and CRC; here we briefly describe the theoretical approaches that have been undertaken. Models
for colon crypts have tended to be stochastic population-based, compartmental or individual-cell-
based spatial (2D grid and 2D lattice-free) models.
Stochastic population-based Models
Stochastic models are a natural approach for modelling mutations, which, by their very nature,
are random occurrences. Komarova and colleagues have produced a series of models to ex-
amine the population genetics of colorectal cells (Komarova & Wang, 2004; Nowak et al., 2004;
Komarova & Cheng, 2006). They have found, perhaps counter-intuitively, that it is unlikely that
a double-hit occurs in a stem cell. It is more likely that a single hit occurs in a stem cell and the
second hit in a transit cell (as there are many more transit cells than stem cells dividing, though
they usually leave the crypt before they acquire two mutations). In Komarova & Cheng (2006) the
authors suggest that, given a similar probability of mutation in stem and normal cells, the likelihood
of acquiring two mutations falls as the number of stem cells at the base of a crypt increases (since
each lineage undergoes fewer divisions in a certain period of time).
The way in which a stem cell divides remains unknown. In 1997 Loeﬄer et al. developed a com-
partmental stochastic model to study the different alternatives: assuming that stem cells can divide
symmetrically and give rise to two stem cells; asymmetrically to one stem cell and one differenti-
ated cell; or symmetrically to two differentiated cells. When the phenotype of the daughter cell is
assumed to be stochastic, the model generates results which appear to replicate the observed slow
spread of monoclonality (eventually all cells are clones/descendants of one original cell) throughout
the crypt .
Spatially-averaged lumped-parameter Models
These models consist of compartments representing all of the cells throughout a spatial location, with
separate variables for different cell populations (with usually one ‘lumped-parameter’ representing
the different behaviours of separate cell types), with ODEs describing the exchange of cells from one
‘compartment’ to another. Tomlinson & Bodmer (1995) used this approach to create simple models
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for populations of stem cells, semi-differentiated cells, fully differentiated cells and dying cells. They
predict that the failure of programmed cell death in stem cells is sufficient for tumourigenesis but,
more interestingly, they also predict that tumourigenesis can occur when semi-differentiated cells
acquire a mutation which prevents programmed cell death. D’Onofrio & Tomlinson (2007) extended
Tomlinson & Bodmer’s (1995) model to account for fluctuations in parameter values (such as death
rates). This “generally makes exponential growth of a tumour more likely” and can lead to a long
plateau of cell numbers, mimicking equilibrium, before exponential growth starts. If this happens
in vivo then it may be impossible to predict when an apparently stable tumour may start to grow
rapidly. Johnston et al. (2007) have also extended Tomlinson & Bodmer’s (1995) model to allow for
asynchronous cell-division.
Boman et al. (2001) developed a compartmental approach to study how the numbers of stem cells,
transit cells (in each of the stages of the cell cycle), differentiated cells, terminally differentiated cells
and apoptotic cells within a crypt change over time. They showed that the size of a crypt population
is very sensitive to stem cell proliferation rates, and suggest that this validates the hypothesis that
stem cell mutations are responsible for CRC initiation. Michor et al. (2005) used a similar approach
to study genetic instability by modelling the number of cells harbouring different types of mutation,
with a CIN mutation making further mutations more likely. They suggest that the presence of one
or two CIN (Chromosomal Instability) genes in the entire genome may mean that colorectal cancer
is likely to be instigated and accelerated by CIN mutations.
Cell-based Models
Individual cell-based models treat each biological cell as a discrete entity. Rather than taking a
continuum approach for one or more variables, discrete values for the variables are contained within
separate cells. Cell-based models for avascular tumours are reviewed in Drasdo & Hoehme (2003);
here we briefly describe some models of this type which have been applied to colorectal crypts.
3D crypts have been represented by 2D grid models, with the crypt ‘rolled out’ along its axis and
periodic boundary conditions imposed. Loeﬄer et al. (1986, 1988) proposed the first such models,
consisting of ‘squares’ representing individual cells, with cells around the circumference of the crypt
on the ‘x-axis’ and cells along the crypt axis on the ‘y-axis’. Stem cells are held at the bottom of the
crypt and cells are removed from the top to represent sloughing. These models were used to explain
how cell proliferation may vary within a crypt to produce the turnover and distribution observed.
The main weakness of models of this type is due to the fixed grid structure. For example, in order to
insert a new daughter cell an entire column of cells must be moved upwards, breaking the contacts
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between a large number of cells, when studying the effects of variable cell-cell adhesion or the lateral
spread of populations around the crypt such models become unrealistic.
To overcome these problems Meineke et al. (2001) developed a 2D lattice-free model, in which cells
are attached by spring-like attractive and repulsive forces. This model appears to reproduce the
experimentally-observed cell migration in a crypt. We will describe this model in depth in Chapters
5 & 6. When the cells in a lattice-based model are moving up the crypt with a fixed velocity at
each ‘y’ coordinate then such lattice-free models will exhibit the same behaviour as a lattice-based
model.
Drasdo & Loeﬄer (2001) formulated a lattice free cell-based model for crypt fission. They start with
a 1D ‘line’ of cells arranged into a 2D vertical section of a crypt. Forces on each cell include elastic
bonds between neighbouring cells, a bending force when the curvature of the cells is too great, a
force acting on the bottom of the crypt (ensuring it spreads upwards rather than downwards) and
a force keeping the crypt orifice in position. In healthy cells a crypt keeps its shape whilst cells
migrate up the crypt. If mutant cells with faster cell cycles and reduced Young’s modulus values
are introduced then crypt buckling and fission is observed.
Studies of marked cells have shown that epidermal cells proliferate in ‘mosaic’ clusters of between
20–350 cells in size (Asplund et al., 2001). This suggests small pockets of stem cells maintain a
larger group of surrounding cells. One of these epidermal ‘clusters’ is analogous to an epithelial
colorectal crypt — the difference being the 3D surface on which the cells lie. Savill & Sherratt
(2003) modelled these clusters on epidermal monolayers by adapting an earlier Cellular Potts Model
(CPM) (see Graner & Glazier, 1992; Glazier & Graner, 1993) to investigate the effects of cell-cell
signalling on differentiation. A CPM moves cells in order to minimise their ‘surface energies’, which
can be any functions of interest, such as surface area for a given volume. Savill & Sherratt results
suggest that stem cells must adhere to one another much more strongly than they do to differentiated
cells and that regulation of differentiation is the main mechanism for controlling cluster size. If
Savill & Sherratt’s conclusions are correct, it is also probable that regulation of differentiation plays
a key role in controlling crypt length.
1.6 Thesis Structure
We perform a multiple-timescale analysis of a detailed model for the Wnt signalling pathway pro-
posed by Lee et al. (2003) in chapter 2, and show how it may be reduced to a single ODE describing
the evolution of β-catenin levels. In chapter 3 we investigate how Wnt signalling might affect the
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cell cycle in the colorectal crypts, by using a variation of the simple Wnt-signalling model derived in
chapter 2. We use the simple model to predict the effect mutations in the Wnt pathway have on the
level of β-catenin. We then use this level of β-catenin as an input into an existing cell-cycle model,
as β-catenin is a transcription factor for Cyclin D.
Recent experiments by Sansom et al. (2007) suggest that c-Myc is the most important downstream
target of aberrant Wnt signalling; a double APC and c-Myc knockout reverts the effects of an APC
knockout. The model of chapter 3 cannot reproduce this effect, as c-Myc is not represented in the
model. In chapter 4 we develop a more detailed model to describe the influence of β-catenin on the
cell cycle, by modelling the amount of c-Myc and Cyclin D:CDK4 complex available to trigger the
cell cycle.
We introduce the Cancer, Heart And Soft Tissue Environment program (CHASTE) and describe
its development and implementation for simulations of the Meineke et al. (2001) crypt-dynamics
model in chapter 5. We extend the model due to Meineke et al. (2001), present experimental data
on crypt-dynamics, and compare them to the results of CHASTE simulations in chapter 6. The
thesis ends in chapter 7 with a discussion of our findings and suggestions for future work.
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Chapter2
Wnt Signalling Models
2.1 Introduction
I
n section 1.4.5 we saw that studying the Wnt pathway is fundamental to understanding the
initiation of colorectal cancer. The model developed by Lee et al. in (2003) is probably the most
detailed theoretical description of Wnt signalling to date, with experimental data matching its
predictions very closely. In this chapter we analyse Lee et al.’s model, characterising its behaviour
on different timescales. This analysis reveals that changes in the ‘output’ of the Wnt pathway (i.e.
changes in β-catenin levels) occur over a long timescale and we exploit this result to reduce the full
model to a simpler system.
The remainder of this chapter is organised as follows: in section 2.2 we present Lee et al.’s model,
recasting it in terms of nondimensional variables, before presenting typical numerical results. Guided
by these simulations we proceed in section 2.3 with an asymptotic analysis of the governing equa-
tions, thereby identifying which components of the pathway are active on different timescales and
using these results to reduce the model to a simpler one, which retains the key features of the full
model. In section 2.4 we perform a similar analysis on the Cho et al.’s extension to the original
model (Cho et al., 2006). The chapter concludes in section 2.5 with a summary of our findings and
suggestions for future work.
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2.2 The Lee et al. (2003) Wnt Signalling Model
2.2.1 Model Formulation
In this section we introduce the deterministic model of the Wnt signalling pathway that was de-
veloped by Lee et al. (2003) and formulated as a system of coupled ODEs. Known interactions
between the ‘core components’ of the canonical pathway are included, the core components being:
Wnt, Dishevelled, GSK3β, APC, Axin, β-catenin and TCF. As we saw in section 1.4.3, many more
proteins influence the Wnt pathway, but the above components are all essential to its operation. A
schematic diagram of the biochemical interactions is shown in Figure 2.1.
β-catenin is known to localise to both the cell membrane and the nucleus (Harris & Peifer, 2005;
Sta¨deli et al., 2006). A system of partial differential equations (PDEs) could be used to model
these spatial effects. However the mechanisms by which these processes are regulated are, as yet,
poorly understood and remain very difficult to model. Lee et al. consider the cytoplasmic levels
of the pathway components, as the destruction complex is thought to act only in the cytoplasm.
The proteins are assumed to be well-mixed, so a system of time-dependent ordinary differential
equations (ODEs) for the concentrations of each component is formulated. Lee et al.’s model consists
of 15 ODEs, one for each protein or protein complex shown in Figure 2.1. Some reactions are
known to proceed more rapidly than others, so they make rapid equilibrium approximations to the
relevant ODEs, in order to simplify the governing equations. This process is discussed in detail in a
supplementary paper (Kruger & Heinrich, 2004).
In formulating their model Lee et al. assume that Axin and β-catenin are the only components
that degrade. In more detail, β-catenin is assumed to be labelled for degradation in the ‘destruc-
tion core cycle’ and also is degraded in its free un-complexed form, albeit at a lower rate than
destruction-complex-dependent degradation (the ‘non-Axin dependent proteolysis’ in Figure 2.1).
Axin is assumed to degrade only from its free state. The levels of Dishevelled, GSK3β, APC and
TCF have not been observed to vary as the Wnt pathway operates, so these components are assumed
to be conserved (produced and degraded at the same rates), and are labelled Dsh0, GSK0, APC0
and TCF 0 respectively. Using these approximations Lee et al. reduced their system of 15 ODEs to
7 ODEs which we present below. For clarity we use the same notation as Lee et al. to represent the
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Figure 2.1: The reaction steps of the Wnt pathway, protein complexes being denoted by the
names of their components. Phosphorylated components are marked by an asterisk.
Single-headed solid arrows characterise reactions taking place only in the indicated
direction. Double-headed arrows denote binding equilibria. The broken arrows in-
dicate that the components mediate, but do not participate in, the reaction scheme.
The irreversible reactions 2, 4, 5, 9-11, and 13 are unimolecular, and reactions 6, 7,
8, 16, and 17 are reversible binding steps. (Reproduced from Lee et al., 2003, Figure
1.)
model variables, namely the concentrations of
X2(t) Dishevelled,
X3(t) Destruction Complex (active),
X4(t) Destruction Complex (inactive),
X9(t) Destruction Complex (binding β-catenin),
X10(t) β-Catenin (phosphorylated),
X11(t) β-Catenin (free),
X12(t) Axin (free),
in units of nM.
In terms of X2, X3, X4, X9, X10, X11 and X12, with reaction constants numbered according to
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Figure 2.1, the governing equations can be written as:
dX2
dt
= k1W (Dsh
0 −X2)− k2X2, (2.1)
dX4
dt
= −(k3X2 + k4 + k−6)X4 + k5X3 + k6GSK
0 K17X12APC
0
K7(K17 +X11)
, (2.2)
dX9
dt
= K8k9
X3
K8
X11
K8
− k10X9, (2.3)
dX10
dt
= k10X9 − k11X10, (2.4)
dX12
dt
=
(
k3X2X4 −
k6GSK
0APC0K17X12
K7(K17 +X11)
+ k−6X4 + v14 − k15X12 +
dX11
dt
(
APC0K17X12
K7(K17 +X11)2
))/(
1 +
APC0K17
K7(K17 +X11)
)
, (2.5)
whilst
dX3
dt
=
(
k4X4 − k5X3 − k9X11
X3
K8
+ k10X9 −
1
1 + K8X3
(
v12 −
(
k9
X3
K8
+ k13
)
X11
))
/(
1 +
(
1−
1
1 + K8X3
)
X11
K8
)
, (2.6)
dX11
dt
=
(
k4X4 − k5X3 − k9X11
X3
K8
+ k10X9 −
(
K8
X11
+ 1
)(
v12 −
(
k9
X3
K8
+ k13
)
X11
))
/(
X3
K8
−
(
K8
X11
+ 1
)(
1 +
X3
K8
+
TCF 0K16
(K16 +X11)2
+
APC0K17
(K17 +X11)2
))
, (2.7)
whereW is a nondimensional forcing term representing the extracellular Wnt concentration. The k’s
are mass-action rate constants, K’s are Michaelis-Menten dissociation constants, and Dsh0, GSK0,
APC0 and TCF 0 are the total amounts of these proteins, as discussed earlier. We remark that the
ODE for X10 decouples from the rest of the system: X10 appears only in equation (2.4). This is
to be expected since X10 is the concentration of free phosphorylated β-catenin which has left the
destruction complex and is awaiting ubiquitination and subsequent degradation by proteosomes; as
such it can no longer participate in transcription in the nucleus (see Figure 2.1). For this reason we
omit X10 henceforward.
Lee et al. performed in-vitro experiments on Xenopus egg extracts to estimate the system parame-
ters. They then ran a numerical sensitivity analysis of these equations to find the most important
parameters, i.e. the parameters in which small fluctuations caused the largest change in the β-
catenin concentration. Lee et al. then went back and performed further in-vitro experiments to
measure these parameters as directly and accurately as possible, and the resulting parameter values
are stated in Table 2.2.
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The resulting model is then used to predict the result of altering core component concentrations,
with the model’s cytoplasmic levels of β-catenin matching experiment very convincingly in a number
of different scenarios (Lee et al., 2003, Figure 2). The model suggested that the Wnt pathway is
most sensitive to fluctuations in Axin0, the total amount of Axin in a cell. Since Axin was found to
be present at a much lower concentration than APC (0.02nM as opposed to 100nM), it was proposed
that Axin is the limiting factor (and therefore acts as the major regulatory protein) for destruction
complex formation. Previously it had been thought that APC must be the most important protein
in destruction complex control, as it is the most commonly mutated protein in colorectal cancers
(Rowan et al., 2000).
While Lee et al. did not perform a systematic non-dimensionalisation of their model, they were able
to estimate some of the system parameters. In the following sections we perform a systematic non-
dimensionalisation and asymptotic analysis of Lee et al.’s model, in order to gain more insight into
the processes controlling the levels of β-catenin within a cell.
2.2.2 Model Nondimensionalisation
Equations (2.1)–(2.7) appeared in Lee et al. (2003), what follows is our extended analysis of their
model. We rescale the model equations by first introducing the nondimensional variables and scalings
shown in Table 2.1. Time is scaled such that t′ = k5t denotes the nondimensional time, chosen
because 1/k5 is a characteristic timescale for inactivation of the destruction complex, and so we
expect it to be an important timescale for the activation of the Wnt pathway.
β-catenin is scaled with K16, the dissociation constant for β-catenin/TCF. Free Axin and all the
complexes containing Axin are scaled with v14/k5 which, we will see later, is the concentration of
Axin produced if the system is at equilibrium. Introducing these scalings into equations (2.1)–(2.7)
gives the following system of nondimensional equations:
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Table 2.1: Model variables and nondimensionalisation scalings
Nondimensional Scaling Lee Model Protein/Complex Lee Model (Figure 2.1)
Variable Variable Description Protein/Complex Notation
V (t′) =
1
Dsh0
X2 Dishevelled Dsha
Ba(t′) =
1
K16
X11 β-catenin (active) β-catenin
Da(t′) =
k5
v14
X3 Destruction Complex (active) (APC*/Axin*/GSK3)
Db(t
′) =
k5
v14
X9 Destruction Complex (bound) (β-catenin*/APC*/Axin*/GSK3)
Di(t′) =
k5
v14
X4 Destruction Complex (inactive) (APC/Axin/GSK3)
X(t′) =
k5
v14
X12 Axin Axin
dV
dt′
= k′1W (1− V )− k
′
2V, (2.8)
dDi
dt′
= −(k′3V + k
′
4 + k
′
−6)Di +Da + k
′
6
X
1 +K ′16Ba
, (2.9)
dDb
dt′
= k′9BaDa − k
′
10Db, (2.10)
dX
dt′
=
(
(k′3V + k
′
−6)Di −
(
k′6
(1 +K ′16Ba)
+ k′15
)
X + 1
+K ′16
dBa
dt′
K ′7X
(1 +K ′16Ba)
2
)/(
1 +
K ′7
(1 +K ′16Ba)
)
, (2.11)
dDa
dt′
=
((
k′4Di −Da − (k
′
9DaBa − k
′
10Db)
)
−
DaK
′
8 (v
′
12 − k
′
14DaBa − k
′
13Ba)
1 + k′6v
′
14Da +
TCF 0′
(1+Ba)2
+ APC
0′
(1+K′16Ba)
2
)
/1 +K ′8Ba − v′14K ′8BaDa
1 + k′6v
′
14Da +
TCF 0′
(1+Ba)2
+ APC
0′
(1+K′16Ba)
2
 , (2.12)
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dBa
dt′
=
(
v′14
K ′8
(
k′4Di −Da − (k
′
9DaBa − k
′
10Db)
)
−
1 +K ′8Ba
K ′8Ba
(
v′12 − k
′
14DaBa − k
′
13Ba
))/
(
v′14Da −
1 +K ′8Ba
K ′8Ba
(
1 + k′6v
′
14Da +
TCF 0
′
(1 +Ba)2
+
APC0
′
(1 +K ′16Ba)
2
))
, (2.13)
where nondimensional parameters are denoted by primes and their values are shown in Table 2.2.
2.2.3 Numerical Simulations
The results from a numerical simulation of equations (2.8)-(2.13), where a Wnt stimulus is applied
between t′ = 0 and t′ = 300, are presented in Figure 2.2, and were generated using the numerical stiff
ODE solver routine ode15s in MatLab. The protein levels are initially given by their steady states in
the absence of a Wnt stimulus (W = 0), and parameter values are as per Lee et al. (2003) (see Table
2.2). The sudden introduction of Wnt leads to a disabling of the destruction complex and a gradual
build up of β-catenin. Once the Wnt stimulus is removed the destruction complex is reactivated and
β-catenin is degraded until it returns to its original levels. We note that following Wnt stimulation
different species respond over markedly different timescales. For example, V (Dishevelled) rapidly
evolves to a new steady state value at t′ = 2, whilst Ba (β-catenin) is still increasing at t
′ = 200.
By t′ = 300 all variables have attained their steady state values. We then remove the Wnt stimulus
and the proteins return to their original Wnt-free steady states, again over different timescales.
In the next section we explain how to exploit the fact that the non-dimensional parameters in
(2.8)-(2.13) vary markedly in magnitude (see Table 2.2) in order to simplify the model equations.
2.3 Model Analysis
2.3.1 Reduction of Model
The numerical simulation in Figure 2.2 and the variation in the dimensionless parameter estimates
in Table 2.2 suggest that processes occur over at least two distinct timescales (it will turn out that
there are in fact three distinct timescales). To understand such a complicated model it is therefore
necessary to examine the behaviour of each equation on each of the different timescales.
We introduce ε = k′13 = k13/k5 = 1.93× 10
−3; this small parameter measures the ratio of the rate
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Table 2.2: Parameter values from Lee et al. (2003) and our nondimensionalised parameters
Dimensional Estimate Units Non-dimensional Estimate Scaled Non-dimensional Estimate
Parameter (dimensional) Parameter (dimensionless) Parameter (dimensionless)
Dsh0 100.0 nM — — — —
APC0 100.0 nM APC0
′
= APC0/K17 8.3×10−2 ÂPC
0
= ε−1APC0
′
43.01
TCF 0 15.0 nM TCF 0
′
= TCF 0/K16 0.50 T̂CF
0
= ε0TCF 0
′
0.50
GSK0 50.0 nM — — — —
K7 50.0 nM K ′7 = APC
0/K7 2.00 Kˆ7 = ε0K ′7 2.00
K8 120.0 nM K ′8 = K16/K8 0.25 Kˆ8 = ε
0K ′8 0.25
K16 30.0 nM K ′16 = K16/K17 2.5×10
−2 Kˆ16 = ε−1K ′16 12.95
K17 1200.0 nM — — — —
K18 10.0 nM K ′18 = K16/K18 3.0 Kˆ18 = ε
0K ′18 3.0
k1 0.182 min−1 k′1 = k1/k5 1.37 kˆ1 = ε
0k′1 1.37
k2 1.82 ×10−2 min−1 k′2 = k2/k5 0.137 kˆ2 = ε
0k′2 0.137
k3 5.0 ×10−2 nM−1 min−1 k′3 = Dsh
0k3/k5 0.376 kˆ3 = ε0k′3 0.376
k4 0.267 min−1 k′4 = k4/k5 2.01 kˆ4 = ε
0k′4 2.01
k5 0.133 min−1 — — — —
k6 9.09 ×10−2 nM−1 min−1 k′6 =
k6GSK
0APC0
(K7k5)
68.4 kˆ6 = ε0k′6 68.4
k−6 0.909 min−1 k′−6 = k−6/k5 6.84 kˆ−6 = ε
0k′
−6 6.84
k9 206.0 min−1 k′9 = k9K16/(k5K8) 387.25 kˆ9 = ε
1k′9 0.75
k10 206.0 min−1 k′10 = k10/k5 1549 kˆ10 = ε
1k′10 2.99
k11 0.417 min−1 k′11 = k11/k5 3.14 kˆ11 = ε
0k′11 3.14
k13 2.57 ×10−4 min−1 k′13 = k13/k5 1.93 ×10
−3 ε = k′13 —
k15 0.167 min−1 k′15 = k15/k5 1.26 kˆ15 = ε
0k′15 1.26
k18 1.0 ×10−6 min−1 k′18 = k18K16/v14 0.365 kˆ18 = ε
0k′18 0.365
k18b 1.0 ×10
−4 nM min−1 k′18b = k18bK16/(v14K18) 3.65 kˆ18b = ε
0k′18b 3.65
v12 0.423 nM min−1 v′12 = v12/(k5K16) 0.106 vˆ12 = ε
−1v′12 54.92
v14 8.22 ×10−5 nM min−1 v′14 = v14/(k5K8) 5.15 ×10
−6 vˆ14 = ε−2v′14 1.38
k′14 = k9v
′
14/k5 7.98 ×10
−3 kˆ14 = ε−1k′14 4.13
W 1.00 Wˆ = ε0W 1.00
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Figure 2.2: A simulation of equations (2.8)-(2.13), for which the Wnt stimulus, W , is increased
suddenly from 0 to 1 at time t = 0 and removed at t = 300. Top: solid line X (Axin),
dashed line Ba (β-catenin). Middle: solid line Db (destruction complex bound to
β-catenin), dashed line V (active Dishevelled). Bottom: solid line Di (inactive de-
struction complex), dashed line Da (active destruction complex). Parameter values
can be found in Table 2.2 and the initial conditions are the steady states for W = 0,
shown in Table 2.3.
at which β-catenin is degraded in a destruction-complex-independent manner compared to the rate
at which the destruction complex becomes inactive. Guided by Lee et al.’s parameter estimates (see
Table 2.2) we rescale the dimensionless parameters by multiplying them by appropriate powers of ε
so that they are O(1) (this process cannot of course be done unambiguously). In our system each
equation must be capable of displaying a steady state on each timescale, so that for example kˆ6 is
chosen to be equal to ε0k′6 instead of ε
1k′6 to avoid an unrealistic exponential increase in Db on an
O(ε) timescale (equation (2.16)). The transformed parameters are denoted by ˆ’s and their values
are shown in the last column of Table 2.2. Under these parameter transformations, and dropping
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Table 2.3: Initial conditions for the Lee et al. (2003) Wnt Signalling Model, for dimensional
and nondimensional variables. These values are referred to in Lee et al. (2003) as the
‘reference state’, the steady state in the absence of Wnt signalling (W = 0).
Nondimensional Dimensional
Variable Value Variable Value Units
V (0) = 0 X2(0) = 0 nM
Ba(0) = 0.836 X11(0) = 25.1 nM
Da(0) = 15.7 X3(0) = 4.83 ×10
−3 nM
Db(0) = 3.27 X9(0) = 2.02 ×10
−3 nM
Di(0) = 7.80 X4(0) = 4.83 ×10
−3 nM
X(0) = 0.796 X12(0) = 4.93 ×10
−3 nM
the primes on time t for ease of notation, equations (2.8)-(2.13) become
dV
dt
= kˆ1W (1− V )− kˆ2V, (2.14)
dDi
dt
= −(kˆ3V + kˆ4 + kˆ−6)Di +Da + kˆ6
X
1 + εKˆ16Ba
, (2.15)
dDb
dt
= ε−1
(
kˆ9BaDa − kˆ10Db
)
, (2.16)
dX
dt
=
(
(kˆ3V + kˆ−6)Di −
(
kˆ6
(1 + εKˆ16Ba)
+ kˆ15
)
X + 1
+εKˆ16
dBa
dt
Kˆ7X
(1 + εKˆ16Ba)2
)/(
1 +
Kˆ7
(1 + εKˆ16Ba)
)
, (2.17)
dDa
dt
=
((
kˆ4Di −Da −
1
ε
(kˆ9DaBa − kˆ10Db)
)
−
εDaK
′
8
(
vˆ12 − kˆ14DaBa −Ba
)
1 + ε2kˆ6vˆ14Da +
T̂CF
0
(1+Ba)2
+ εÂPC
0
(1+εKˆ16Ba)2
)
/1 + Kˆ8Ba − ε2vˆ14Kˆ8BaDa
1 + ε2kˆ6vˆ14Da +
T̂CF
0
(1+Ba)2
+ εÂPC
0
(1+εKˆ16Ba)2
 , (2.18)
dBa
dt
=
(
ε2
vˆ14
Kˆ8
(
kˆ4Di −Da −
1
ε
(kˆ9DaBa − kˆ10Db)
)
−
ε
(
1 + Kˆ8Ba
Kˆ8Ba
)(
vˆ12 − kˆ14DaBa −Ba
))/
(
ε2vˆ14Da −
1 + Kˆ8Ba
Kˆ8Ba
1 + ε2kˆ6vˆ14Da + T̂CF 0
(1 +Ba)2
+
εÂPC
0
(1 + εKˆ16Ba)2
). (2.19)
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Rearranged in powers of ε equations (2.18) and (2.19) read
dDa
dt
= −
1
ε
(
kˆ9DaBa − kˆ10Db
)
1 + Kˆ8Ba
+
kˆ4Di −Da
1 + Kˆ8Ba
+O(ε).
dBa
dt
= ε
((
vˆ12 − kˆ14DaBa −Ba
)
−
vˆ14Ba
1 + Kˆ8Ba
(
kˆ9DaBa − kˆ10Db
)
+O(ε)
)
/(
1 +
T̂CF
0
(1 +Ba)2
+O(ε)
)
.
Since T̂CF
0
= 0.5 and numerical simulations show that Ba > 1, then
T̂CF
0
/(1 + Ba)
2 < 18 , so we treat the grouping T̂CF
0
/(1 + Ba)
2 as small relative to 1, as a result
the ODE for Ba can be simplified to read
dBa
dt
= ε
((
vˆ12 − kˆ14DaBa −Ba
)
−
vˆ14Ba
1 + Kˆ8Ba
(
kˆ9DaBa − kˆ10Db
))
+O(ε2). (2.20)
Using (2.20) in equation (2.17) we find that
dX
dt
=
((
kˆ3V + kˆ−6
)
Di −
(
kˆ6 + kˆ15
)
X + 1
)/(
1 + Kˆ7
)
+O(ε). (2.21)
Combining the above results and retaining only the dominant terms, our reduced model can be
written
dV
dt
= kˆ1Wˆ (1− V )− kˆ2V, (2.22)
dDi
dt
= −(kˆ3V + kˆ4 + kˆ−6)Di +Da + kˆ6X, (2.23)
ε
dDb
dt
= kˆ9DaBa − kˆ10Db, (2.24)
dX
dt
=
(
kˆ3V + kˆ−6
)
Di −
(
kˆ6 + kˆ15
)
X + 1
1 + Kˆ7
, (2.25)
dDa
dt
= −
1
ε
(
kˆ9DaBa − kˆ10Db
)
1 + Kˆ8Ba
+
kˆ4Di −Da
1 + Kˆ8Ba
, (2.26)
1
ε
dBa
dt
=
(
vˆ12 − kˆ14DaBa −Ba
)
−
vˆ14Ba
1 + Kˆ8Ba
(
kˆ9DaBa − kˆ10Db
)
. (2.27)
We note that equation (2.22) decouples from equations (2.23) – (2.27) and admits an analytic solution
for V when there is a constant Wnt stimulus (i.e. W (t) = Wˆ , constant):
V (t) =
kˆ1Wˆ
kˆ1Wˆ + kˆ2
+
−kˆ1Wˆ + (kˆ1Wˆ + kˆ2)V0
kˆ1Wˆ + kˆ2
e−(kˆ1Wˆ+kˆ2)t −→
kˆ1Wˆ
kˆ1Wˆ + kˆ2
as t→∞.
We note further that equations (2.24) and (2.27) have time derivatives that are multiplied by orders of
ε. This suggests that the system has processes that operate on different timescales, and is consistent
with the sudden spikes and slow accumulations shown in Figure 2.2. In the next section we analyse
the system’s behaviour on the different O(εn) timescales.
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2.3.2 Asymptotic Analysis
As revealed in the previous section, equations (2.22)–(2.27) operate on distinct timescales. This
situation can arise if some reactions happen faster than others, but also when proteins at a low
concentration (such as the destruction complex) act on populations of proteins at high concentrations
(such as β-catenin). We might therefore expect the destruction complex concentration to change
more quickly than the β-catenin concentration.
We will analyse the model on short, medium and long timescales, for which t = O(ε), t = O(1)
and t = O(ε−1) respectively, since these timescales appear on the left-hand side of equations (2.22)–
(2.27) and appear to give a complete description of the ε → 0 asymptotic behaviour. In each case
asymptotic expansions in powers of ε are sought for the dependent variables and used to simplify
the governing equations. We will explain why the different timescales appear and their physical
significance. We consider the situation shown in Figure 2.2 where a Wnt stimulus is applied to a
system which is initially at its Wnt-free equilibrium.
Short Timescale, t = O(ε): the phosphorylation of bound β-catenin
Noting from equation (2.24) that the shortest timescale is O(ε), we now introduce a new timescale,
τ = t/ε. We seek solutions on this short timescale that are regular power series expansions in ε so
that, for example
V (τ) = V0(τ) + εV1(τ) + ε
2V2(τ) + . . .
Firstly we substitute this approximation into equation (2.22) to give
d
dτ
(V0 + εV1) = ε (k
′
1W (1− V0 − εV1)− k
′
2V0 − εk
′
2V1) .
Equating coefficients of O(εn) gives
dV0
dτ
= 0, (2.28)
dV1
dτ
= k′1W (1 − V0)− k
′
2V0.
We find that in all cases the leading order behaviour captures the necessary system dynamics and
the correction terms are not important. So V0(τ) = constant = V (0) and we have a linear ODE for
V1(τ). Applying the same procedure to equations (2.23)-(2.27) it is straightforward to show that
dDi0
dτ
= 0,
dX0
dτ
= 0,
dBa0
dτ
= 0, (2.29)
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Figure 2.3: Components of the signalling pathway which vary over short (top), medium (middle)
and long (bottom) timescales. The active components on each timescale are high-
lighted with bold borders. The schematic is based upon Figure 2.1, which is adapted
from Lee et al. (2003, Figure 1).
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dDa0
dτ
= −
(
kˆ9Ba0Da0 − kˆ10Db0
)/(
1 + Kˆ8Ba0
)
, (2.30)
dDb0
dτ
=
(
kˆ9Ba0Da0 − kˆ10Db0
)
. (2.31)
Noting that Ba0 = Ba(0), equations (2.30) and (2.31) can be solved analytically to give the solutions
Da0(τ) = αe
−γτ + µ, (2.32)
Db0(τ) = ζe
−γτ + η, (2.33)
where
γ =
φ
1 + Kˆ8Ba(0)
,
α =
kˆ9Da(0)Ba(0)− kˆ10Db(0)
φ
,
µ = kˆ10
Da(0) + Kˆ8Da(0)Ba(0) +Db(0)
φ
,
ζ =
kˆ10Kˆ8Ba(0)Db(0)− kˆ9Da(0)Ba(0) + kˆ10Db(0)− kˆ9Kˆ8Da(0)Ba(0)
2
φ
,
η =
kˆ9
kˆ10
Ba(0)µ,
φ = kˆ10 + kˆ9Ba(0) + kˆ10Kˆ8Ba(0).
Using equations (2.32) and (2.33) it is straightforward to see that, on this short timescale, Da and
Db evolve from their initial conditions Da(0) and Db(0) to limiting values (D
∞
a0 and D
∞
b0 ) which are
related as follows
D∞b0 =
kˆ9
kˆ10
Ba(0)D
∞
a0,
Once Da and Db reach this equilibrium no other processes occur until t = O(1), with the other
variables retaining their initial conditions.
From equations (2.32) and (2.33) we deduce that the values of the steady state solutions depend upon
the initial concentrations and the concentration of active β-catenin, Ba (which does not vary on this
timescale, equation (2.29)). The dominant biological processes occurring on this fast timescale there-
fore involve only Da and Db, the active destruction complex and the β-catenin bound destruction
complex, i.e. the components of the ‘destruction core cycle’ (see top schematic of Figure 2.3). The
characteristic reaction for this timescale is therefore the phosphorylation (and release) of β-catenin
by the destruction complex; the ‘destruction core cycle’ settles into an equilibrium faster than any
of the other components change (either the amount of destruction complex in the core cycle or
the amount of free β-catenin). Note that the ‘destruction core cycle’ consists of three components.
Lee et al.’s (2003) model employs only two equations for these three components since they assumed
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that β-catenin/APC*/Axin*/GSK3β quickly reached an equilibrium value. We will see in the next
section that this approximation could also have been made for Db without affecting the behaviour
of the system.
In Figures 2.4 and 2.5 we introduce a Wnt stimulus into a pathway which has achieved equilibrium
(defined in Table 2.3). Although reactions between Da and Db are happening on the short timescale,
they are, as yet, independent of Wnt signalling since Dishevelled, V , does not become activated on
this timescale (equation (2.28)), and no downstream components of the pathway can be affected.
Da and Db therefore remain at their initial values. We compare the predicted steady concentrations
with the numerical solutions of the full equations (2.8)-(2.13) in Figures 2.4 and 2.5. The short time
approximations of the variables are in good agreement with the numerical solutions of the full model
until time t = O(1); in the next section we consider the system’s behaviour for t = O(1).
Intermediate Timescale, t = O(1): formation of active destruction complex
As before, we seek model solutions that are regular power series expansions in ε, so that, for example
V (t) = V0(t) + εV1(t) + ε
2V2(t) + . . .
Substituting into equation (2.22) and equating coefficients of ε gives
dV0
dt
= kˆ1Wˆ (1 − V0)− kˆ2V0,
while substitution into equations (2.23)–(2.27) produces the following set of leading order equations
for times t = O(1)
Ba0(t) = Ba(0), (2.34)
Db0(t) =
kˆ9
kˆ10
Ba(0)Da0(t), (2.35)
dV0
dt
= kˆ1Wˆ (1− V0)− kˆ2V0, (2.36)
dDa0
dt
=
(
kˆ4Di0 −Da0
)/(
1 + Kˆ8Ba(0) +
kˆ9
kˆ10
Ba(0)
)
, (2.37)
dDi0
dt
= −(kˆ3V0 + kˆ4 + kˆ−6)Di0 +Da0 + kˆ6X0, (2.38)
dX0
dt
=
(
kˆ3V0Di0 + kˆ−6Di0 + 1− kˆ15X0 − kˆ6X0
)/(
1 + Kˆ7
)
. (2.39)
At this intermediate timescale Ba is still constant; we have an algebraic expression for Db and four
ODEs to describe the intermediate timescale behaviour. Plots of numerical solutions to equations
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Figure 2.4: Model reaction to a sudden Wnt stimulus (W = 1) introduced into a system in equilibrium (W = 0) at t = 0. Numerical
simulations of equations (2.8)–(2.13) are shown with a solid line. Short, medium and long time approximations are shown with
dash-dotted, dotted and dashed lines respectively. There is good agreement between the approximations and numerical solutions
at all timescales. Parameter values can be found in Table 2.2.
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(2.36)–(2.39) are shown in Figures 2.4 and 2.5 and the results compare well with solutions of the
original equations (2.8)–(2.13).
The Wnt stimulus now affects most of the pathway; we highlight components that change on this
intermediate timescale in yellow in the middle schematic of Figure 2.3. Dishevelled is activated and
lowers the level of the destruction complex (in all its forms) causing Axin levels to build up. We
examine these processes in more detail below. The interpretation of equations (2.34)–(2.39) is aided
by studying Figures 2.3, 2.4 and 2.5.
As we see in Figure 2.1, the initial response to a Wnt signal is in equation (2.36) as Dishevelled
is the only protein directly activated by Wnt, and so V0 (active Dishevelled protein) rises. The
increase in V0 leads to more of the inactive destruction complex (Di =APC/Axin/GSK3β) being
decomposed into GSK3β and APC/Axin (the first term in equation (2.38)). At the same time the
level of free Axin (X) rises (the first term in equation (2.39)) as Lee et al. made a rapid equilibrium
approximation for the APC/Axin ⇋ APC + Axin reaction. The level of Axin (X) reaches a
maximum at approximately the same time as V reaches its new steady state.
Equation (2.37) shows how the level of active destruction complex (Da) falls as a result of the
reduction of inactive complex (Di), since the system moves to restore the equilibrium
(APC/Axin/GSK3β) ⇄ (APC*/Axin*/GSK3β).
Equation (2.35) is a rapid equilibrium approximation for the reactions happening on the fast
timescale (equations (2.32) and (2.33)) and states that the level of bound destruction complex
Db (phosphorylating β-catenin) will be proportional to the level of active destruction complex (Da)
and active β-catenin (Ba, which is not changing over this timescale). Therefore the level of bound
destruction complex, Db, falls in line with the level of active destruction complex, Da. Note that the
‘destruction core cycle’ reactions occur on the faster timescale (t = O(ε)), but their ‘equilibrium’
values are now changing because Da is evolving over this intermediate timescale, as a result of the
fall in Di.
As the level of Axin quickly reaches a maximum, the decomposition ofDi is slowed (equation (2.38)).
The free pool of Axin then more slowly reduces (kˆ15 ≈ 1 as opposed to kˆ6 ≈ 70) to its steady state
value, whilst the inactive and active destruction complex levels also gradually re-adjust to this new
level of Axin.
The characteristic reaction for this intermediate timescale is therefore the inactivation of the de-
struction complex. Note that Ba, the level of free β-catenin, still does not change (equation (2.34)):
it evolves over an even longer timescale, which we examine in the next section.
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Long Timescale, t = O(ε−1): degradation of free β-catenin
Equation (2.27) suggests that the longest timescale of interest is of O(ε−1). In terms of this long
timescale T = εt equations (2.22)–(2.27) become
ε
dV
dT
= kˆ1Wˆ (1− V )− kˆ2V, (2.40)
ε
dDi
dT
= −(kˆ3V + kˆ4 + kˆ−6)Di +Da + kˆ6
X
1 +K ′16Ba
, (2.41)
ε2
dDb
dT
= kˆ9DaBa − kˆ10Db, (2.42)
ε
dX
dT
=
(
(kˆ3V + kˆ−6)Di −
(
kˆ6
(1 + εKˆ16Ba)
+ kˆ15
)
X + 1
)
/(
1 +
Kˆ7
(1 + εKˆ16Ba)
)
, (2.43)
ε2
dDa
dT
=
ε(kˆ4Di −Da)− (kˆ9DaBa − kˆ10Db)
1 + Kˆ8Ba
, (2.44)
dBa
dT
=
(
vˆ12 − kˆ14DaBa −Ba
)
−
vˆ14Ba
1 + Kˆ8Ba
(
kˆ9DaBa − kˆ10Db
)
. (2.45)
Assuming that the dependent variables can be expanded as regular power series in ε and equating
to zero coefficients of O(1) in equation (2.40) we obtain the following relationship between V0(T )
and the applied Wnt stimulus W (T ):
V0(T ) =
kˆ1W (T )
kˆ1W (T ) + kˆ2
.
Similarly equations (2.41)–(2.45) give rise to the following equations for the leading-order behaviour
on the long timescale:
X0(T ) =
1
kˆ15
, (2.46)
V0(T ) =
kˆ1W (T )
kˆ1W (T ) + kˆ2
, (2.47)
Di0(T ) =
X0(T )kˆ6(
kˆ3V0(T ) + kˆ−6
)(
1 +K ′16Ba0(T )
) , (2.48)
Da0(T ) = kˆ4Di0(T ), (2.49)
Db0(T ) =
kˆ9
kˆ10
Da0(T )Ba0(T ), (2.50)
d
dT
Ba0(T ) = vˆ12 −
(
kˆ14Da0(T ) + 1
)
Ba0(T ). (2.51)
The components of the pathway that vary on the long timescale are highlighted on the bottom
schematic of Figure 2.3; over this long timescale only the level of free β-catenin (Ba) and the level of
53
2.3 Model Analysis Chapter 2: Wnt Signalling Models
destruction-complex-bound β-catenin (Db) vary. In Figures 2.4 and 2.5 we show the good agreement
between the approximate solutions and those of the full system (equations (2.8)–(2.13)).
On the intermediate timescale we saw how destruction complex levels were controlled by the intro-
duction of Wnt via the action of Dishevelled. On this timescale the level of destruction complex
controls the rate at which β-catenin is degraded, whereas Axin (X) has already evolved to a steady
level that is independent of Wnt signalling (equation (2.46)). In contrast, the final levels of Di and
Da depend, via V , on the Wnt signal strength (see equations (2.48) and (2.49)).
Under an increased Wnt stimulus the level of active β-catenin, Ba, increases because there is less
active destruction complex, Da, present for its degradation (equation (2.51)). Interestingly, and
perhaps counter-intuitively, the level of bound destruction complex, Db, increases over this timescale,
having decreased over the intermediate timescale (see Figure 2.5). In fact, on medium and long
timescales Db is proportional to both the levels of active destruction complex and active β-catenin
(equation (2.35) and (2.50)). For this reason, the level of Db falls as active destruction complex is
removed, and rises again as β-catenin builds up. At the steady state, however, there is a slightly
lower level of Db when the Wnt signal is active, and much lower levels of Da and Di. It is simply
the case that any destruction complex that is present will quickly bind to free β-catenin, as there is
so much more β-catenin around.
The characteristic reaction for this long timescale is therefore the degradation of free β-catenin,
which is surprising given that the characteristic reaction for the fastest timescale was the action of
the ‘destruction core cycle’. The reason this can happen is the disparity between the low levels of
destruction complex and the high levels of β-catenin.
If we are interested in the levels of β-catenin produced in response to a Wnt signal then there is
no need to consider the action of Wnt on shorter timescales; the long timescale analysis captures
the dynamics of β-catenin. In the above sections we analysed the behaviour of the Lee et al. (2003)
model on different timescales and have found that only one ODE is relevant at such long times. In
the next section we consider how this single ODE performs as a simpler Wnt signalling model.
2.3.3 Reduction to a simpler Wnt signalling model
We have seen that the accumulation of active β-catenin occurs only on a long timescale. Since active
β-catenin is the major downstream target of the Wnt pathway, it is often the only protein of interest
to those studying the pathway. In this regard equation (2.51), a single ODE, describes the output of
the whole signalling pathway. In terms of the original dimensional variables, equation (2.51) takes
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the form
dX11
dt
= v12 −
(
a
(
W (t)
) K17
K17 +X11(t)
+ k13
)
X11(t), (2.52)
where
a
(
W (t)
)
=
k4k6k9v14GSK
0APC0
k5k15K7K8
(
k1W (t) + k2
(k1k3Dsh0 + k1k−6)W (t) + k2k−6
)
. (2.53)
with all parameter values as given by Lee et al. (2003) (see Table 2.2). Note that a
(
W (t)
)
has a
Michaelis-Menten type dependence on W (t), meaning that β-catenin levels can increase in response
to a Wnt stimulus, but the rate reaches a saturation point with increasing Wnt.
A comparison of the steady states of equation (2.52) with those of the original system of equations
(2.1)–(2.7) is shown in Figure 2.6. The reduced model behaves in exactly the same way as the full
model at low Wnt stimulus and follows the same trend as Wnt levels are increased. The equilibrium
β-catenin concentration at a high Wnt stimulus associated with the reduced model is slightly lower
than that for the full model (137 nM versus 153 nM for the parameter values chosen). This error
propagates from the approximations made for Ba in the reduction of equation (2.19) to equation
(2.27).
We have used the estimates for parameter values in equation (2.52) for the model which we subse-
quently formulate from first principles in chapter 3, compare with equation (3.7).
We subject the reduced model to the same transient Wnt stimulus as Lee et al. (2003, Figure 6) to
determine how well the transient (rather than steady-state) behaviour has been preserved. A Wnt
stimulus of W = e−t/20 is applied to a system resting at a steady state with W (0) = 0; the results
are presented in Figure 2.7. We observe the same behaviour, although for the reduced model the
response peaks slightly earlier than for the full model as we have essentially said that most reactions
reach equilibrium instantly.
Often of interest to biologists and modellers is the level of β-catenin/TCF complex, as the main
downstream transcription factor of the Wnt pathway (Pinto & Clevers, 2005). Lee et al. denote
[β-catenin/TCF] as X14 and use the equilibrium condition
X14 =
TCF 0X11
K16 +X11
. (2.54)
Equation (2.54) could be used together with equation (2.52) to form a simpler model than Lee et al.
(2003) for predicting the transcription factor response to Wnt signalling.
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Figure 2.6: Diagram showing how the steady state level of β-catenin changes as the magnitude
of the applied Wnt stimulus varies. Solid line for the full model (equations (2.1) –
(2.7)) and dashed line for the reduced model (equation (2.52)), the lines are indis-
tinguishable. Parameter values: see Table 2.2.
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Figure 2.7: Diagram showing the response of β-catenin to a transient Wnt stimulus (W = e−t/20,
introduced into a system at steady state with W = 0 at t = 0). Solid line for the
full model (equations (2.1) – (2.7)) and dashed line for the reduced model (equation
(2.52)). Parameter values: as per Table 2.2.
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2.4 Axin Feedback
2.4.1 Formulation of the Model
Cho et al. (2006) adapted the Lee et al. (2003) model to include Axin2 production in response to β-
catenin/TCF transcription (Jho et al., 2002). The model, including this feedback, has been used in
further articles (Wawra et al., 2007; Kim et al., 2007). In this section we examine how such feedback
changes our analysis of the pathway.
An additional production term of the form k18(X11 + X14) was introduced into equation (2.5) by
Cho et al. (2006) to model Axin2 produced in response to β-catenin/TCF. We will conduct our
previous analysis on the model as proposed by Cho et al. (2006). Including this feedback into
equation (2.5) gives
dX12
dt
=
(
k3X2X4 −
k6GSK
0APC0K17X12
K7(K17 +X11)
+ k−6X4 + v14 − k15X12 +
k18
(
X11 +
TCF 0X11
K16 +X11
)
+
dX11
dt
(
APC0K17X12
K7(K17 +X11)2
))
/(
1 +
APC0K17
K7(K17 +X11)
)
. (2.55)
2.4.2 Reduction of Model
When the new feedback term is included, the non-dimensional form of equation (2.17) becomes
dX
dt
=
(
(kˆ3V + kˆ−6)Di −
(
kˆ6
(1 + εKˆ16Ba)
+ kˆ15
)
X + 1 + kˆ18
1 + T̂CF 0
1 +Ba
Ba
+εKˆ16
dBa
dt
Kˆ7X
(1 + εKˆ16Ba)2
)/(
1 +
Kˆ7
(1 + εKˆ16Ba)
)
. (2.56)
To compare the overall behaviour of the system when equation (2.56) is substituted in place of
equation (2.17) we solve the equations numerically, and the results are shown in Figure 2.8. Notice
that we use the same initial conditions as in Figure 2.2, and a small adjustment to the system’s
new steady state for −100 < t′ < 0 can be seen. When comparing Figures 2.2 and 2.8 the main
differences are that more Axin (X) is produced, more destruction complex becomes activated (Da)
and the level of β-catenin is therefore reduced. This effect is small in the absence of a Wnt stimulation
(−100 < t′ < 0), but marked when Wnt is introduced (0 < t′ < 300), roughly halving the steady
state level of Ba.
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Figure 2.8: A simulation of the Wnt model with Axin feedback (equations (2.14), (2.15), (2.16),
(2.18), (2.19) and equation (2.56)) for comparison with the original Wnt model (see
Figure 2.2). The Wnt level, W , is increased from 0 to 1 at time t = 0 and removed
at t = 300. Top: solid line X (Axin), dashed line Ba (β-catenin). Middle: solid line
Db (destruction complex bound to β-catenin), dashed line V (active Dishevelled).
Bottom: solid line Di (inactive destruction complex), dashed line Da (active destruc-
tion complex). Parameter values can be found in Table 2.2 and the initial conditions
are the steady states for the Lee model without feedback and W = 0, as shown in
Table 2.3.
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Using equation (2.56) in place of equation (2.17) and repeating the analysis of section 2.3.1, we
obtain, in place of equation (2.25), the following ODE for Axin:
dX
dt
=
(
kˆ3V + kˆ−6
)
Di −
(
kˆ6 + kˆ15
)
X + 1 + kˆ18
(
1 + T̂CF
0
1+Ba
)
Ba
1 + Kˆ7
. (2.57)
2.4.3 Multiple Timescale Analysis
The behaviour of the system on a short timescale (t = O(ε)) does not change, since there are no
terms which are O(ε−1) in equation (2.57) and so the concentration of Axin does not change. We
compare the predicted steady concentrations at a short-time with the numerical solutions of the full
equations (2.14),(2.15), (2.16), (2.18), (2.19) and equation (2.56) in Figures 2.9 and 2.10. As before,
we find an excellent fit until times increase to t = O(1).
On an intermediate timescale (t = O(1)) we can repeat the analysis of section 2.3.2, the result being
the replacement of equation (2.39) with
dX0
dt
=
(
kˆ3V0Di0 + kˆ−6Di0 + 1− kˆ15X0 − kˆ6X0 + kˆ18
(
1 +
T̂CF
0
1 +Ba0
)
Ba0
)/(
1 + Kˆ7
)
. (2.58)
In equation (2.58) there is a kˆ18 term providing feedback from β-catenin levels. However because
β-catenin remains constant on the intermediate timescale the feedback loop has not yet activated,
consequently the behaviour of Cho et al.’s feedback model is similar to that of the original Lee et al.
model (comparing the dotted lines of Figures 2.4 & 2.5 with those of Figures 2.9 & 2.10).
On the long timescale (t = O(ε−1)) we have already seen that the behaviour of the system changes
substantially (see Figure 2.8). The only change to the long time behaviour of equations (2.46)–(2.51)
is the replacement of equation (2.46), X0(T ) = 1/kˆ15, with
X0(T ) =
1
kˆ15
1 + kˆ18(1 + T̂CF 0
1 +Ba0(T )
)
Ba0(T )
 . (2.59)
We can see that the value of the long-time approximation of X has increased, and is now dependent
on Ba0 and hence time, T , rather than being constant. While this change propagates through
equations (2.48)–(2.51), the functional form of equation (2.51) remains unchanged with a single
ODE for Ba0(T ):
d
dT
Ba0(T ) = vˆ12 −
(
kˆ14Da0(T ) + 1
)
Ba0(T ).
In Lee et al.’s model only Db and Ba varied on the long timescale (Figure 2.3), whilst in Cho et al.
(2006)’s model, all variables, apart from V , vary over this timescale (as they all depend on Ba).
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Figure 2.9: Cho model reaction to a sudden Wnt stimulus (W = 1) introduced into a system in equilibrium (W = 0) at t = 0. Numerical
simulations of the full equations (2.14), (2.15), (2.16), (2.18), (2.19) and equation (2.56) are shown with a solid line. Short, medium
and long time approximations are shown with dash-dotted, dotted and dashed lines respectively. There is good agreement between
the approximations and numerical solutions at all timescales. Parameter values can be found in Table 2.2.
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Figure 2.10: Cho model reaction to a sudden Wnt stimulus (W = 1) introduced into a system in equilibrium (W = 0) at t = 0. Numerical
simulations of the full equations (2.14), (2.15), (2.16), (2.18), (2.19) and equation (2.56) are shown with a solid line. Short, medium
and long time approximations are shown with dash-dotted, dotted and dashed lines respectively. There is good agreement between
the approximations and numerical solutions at all timescales. Parameter values can be found in Table 2.2.
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Biologically the increase in Ba (as a result of the processes discussed in section 2.3.2) leads to
increased expression of Axin (X) over a long timescale. As Axin is the limiting factor in destruction
complex formation this allows the levels of destruction complex, in all forms, to increase (as the
levels of each separate pool of destruction complex equilibrate on an intermediate timescale). This
increase in destruction complex levels leads in turn to more phosphorylation of β-catenin which
reduces its level below that seen when the feedback loop is absent.
The feedback model’s equivalent of equation (2.51) for the evolution of β-catenin on a long timescale
reads
d
dT
Ba0(T ) = vˆ12 −
(
kˆ14kˆ4kˆ6
kˆ15
(
kˆ3V0(T ) + kˆ−6
)(
1 +K ′16Ba0(T )
) ×
(
1 + kˆ18
(
1 +
T̂CF
0
1 +Ba0(T )
)
Ba0(T )
)
+ 1
)
Ba0(T ), (2.60)
with the dimensional form given by
dX11
dt
= v12 −
(
a
(
W (t)
) k18K17
K17 +X11(t)
(
1 +
TCF 0
K16 +X11(t)
)
X11(t) + k13
)
X11(t), (2.61)
where a
(
W (t)
)
is given by equation (2.53), as before.
Equation (2.61) represents a simpler model of Wnt signalling with Axin feedback than that presented
by Cho et al. (2006) in that we have substantially reduced the number of equations in the system.
Note that equation (2.61) is the equivalent of equation (2.52), but including Axin feedback. Equa-
tion (2.61) could be combined with equation (2.54) to produce a simple model for β-catenin/TCF
transcription in response to Wnt signalling.
2.4.4 Variation of Feedback Model
We remark that a production term of the form k18(X11 + X14) (equation (2.55)) seems a strange
choice, since there is no evidence that free β-catenin ([β-catenin] = X11) stimulates production
of Axin2 unless it is in complex with TCF ([β-catenin/TCF] = X14). We would suggest a more
conventional rate-limiting term of the form k18X14/(K18 + X14), where Axin2 production is an
increasing and saturating function of β-catenin/TCF.
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Replacing Cho et al.’s term in equation (2.55) with the suggested term leads to
dX12
dt
=
(
k3X2X4 −
k6GSK
0APC0K17X12
K7(K17 +X11)
+ k−6X4 + v14 − k15X12 +
k18b
TCF 0X11
K18 + (K18 + TCF 0)X11
+
dX11
dt
(
APC0K17X12
K7(K17 +X11)2
))
/(
1 +
APC0K17
K7(K17 +X11)
)
. (2.62)
Note that k18b must take different units, and therefore a different value, in this equation; results
are approximately the same when the original value of k18 = 1 × 10
−6 min−1 is modified to read
k18b = 1 × 10
−4 nM min−1 and K18 = 1.0 nM. We show the result of a typical run for this model
in Figure 2.11, to be compared with the results presented in Figure 2.8. We see very similar results
both qualitatively and quantitatively, with slightly higher levels of Axin (X) present.
The change is reflected in the nondimensional equation (2.56) as follows
dX
dt
=
(
(kˆ3V + kˆ−6)Di −
(
kˆ6
(1 + εKˆ16Ba)
+ kˆ15
)
X + 1 + kˆ18b
T̂CF
0
Ba0(T )
1 +
(
1 + Kˆ18T̂CF
0)
Ba0(T )
+εKˆ16
dBa
dt
Kˆ7X
(1 + εKˆ16Ba)2
)/(
1 +
Kˆ7
(1 + εKˆ16Ba)
)
. (2.63)
With
dX
dt
=
(kˆ3V + kˆ−6)Di − (kˆ6 + kˆ15)X + 1 + kˆ18b T̂CF 0Ba
1 +
(
1 + Kˆ18T̂CF
0)
Ba
/(1 + Kˆ7
)
,
(2.64)
following directly as a replacement for equation (2.57).
These changes continue through the equations of section 2.4.3 to give the following long-time ap-
proximation for Axin levels:
X0(T ) =
1
kˆ15
1 + kˆ18b T̂CF 0Ba0(T )
1 +
(
1 + Kˆ18T̂CF
0)
Ba0(T )
 . (2.65)
Again the functional form of the long-time approximation (equation (2.51)) remains unchanged.
Substituting in equation (2.65) we are left with a dimensional equation which reads
dX11
dt
= v12 −
(
a
(
W (t)
) k18K17
K17 +X11(t)
(
TCF 0X11(t)
K18 + (K18 + TCF 0)X11(t)
)
+ k13
)
X11(t). (2.66)
where a (W (t)) is unchanged and given by equation (2.53).
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Figure 2.11: A simulation of the Wnt model with Axin feedback (equations (2.14), (2.15), (2.16),
(2.18), (2.19) and equation (2.63)) for comparison with the Cho et al. (2006) model
(see Figure 2.8). The Wnt level, W , is increased from 0 to 1 at time t = 0 and
removed at t = 300. Top: solid line X (Axin), dashed line Ba (β-catenin). Mid-
dle: solid line Db (destruction complex bound to β-catenin), dashed line V (active
Dishevelled). Bottom: solid line Di (inactive destruction complex), dashed line
Da (active destruction complex). Parameter values can be found in Table 2.2 and
the initial conditions are the steady states for the Lee model without feedback and
W = 0, as shown in Table 2.3.
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This variation of the feedback model yields excellent asymptotic matches for the asymptotics, almost
identical to those shown in Figures 2.9 and 2.10, and equation (2.66) forms another single-ODEmodel
which encapsulates the response of β-catenin to Wnt signalling.
2.5 Discussion
The Lee et al. (2003) Wnt signalling model is an excellent example of how experiments carried out
in partnership with modelling can enhance understanding of a biological system, with fresh insight
into the role of Axin resulting. By nondimensionalising their model and performing a systematic
asymptotic analysis we have been able to make some interesting observations about the action of
the Wnt pathway.
The pathway operates on three distinct timescales. The fastest timescale is associated with the
action of the destruction complex, which quickly both phosphorylates and releases β-catenin. Over
an intermediate timescale the dominant reactions regulate levels of destruction complex by removing
Axin under the influence of Wnt and Dishevelled. Changes in β-catenin levels happen over a slower
timescale than either of these processes. Guided by comparison with the full models we conclude
that our reduced models (equations (2.52) and (2.61)) retain the essential behaviour of the Lee et al.
(2003) and Cho et al. (2006) models that is needed to study the effect of Wnt signalling on β-catenin
accumulation.
Use of this simplified model could reduce the complexity of models such as Kim et al. (2007) con-
siderably. The full Wnt pathway in Kim et al.’s model could be represented by equation (2.61),
with only the slight modification of GSK0 in equation (2.53) being replaced by
(
GSK0 −X28(t)
)
to
couple to the rest of their model, and equation (2.54) giving the output of the Wnt pathway. This
would eliminate 14 ODEs from their system and, we believe, facilitate a much greater understanding
of the underlying processes.
Many of the parameter values we have used derive from experiments performed in vitro on Xenopus
egg extracts by Lee et al.; many others could not be measured directly. Ideally, the parameter values
should be based on kinetic parameters, directly measured from human cells in vivo. However the
Wnt/β-catenin pathway is thought to be highly conserved between species, so the operation of the
human pathway is likely to be very similar to that of the Xenopus pathway.
Many of the Wnt pathway’s components exist in separate ‘compartments’ inside the cell (such as
the nucleus, membrane and cytoplasm) and spatial effects have been considered for β-catenin in
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van Leeuwen et al. (2007); possible future work would be considering the localisation of other Wnt
pathway components, which have been shown to localise to the cell membrane and cytoskeleton,
and considering the role of nuclear import and export of various components.
Through our asymptotic analysis we have provided insight into the biological action of many of the
components in the overall system. Given that it is the accumulation and degradation of β-catenin
that is often of interest to biologists and modellers, we have shown how this may be determined from
a highly simplified model which relates the evolution of β-catenin directly to the Wnt stimulus. As
we will include models of Wnt signalling in a cell-based tissue model in chapters 5 and 6 we have
greatly reduced the computation involved in running such simulations.
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Chapter3
The Impact of Wnt Signalling on the
Cell Cycle in the Colorectal Crypt
3.1 Introduction
A
s mentioned in chapter 1, over 90% of colorectal cancer (CRC) tumours carry mutations
which result in abnormal activation of the Wnt signalling pathway. A number of mathe-
matical models of CRC have been proposed (see van Leeuwen et al., 2006, for a review),
but as yet none quantitatively link aberrant Wnt signalling to cancer initiation. In this chapter we
develop a deterministic model to study a possible mechanism by which Wnt signalling affects cell
proliferation in the colon.
β-catenin is a transcription factor for D-type cyclins (Tetsu & McCormick, 1999; Shtutman et al.,
1999; Sansom et al., 2004). The level of β-catenin/TCF target-gene expression in a colorectal crypt
is observed to be highest at the base of a crypt, where the proliferating cells are located, and to
decrease towards the top (Gaspar & Fodde, 2004; Larsson, 2006). In this chapter we develop a model
to investigate how Wnt signalling might influence the cell cycle. Hence we determine whether a Wnt
gradient in a colorectal crypt may be responsible for the observed proliferative hierarchy along the
crypt axis. We will also examine the impact of mutations in components of the Wnt pathway.
In section 1.3.3 we reviewed several mathematical models of the cell cycle that include Cyclin D
(Obeyesekere et al., 1997; Obeyesekere & Zimmerman, 1999; Aguda & Tang, 1999; Novak & Tyson,
2004). Below we introduce a model which reproduces two specific phenomena observed in the
crypts: firstly, lack of Cyclin D can induce quiescence (Gemin et al., 2005) and, secondly, reduction
of Cyclin D levels can slow the onset of the G1/S transition (Han et al., 1999). In section 3.2 we
develop a simple model for the Wnt signalling pathway, based upon our findings in chapter 2. In
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section 3.3 we couple the models and use them to predict proliferation patterns in healthy and
aberrant colorectal crypts.
3.1.1 The Swat et al. (2004) Cell-Cycle Model
The cell-cycle model on which we focus was developed by Swat et al. (2004) and is, we believe, a
minimal one able to exhibit the behaviour we would like to describe. The model takes the form
of a system of coupled ODEs; with each ODE describing the rate of change in the concentration
of a single protein or complex. In the ‘core model’ the key variables are the concentrations of
retinoblastoma protein, [pRb], and a transcription factor, [E2F1]. As discussed in section 1.3, these
proteins govern the G1/S transition. Following Swat et al.’s notation we denote by [CycDa] and
[CycDi] the concentrations of active or inactive Cyclin D kinase complexes respectively, and by
[pRbp] that of phosphorylated retinoblastoma protein.
The time evolution of the model variables is derived by referring to the bottom half of Figure 3.3 and
using mass-action kinetics, with Michaelis-Menten kinetics for reaction rates that become saturated.
Figures 3.1 and 3.2 show how the terms that appear in the governing equations can be derived and,
in particular, how the rate of production of a protein is up- or down-regulated by a second protein.
Table 3.1: Dependent variables in the Swat et al. (2004) model.
Swat Model Protein/Complex
Variable Description
[pRb] Retinoblastoma Protein
[pRbp] Retinoblastoma Protein (phosphorylated)
[E2F1] Transcription Factor (for S phase proteins)
[CycDi] Cyclin D (inactive)
[CycDa] Cyclin D (active)
[AP-1] Transcription Factor (for Cyclin D)
The dependent variables for the ‘first extension’ of the Swat model that we utilise here are shown in
Table 3.1. The model is formulated using terms such as those shown in Figures 3.1 and 3.2 and the
schematic shown in Figure 3.3. In general terms, for a non-phosphorylated protein (modifications
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Figure 3.1: Production of protein A is upregulated by protein B (square brackets denote the
concentration of a protein). The production rate of [A] is zero when [B] = 0 and
tends to k as [B]→∞.
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Figure 3.2: Production of protein A is downregulated by protein B (square brackets denote the
concentration of a protein). The production rate of [A] is k when [B] = 0, but tends
to zero as [B]→∞.
needed for phosphorylated proteins are stated in parentheses) we have
rate of change of protein concentration = + increase due to production
+ increase due to dephosphorylation (phosphorylation)
− loss due to (de)phosphorylation
− loss due to degradation.
69
3.1 Introduction Chapter 3: Wnt and the Cell Cycle
Figure 3.3: A schematic diagram of our model for the Wnt pathway and how it is linked to
the Swat et al. (2004) model for the G1/S transition of the cell cycle in mammalian
cells. The lower half of the figure is adapted from Swat et al. (2004, Figure 1) by
permission of Oxford University Press.
70
3.1 Introduction Chapter 3: Wnt and the Cell Cycle
This leads to the following set of equations:
d[pRb]
dt
= k1
[E2F1]
Km1 + [E2F1]
J11
J11 + [pRb]
J61
J61 + [pRbp]
−k16[pRb][CycDa] + k61[pRbp]− φpRb[pRb], (3.1)
d[E2F1]
dt
= kp + k2
a2 + [E2F1]2
K2m2 + [E2F1]
2
J12
J12 + [pRb]
J62
J62 + [pRbp]
− φE2F1[E2F1], (3.2)
d[CycDi]
dt
= k3[AP-1] + k23[E2F1]
J13
J13 + [pRb]
J63
J63 + [pRbp]
+k43[CycDa]− k34[CycDi]
[CycDa]
Km4 + [CycDa]
− φCycDi [CycDi], (3.3)
d[CycDa]
dt
= k34[CycDi]
[CycDa]
Km4 + [CycDa]
− k43[CycDa]− φCycDa [CycDa], (3.4)
d[AP-1]
dt
= Fm + k25[E2F1]
J15
J15 + [pRb]
J65
J65 + [pRbp]
− φAP -1[AP-1], (3.5)
d[pRbp]
dt
= k16[pRb][CycDa]− k61[pRbp]− φpRbp [pRbp]. (3.6)
In equations (3.1)–(3.6) the k’s and φ’s are non-negative rate constants, whilst the K’s and J ’s are
(Michaelis-Menten) dissociation constants and Fm represents the mitogenic stimulus applied to the
system (for parameter values, see Table 3.2). The behaviour of the model depends crucially on the
size of Fm, the mitogenic transcription factor.
In Swat et al.’s (2004) paper they established the steady state behaviour of the model as Fm varies,
their results being shown in Figure 3.4: for low Fm there is a unique steady state characterised by
low levels of E2F1 (G0 phase); for high Fm the only steady state has high levels of E2F1 (S phase);
and for intermediate Fm both steady states are present and the steady state that is attained depends
on the initial levels of proteins present. If a cell is exposed to a constant low Fm then its E2F1 levels
will remain low (and the cell will stay in G0 phase). If, however, the stimulus Fm slowly increases
then the cell’s E2F1 levels will move along the lower branch (G1 phase) of Figure 3.4 towards the
phase transition. When the stimulus exceeds a threshold value the only steady state is on the upper
branch and the level of E2F1 jumps (cell enters S phase). This is an irreversible transition — if the
level of Fm now falls slightly then the cell will not return to G1 phase, but will follow the upper
steady state line (stay in S phase).
The three types of behaviour that the system can exhibit are presented in Figure 3.5. For low values
of Fm (upper panel) the cells remain quiescent, whilst for high values (lower panel) the cells complete
the G1/S transition. For intermediate values of Fm (middle panel) the cells progress further through
the cell cycle than for the top simulation, as in this case Fm exceeds the transcritical bifurcation value
seen in Figure 3.4. The lower simulation, having the highest Wnt level, has a mitogenic stimulus
71
3.1 Introduction Chapter 3: Wnt and the Cell Cycle
Table 3.2: Swat et al. (2004) parameters.
Dimensional Nondimensional
k1 = 1.0 nMmin
−1 F = 6× 10−3
k2 = 1.6 nMmin
−1 k˜2 = k2/(Km2φE2F1) = 4.0
k3 = 0.05 min
−1 k˜3 = k3Fa1/(Km4φE2F1a2) = 16.5
k16 = 0.4 nM
−1min−1 k˜16 = k16Km4/φE2F1 = 1.2
k23 = 0.3 min
−1 k˜23 = k23Km2/(Km4φE2F1) = 40
k25 = 0.9 min
−1
k34 = 0.04 min
−1 k˜34 = k34/φE2F1 = 0.4
k43 = 0.01 min
−1 k˜43 = k43/φE2F1 = 0.1
k61 = 0.3 min
−1 k˜61 = k61/φE2F1 = 3.0
a = 0.04 nM a˜ = a/Km2 = 0.01
J11 = 0.5 nM J˜11 = J11φE2F1/k1 = 0.05
J12 = 5.0 nM J˜12 = J12φE2F1/k1 = 0.5
J13 = 2× 10
−3 nM J˜13 = J13φE2F1/k1 = 2.0× 10
−4
J15 = 1× 10
−3 nM
J61 = 5.0 nM J˜61 = J61φE2F1/k1 = 0.5
J62 = 8.0 nM J˜62 = J62φE2F1/k1 = 0.8
J63 = 2.0 nM J˜63 = J63φE2F1/k1 = 0.2
J65 = 6.0 nM
Km1 = 0.5 nM K˜m1 = Km1/Km2 = 0.125
Km2 = 4.0 nM
Km4 = 0.3 nM
kp = 0.05 nMmin
−1 k˜p = kp/(Km2φE2F1) = 0.125
φpRb = 5× 10
−3 min−1 φr = φpRB/φE2F1 = 0.05
φE2F1 = 0.1 min
−1
φCycDi = 0.023 min
−1 φi = φCycDi/φE2F1 = 0.23
φCycDa = 0.03 min
−1 φc = φCycDa/φE2F1 = 0.3
φAP -1 = 0.01 min
−1
φpRbp = 0.06 min
−1 φp = φpRBp/φE2F1 = 0.6
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Figure 3.4: Steady E2F1 levels for different mitogenic stimuli, Fm. The solid lines are stable
steady states and the dashed lines are unstable steady states. Reproduced from
Swat et al. (2004, Figure 3) by permission of Oxford University Press.
above both the transcritical and saddle node bifurcations and quickly enters S phase. As discussed
in section 1.3, β-catenin acts as a transcription factor for Cyclin D. In section 3.2 we formulate a Wnt
signalling model for the accumulation of β-catenin in cells exposed to an external Wnt stimulus. In
section 3.3 we link this model to that of Swat et al. in order to examine the effect of Wnt signalling
on the cell cycle, and use the coupled model to determine whether a Wnt gradient in a colorectal
crypt may be responsible for the pattern of proliferation that characterises normal crypts. We also
use the model to examine the impact of mutations in components of the Wnt pathway, discussing
Table 3.3: Initial conditions for the first extension of Swat et al.’s cell-cycle model
Dimensional Dimensional Units Dimensionless Dimensionless
variable value variable value
[pRb] = 7.357 nM r = 0.735
[CycDi] = 0.0207 nM i = 0.069
[E2F1] = 0.6852 nM e = 0.171
[CycDa] = 0.001 nM j = 0.003
[pRbp] = 0.001 nM p = 0.0001
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Figure 3.5: A series of simulations showing how the evolution of [pRb] (solid lines) and [E2F1]
(dashed lines) change as the strength of the mitogenic stimulus (Fm) varies. In
the top simulation, the mitogenic stimulation is very small (Fm = 0.001) and the
cell stays in G0 phase; in the middle simulation (Fm = 0.003) the cell makes some
progress through G1 phase, but does not produce enough Cyclin D to progress into
S phase and so becomes quiescent (albeit at a later stage of G1); and in the bot-
tom simulation (Fm = 0.0045) the cell passes through the G1 phase and its E2F1
levels rise, marking the progression into S phase. The parameter values and initial
conditions used to obtain the above simulations are presented in Tables 3.2 and 3.3
respectively.
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our findings in section 3.4.
3.2 Wnt Signalling Model
In this section we derive a Wnt signalling model for the amount of β-catenin available to act as a
transcription factor for Cyclin D. We focus on the transcriptional side of the Wnt pathway, and for
simplicity ignore β-catenin’s other roles in functions such as cell-cell adhesion.
3.2.1 Formulating the Model
Since we want a system that permits a full analysis of its behaviour, our model formulation is much
simpler than that of Lee et al. (2003), and is based upon our reduced version of Lee et al. (2003)
(equation (2.52) in chapter 2) which was shown to reproduce all of the necessary behaviour. In
particular, the main component of our model is the concentration of β-catenin, [β-cat]. We have
added another variable: active APC/Axin/GSK3β destruction complex, [Cactive] in order to study
the effect of mutations in APC on the Wnt pathway. The concentration of extracellular Wnt, [Wnt],
is an input parameter.
We assume that β-catenin is produced at a constant rate (a1) inside cells, and is degraded at a
rate proportional to its concentration (with rate constant a2). As shown in Figure 3.3, Cactive
phosphorylates β-catenin (with rate constant a3) which marks it for subsequent degradation (see
section 1.4.3). Using a mass-action formulation this leads to the equation
d[β-cat]
dt
= a1 − (a2 + a3[Cactive]) [β-cat]. (3.7)
We remark that this ODE is very similar in structure to that of equation (2.52) and our model
predicts that [β-cat] will be maintained at a constant level (a1/a2) in the absence of Cactive. Some
Wnt signalling pathway feedback targets have been identified1. For example, Axin2 is upregulated
by β-catenin (Jho et al., 2002), but β-catenin-induced feedback is omitted in Lee et al.’s detailed
model which appears to simulate the pathway accurately. We therefore neglect feedback and assume
that the total amount of destruction complex in the cell remains constant over time, i.e. [CTotal] =
[Cactive] + [Cinactive] = constant. In reality the ‘inactive destruction complex’ may not constitute a
destruction complex, the components remaining dissociated within the cell. However, this remains
a useful way to describe the level of destruction complex contained within the cell. It appears that
the limiting protein in the formation of the destruction complex is Axin, since it is present in the
1http://www.stanford.edu/~rnusse/pathways/targetcomp.html
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Table 3.4: Parameter values for the Wnt pathway model
Dimensional Nondimensional
a1 = 0.423 nMmin
−1
a2 = 2.57×10
−4 min−1 a˜2 = a2/φE2F1 = 2.57×10
−3
a3 = 1.72 nM
−1min−1 a˜3 = a3[CTotal]/φE2F1 = 0.344
a4 = 10.0 nM
−1min−1 a˜4 = a4[Wnt]max/φE2F1 = 1000
a5 = 0.5 min
−1 a˜5 = a5/φE2F1 = 5.00
[CTotal] = 0.02 nM [Wnt]max = 10.0 nM
cell in by far the lowest concentration (see Lee et al. (2003) and section 2.2.2) and so we base our
estimate of [CTotal] on the concentration of Axin.
The ratio of active to inactive complex is influenced by the Wnt signal. In reality this process is
initiated by extracellular Wnt binding to a Frizzled receptor, which initiates a cascade of events
including the disabling by Dishevelled and LRP6 of the active destruction complex. We model this
as a single interaction — more Wnt leads to more inactivation of the destruction complex. We use
a mass-action formulation, based on the interactions depicted in Figure 3.3, leading to the following
equation
d[Cactive]
dt
= −a4[Wnt][Cactive] + a5[Cinactive],
= a5[CTotal]− (a4[Wnt] + a5)[Cactive]. (3.8)
In equation (3.8) a4 represents the rate at which Cactive is inactivated by Wnt and a5 that at which
Cinactive is activated. Equations (3.7) and (3.8) constitute our model of the Wnt signalling pathway.
In chapter 2 we estimated values for a1 to a5 (Table 3.4) by reducing the Lee et al. (2003) model,
for which the parameter values were inferred from experimental results.
3.2.2 Rescaling the Model
It is again helpful to rescale the protein concentrations in terms of dimensionless values as this
simplifies the governing equations. We denote our measure of the destruction complex by ‘c’ and set
c =
[Cactive]
[CTotal]
,
so that 0 6 c 6 1. Similarly we scale β-catenin levels with the highest steady state value, a1/a2
(this is the steady state concentration of equation (3.7) when no destruction complex is present).
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Then a measure of β-catenin levels becomes ‘b’ where
b =
[β-cat]
[a1/a2]
,
so that the steady state of b will satisfy 0 6 b 6 1. We also scale our Wnt stimulus so that
W =
[Wnt]
[Wnt]max
,
where [Wntmax] is the maximum concentration of Wnt observed in the crypt and therefore 0 6
W 6 1. We have chosen this value (see Table 3.4) to be that value beyond which only small
changes to behaviour are observed. Finally, we scale time, t, on a characteristic degradation time
(1/degradation rate) for E2F1, denoted by φE2F1 in the full equations (3.1)–(3.6), so that
t∗ = φE2F1t.
Swat et al. (2004) estimate φE2F1 = 0.1 min
−1. In terms of the new rescaled variables our two
model equations become
dc
dt∗
= a˜5(1 − c)− a˜4Wc, (3.9)
db
dt∗
= a˜2(1 − b)− a˜3bc. (3.10)
Rescaled parameter values are shown in Table 3.4. The steady states of our wild-type (wt) model,
csteady and bsteady, can be easily determined by setting d/dt = 0 in equations (3.9) and (3.10) to
give
cwtsteady =
a˜5
a˜4W + a˜5
=
(
1 +
a˜4
a˜5
W
)−1
, (3.11)
and
bwtsteady =
a˜2
a˜2 + a˜3csteady
=
(
1 +
a˜3
a˜2
csteady
)−1
. (3.12)
Note that equations (3.11) and (3.12) have only two nondimensional parameter groupings, which is
advantageous when examining the effects of parameter changes on the steady states. In Figure 3.6
bsteady is plotted for various levels of Wnt stimulation, W . For comparison, the associated steady
levels of β-catenin for the most commonly detected CRC mutations are also shown, being obtained
using the approach outlined below.
3.2.3 Modelling Mutations
APC mutations can occur at many different sites on the gene, leading to proteins with many
different structures. The majority of mutations are harmless, but of those APC mutations observed
77
3.2 Wnt Signalling Model Chapter 3: Wnt and the Cell Cycle
0 0.2 0.4 0.6 0.8 1
0
0.2
0.4
0.6
0.8
1
Level of Wnt stimulus, W
β−
ca
te
ni
n 
(no
n−
dim
)
 
 
Wild Type
APC +/−
β−catenin∆45
APC −/−
Figure 3.6: The steady level of β-catenin under different Wnt stimuli for wild type cells and cells
with the common mutations, given by equations (3.12)–(3.15) using the parameter
values in Table 2.2. Dimensionless values are plotted.
in tumours there are two different categories of mutation which have different effects if only one
APC allele is mutated (a ‘single hit’). Some mutations lead to APC forming a destruction complex
that cannot function properly, the destruction complexes will be permanently inactive and incapable
of degrading β-catenin; other mutations render APC unable to bind to Axin and hence to the other
destruction complex components, but these components are still able to bind to normal APC encoded
by the other allele and thus to create additional active destruction complexes, that can still degrade
β-catenin. If both APC alleles are mutated (a ‘double hit’) then either scenario leads to complete
absence of active destruction complex.
We model a single hit as one which causes APC to form inert destruction complexes (the worst-case
scenario for the cell), we assume that half of the destruction complexes become active and degrade
β-catenin, b. If both copies of the APC gene are mutated then there are no active destruction
complexes present. We can therefore represent the one and two hit cases by varying the parameter
a˜3 term that appears in equation (3.10), to half its wild-type value for a single-hit (APC
+/−) and
to zero for a double-hit (APC−/−). The steady state of β-catenin then becomes
bapc
+/−
steady =
a˜2
a˜2 +
a˜3
2 csteady
, (3.13)
for APC+/−, where csteady is given by equation (3.11), and
bapc
−/−
steady = 1, (3.14)
for APC−/−. To model a mutation in a single β-catenin allele we decompose b into two subtypes,
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with the wild-type produced with proportion 0 < θ < 1 and the mutant produced with proportion
0 < (1 − θ) < 1; we assume that subtype b1is wild-type and can be degraded by the destruction
complex and b2 is mutant and cannot:
b = θb1 + (1− θ) b2,
db1
dt∗
= a˜2 (θ − b1)− a˜3b1c,
db2
dt∗
= a˜2 ((1− θ)− b2) .
In these equations b1 is the wild-type protein (without mutations), whilst b2 represents the mutated
protein. We stress that this model accounts only for those mutations observed in tumours, which
allow β-catenin to function whilst being immune to the destruction complex. The steady state level
of b for a single mutant β-catenin (β-cateninmut) is given by
bmutsteady = b1 steady + b2 steady =
(
(1− θ) +
θa˜2
a˜3csteady + a˜2
)
. (3.15)
As can be seen by comparing equations (3.12)–(3.15) it is always true that
bwtsteady < b
apc+/−
steady < b
apc−/−
steady ,
and
bwtsteady < b
mut
steady < b
apc−/−
steady .
The inequality for bmutsteady and b
apc+/−
steady cannot be determined until θ is chosen. We choose θ =
1
2
(equal expression of wild type and mutant β-catenin) to establish that bapc
+/−
steady < b
mut
steady. The
steady levels of β-catenin resulting from the three mutations mentioned above are shown alongside
a healthy (wild-type) cell’s response to Wnt signals in Figure 3.6. The qualitative behaviour of the
results presented in Figure 3.6 are robust to variations in parameter values. The model suggests
that in wild type cells, with a zero Wnt stimulus, the destruction complex is highly active and so the
level of β-catenin will be kept low. As the Wnt signal increases, the destruction complex becomes
inactivated and the equilibrium concentration of β-catenin rises before plateauing as Wnt reaches
its maximum value (W = 1). Taken together these results suggest that the observed variation in
β-catenin seen along the crypt axis (Gaspar & Fodde, 2004) may be due to variation in the Wnt
concentration, the action of the Wnt pathway being mediated by the destruction complex.
APC+/− cells present a slightly higher level of β-catenin than wild type cells. Moreover, β-
catenin∆45 cells have much higher β-catenin levels under a low Wnt stimulus, with a larger β-
catenin concentration than the APC+/− for all levels of Wnt. In APC−/− cells the destruction
complex cannot phosphorylate β-catenin and the latter reaches its highest level, independent of the
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Wnt stimulus. In these three types of mutations Wnt has successively less control over levels of
β-catenin; in APC−/− mutants Wnt’s control is completely lost.
3.3 Coupling Wnt Signalling and Cell Proliferation
To form the full coupled model we simplify equations (3.1)–(3.6) by nondimensionalising using the
rescalings
[pRb] = k1φE2F1 r, [E2F1] = Km2e, [CycDi] = Km4i,
[CycDa] = Km4j, [AP-1] =
Fma1
φE2F1a2
x, [pRbp] =
k1
φE2F1
p,
t = t∗/φE2F1, [Wnt] = [Wnt]maxW .
As discussed above, we also rescale the Wnt pathway components, according to
c =
[Cactive]
[Ctotal]
, b =
[β-cat]
[a1/a2]
.
β-catenin is a direct transcription factor for Cyclin D, so we can ignore equation (3.5) and use β-
catenin instead of AP-1 in the transcription-factor-dependent production term in equation (3.3). A
scaling factor F premultiplies the rate constant k3 to account for the fact that β-catenin and AP-1
are present at different concentrations: in Swat et al. (2004) 8×10−3 < [AP-1] < 1.24 whereas in Lee
et al. 25 < [β-cat] < 155. We fix F = 6 × 10−3 to compensate for the difference in concentrations.
Since we are interested in the cell-cycle times for a cell under a constant Wnt stimulus, we take the
steady-state level of β-catenin as an input, rather than solving two more ODEs; as a result bsteady is
the input into the cell-cycle model. Under the above transformations, equations (3.1) – (3.6) become
dr
dt∗
=
e
K˜m1 + e
J˜11
J˜11 + r
J˜61
J˜61 + p
− k˜16rj + k˜61p− φrr, (3.16)
de
dt∗
= k˜p + k˜2
a˜2 + e2
1 + e2
J˜12
J˜12 + r
J˜62
J˜62 + p
− e, (3.17)
di
dt∗
= k˜3bsteady + k˜23e
J˜13
J˜13 + r
J˜63
J˜63 + p
+ k˜43j − k˜34i
j
1 + j
− φii. (3.18)
dj
dt∗
= k˜34i
j
1 + j
− (k˜43 + φj)j, (3.19)
dp
dt∗
= k˜16rj − k˜61p− φpp. (3.20)
with the rescaled parameters shown in Table 3.2.
The dimensionless system was solved numerically using routine ode15s (a stiff ODE system solver)
in MatLab. The initial conditions (namely the protein concentrations at the beginning of G1 phase)
were taken as the steady states of the original model with Fm = 0 and are listed in Table 3.3; note
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that these steady states are identical to the steady states of equations (3.16)–(3.20) with bsteady = 0.
We simulated the G1 phase under a steady Wnt stimulus where bsteady is given by one of equations
(3.12)–(3.15) depending on the mutation state.
The cell is deemed to enter S phase when the E2F1 level crosses a suitable threshold (on the phase
transition arrow of Figure 3.4, for example, [E2F1] = 5) and the time this occurs is recorded as the
duration of the G1 phase. Since the level of E2F1 rises very quickly after a slow progression, the
result is not sensitive to the exact choice of threshold value. If the cell never reaches this threshold
because the level of β-catenin, and hence Cyclin D, remains too low (the mitogenic stimulus is to
the left of the right-hand SN bifurcation in Figure 3.4) then the cell is said to be quiescent. The
results of our simulations, for healthy and mutant cells, are shown in Figure 3.7.
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Figure 3.7: The variation in G1 phase duration of our combined model under different Wnt
stimuli, W , for wild type cells and cells with the common mutations, using the
parameter values in Table 3.2 and Table 3.4 with the initial conditions in Table 3.3.
To the left of the vertical sections the cells are quiescent (in G0 phase) and will not
proliferate. Rescaled (dimensionless) values are plotted.
Figure 3.7 shows the general trend for a shorter G1 phase when the cell is exposed to a stronger
Wnt stimulus. We observe that wild-type cells proliferate quickly under a strong Wnt stimulus (e.g.
at the base of a crypt), proliferate less rapidly as the stimulus reduces and become quiescent at low
Wnt stimuli (e.g. at the top of a crypt). This mechanism could explain the observed proliferation
patterns in a healthy crypt. The model predicts a variation in the duration of G1 phase, from
typically around 6 hours (in a strong Wnt signal, W ≈ 1) to 25 hours (under a moderate Wnt
signal, W ≈ 0.6), with quiescent cells under lower Wnt stimuli.
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Cells with a single APC mutation exhibit the same qualitative behaviour as their wild-type coun-
terparts, becoming quiescent under low Wnt stimuli and proliferating more rapidly as Wnt levels
increase. The G1 phase duration in an APC
+/− cell is shorter than wild-type cells for a given Wnt
stimulus, and the Wnt threshold for quiescence is lower.
Cells with a β-catenin∆45 or APC−/− mutation fail to keep levels of β-catenin low enough to remain
(or become) quiescent for any Wnt signal strength. Consequently, they proliferate rapidly (with G1
phase durations always under approximately 8 hours) and uncontrollably, which suggests a route to
adenoma formation and colorectal cancer initiation. β-catenin∆45 cells retain some sensitivity to
Wnt stimulation (the duration of their cell cycle varying between 4.5 and 8 hours) but the APC−/−
cells proliferate independently of the Wnt signal (with the fastest duration of any mutation case
— approximately 4 hours). In reality cells with a double APC hit will probably be regulated
by other factors and may never replicate this quickly. Our model presents the expected increase
in proliferation when the Wnt pathway becomes disregulated and Cyclin D levels are no longer
controlled.
Our model predicts that a β-catenin double-hit would have the same effect on β-catenin concentra-
tions as the APC double-hit (in both cases there would be no phosphorylation by the destruction
complex). The reason that β-catenin−/− cells are not observed in colorectal cancer tumours is that
a β-catenin∆45 mutation removes Wnt’s control of the cell sufficiently to allow colorectal cancer to
develop (Figure 3.7); the cell does not need to acquire another mutation to lose control of prolifer-
ation. In contrast in APC+/− mutants the cell’s activity is still Wnt dependent and there remains
some control of the mutant cell until further genetic alterations are acquired and the cell becomes
Wnt independent.
3.4 Discussion
In this chapter we have coupled a simple model for the intracellular accumulation of β-catenin in
response to Wnt signalling to a simplified model of the G1/S transition of the cell cycle, in order to
gain insight into how extracellular Wnt signalling might affect cell proliferation.
We produced a quantitative model predicting cell proliferation rates in the presence of a Wnt stim-
ulus. The proposed Wnt gradient, through the action of β-catenin and Cyclin D, can explain the
observed proliferation in a colorectal crypt. Some experiments suggest that stem cells (at the very
base of the crypt) proliferate less rapidly than the cells above (Potten et al., 1997); however our
model does not distinguish between stem cells and transit cells, and so does not reproduce this
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effect. There may be other biological processes that have been neglected which limit stem cell
proliferation.
As our model includes those components of the Wnt pathway that become mutated in colorectal
cancer, we have been able to investigate the effects of three common mutations. We predict that a
single APC hit increases the rate of cell proliferation but is unable to disregulate growth completely,
and indeed this mutation is not observed in CRC tumour samples. A single β-catenin mutation
is sufficient to cause disregulated proliferation throughout the crypt, although there is still some
response to Wnt stimulation, whilst a double APC hit removes Wnt control completely, and indeed
these mutations are those most commonly observed in CRC adenomas.
We assumed that all proteins in a cell are freely available to interact with each other; in reality the
localisation of proteins to different parts of the cell may be important. For example, β-catenin is
found in the cytoplasm, at the cell membrane where it acts in cell-cell adhesion and it also moves to
and from the nucleus, where it promotes transcription. Such spatial effects, for β-catenin and the
other proteins in the Wnt pathway, could play an important role. As discussed in section 1.4, it is
probable that, in addition to Cyclin D, other Wnt target genes have some impact on the cell cycle
and could affect our predictions. Furthermore, our model assumes that, of the proteins involved in
the regulation of the Wnt pathway, only β-catenin influences the cell cycle; however GSK3β has been
shown to interact with Cyclin D (Diehl et al., 1998). During the different phases of the cell cycle,
components which influence the Wnt signalling pathway may be temporarily expressed, leading to
feedback loops which are not currently included in this model. Other possible extensions involve
the investigation of the reduced Wnt-signalling-feedback model (derived in the previous chapter, see
equation (2.61)) and the cell cycle.
Many of the interactions that we have modelled are still keenly disputed. Experimental estimates
of parameter values for both the cell cycle and Wnt signalling models in human colorectal tissue are
currently lacking; these would greatly help to validate and improve our model.
At first glance our Wnt pathway model may appear overly simplistic, but it retains the crucial
components for studying colorectal cancer initiation. We believe this is the first quantitative model
linking Wnt signalling to cell proliferation and, therefore, the first to explain how the most common
mutations of the Wnt pathway may be implicated in the initiation of colorectal cancer.
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Chapter4
The Influence of Wnt Signalling
on c-Myc and the Cell Cycle
4.1 Introduction
T
he model constructed in chapter 3 predicts the healthy response of a cell cycle to a Wnt
stimulation, and hyperproliferation following APC or β-catenin mutations. That model
focuses on the link between β-catenin and Cyclin D levels to represent the influence of
Wnt signalling on the cell cycle. Recently Sansom et al. (2007) performed experiments which suggest
that increased levels of c-Myc (or Myc1), rather than Cyclin D, are responsible for the increased
proliferation observed after an APC knockout. The model of chapter 3 cannot replicate these results
because it does not account for the role of Myc. In this chapter we formulate a model which relates
β-catenin, Myc, Cyclin D and CDK4 levels in an attempt to replicate Sansom et al.’s results, which
we discuss in more detail below.
4.1.1 Experimental Results
Sansom et al. (2007) have performed targeted gene-knockout experiments on adult mice. Mice are
engineered with extra markers (loxP) either side of a target gene. This is known as “floxing” a gene.
A compound is injected which activates Cre (Cyclization recombinase enzymes), Cre recognises
the two loxP sites and splices them together, ‘chopping-out’ the floxed target DNA, as shown in
Figure 4.1.
Transcription of the target gene is silenced as there is no longer a ‘start’ site associated with it.
1Whilst other Myc proteins exist, “Myc” generally represents c-Myc and others, such as N-Myc, retain their
prefixes.
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Target Gene Reporter Gene
Stop
Target Gene
Start
Reporter Gene
Stop
loxP loxP
loxP
loxP
Cre active − target gene removed, reporter gene expressed
Cre inactive − target and reporter genes expressed
Start
Cre
Figure 4.1: The action of Cre. Top: Mice are engineered to have two ‘loxP’ sites either side of a
target gene, and to express a reporter gene, such as GFP. The mice will express both
the target gene and the reporter gene in the absence of Cre. Bottom: Cre is induced
and the target gene is removed from the DNA, leaving only the reporter gene being
expressed.
Translation from existing target mRNAs will continue for some time, and the existing target proteins
will not be degraded immediately. Using this inducible-knockout technique means that an organism
develops into its fully grown, wild-type state. The gene knockout can then be performed on healthy
tissue, rather than observing the tissues of an organism that developed with a missing gene.
When Sansom et al. induced APC loss they found highly proliferating crypts, with increased adhe-
sion and decreased migration, as expected and observed previously. Myc knockouts appeared to have
little effect on the homeostasis of the healthy crypt. Surprisingly, a double knockout of APC and
Myc resulted in near-healthy crypts, the Myc knockout reversing the effects of the APC knockout.
We aim to recreate these findings by performing virtual knockout experiments on a mathematical
model. In contrast to the model in chapter 3, we now take into account the action of Myc and CDK4
as well as Cyclin D.
The remainder of the chapter is structured as follows. We develop our model in section 4.2, present
our results in section 4.3, propose possible drug targets in section 4.4 and discuss our conclusions in
section 4.5.
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Figure 4.2: Schematic of the model. Dashed lines indicate promotion of their target, solid lines
denote production of their target and, in the case of a protein, reduction of their
source.
4.2 Model Derivation
We explained in chapter 2 how most Wnt-signalling models predict how a Wnt stimulus might affect
the levels of β-catenin, many using the level of nuclear β-catenin:TCF as their output, so we may
adapt this as the input into our new model.
Figure 4.2 shows how Myc and Cyclin D are upregulated by β-catenin. Myc independently upregu-
lates CDK4. Cyclin D and CDK4 then associate to form a complex Cyclin D:CDK4. A high level
of Cyclin D:CDK4 complex is required to ‘kick-start’ the cell cycle and pass the G1/S checkpoint.
In what follows we use the term “Cyclin D” to represent all D-type cyclins within the crypt, as various
reports indicate that Cyclin D1, Cyclin D2 or both are major targets of β-catenin (Shtutman et al.,
1999; Tetsu & McCormick, 1999; Wang et al., 2002a; Sansom et al., 2005, 2007). Similarly CDK4
and CDK6 appear to be equally important binding partners for Cyclin D. However, since only CDK4
is upregulated by Myc we concentrate on CDK4, neglecting CDK6.
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4.2.1 Governing Equations
The dependent variables of our model are the levels of Myc, Cyclin D, CDK4 and Cyclin D:CDK4
complex, with the concentration of β-catenin:TCF as a prescribed input into the system; the con-
centrations are denoted with square brackets as [Myc], [CycD], [CDK4], [CycD:CDK4] and [β-cat]
respectively, as shown in Table 4.1.
Table 4.1: Summary of independent and dependent model variables and the scalings used to
nondimensionalise the system.
Variable Scaling Nondimensional Protein/complex
variable description
t = 1/φMyc (= τ ) T time
[β-cat] = K1 β β-catenin:TCF (transcriptionally active)
[Myc] = k1bτ M c-Myc (transcriptionally active)
[CycD] = k2bτ Y Cyclin D (free)
[CDK4] = k3bτ K CDK4 (free)
[CycD:CDK4] =
k4
k-4
k2bk3bτ
2 C Cyclin D:CDK4 (active complex)
We assume that Myc is produced at a background rate k1b and also, at a rate k1, in response to
β-catenin:TCF4 binding to the promoter region of c-Myc (He et al., 1998). This reaction can be
represented by a Michaelis-Menten term (see section 3.1.1 and Figure 3.1). In addition we assume
that Myc degrades at a constant rate φMyc. Combining these effects we deduce that the evolution
of [Myc] is governed by the following ODE:
d[Myc]
dt
= k1b + k1
[β-cat]
K1 + [β-cat]
− φMyc[Myc], (4.1)
where K1 is a Michaelis-Menten constant. Myc is also promoted by E2F1 (Bracken et al., 2004),
which is an indicator of the S phase of the cell cycle, and c-Myc levels have been observed to vary
throughout the cell cycle in rat liver development (Sanders & Gruppuso, 2006), but this has not yet
been observed in colorectal tissue and therefore we omit it for simplicity.
We use a similar approach to derive an ODE for [CycD], assuming that Cyclin D is produced at
87
4.2 Model Derivation Chapter 4: Wnt, c-Myc and the Cell Cycle
a constant background rate k2b, and at a rate k2 which is an increasing, saturating function of β-
catenin:TCF. Cyclin D complexes with CDK4 at a rate k4 which is dependent on the concentrations
of the constituent parts, the complex dissociates at a rate k−4 which is dependent on the concen-
tration of the complex. Cyclin D is assumed to degrade from its free state only at a rate φCycD.
Combining these features we arrive at the following ODE for [Cyclin D]:
d[CycD]
dt
= k2b + k2
[β-cat]
K2 + [β-cat]
− k4[CycD][CDK4] + k-4[CycD:CDK4]− φCycD[CycD]. (4.2)
An equation for the concentration of CDK4 can be formed similarly, where k3b is the background
production rate, and k3 represents the additional promotion by c-Myc,K3 is the dissociation constant
and φCDK4 is the degradation rate of CDK4. Again CDK4 is incorporated into a complex with
Cyclin D at a rate k4 and dissociates from Cyclin D:CDK4 at a rate k−4, giving the equation:
d[CDK4]
dt
= k3b + k3
[Myc]
K3 + [Myc]
− k4[CycD][CDK4] + k-4[CycD:CDK4]− φCDK4[CDK4]. (4.3)
We also include the formation of the Cyclin D:CDK4 complex, which is the output of this model,
influencing the cell cycle. We assume that this complex forms at a rate k4 and dissociates at a rate
k-4, there being no explicit degradation from the complex; i.e. the proteins dissociate before they
decay. The evolution of [CycD:CDK4] is then given by
d[CycD:CDK4]
dt
= k4[CycD][CDK4]− k-4[CycD:CDK4]. (4.4)
We use the scalings shown in Table 4.1 to leave the final system
dM
dT
= 1 + k′1
β
1 + β
−M, (4.5)
dY
dT
= 1 + k′2
β
K ′2 + β
− k′43(Y K − C)− φY Y, (4.6)
dK
dT
= 1 + k′3
M
K ′3 +M
− k′42(Y K − C)− φKK, (4.7)
dC
dT
= k′-4 (Y K − C) . (4.8)
Time is scaled so that τ = 1/φMyc, parameters have been rescaled as shown in Table 4.2. It would be
more conventional to rescale so that the coefficients of (Y K −C) in equations (4.6), (4.7) and (4.8)
are identical; this is equivalent to scaling Y , K and C by the same factor. However to eliminate
further parameters and therefore simplify the system to the largest extent possible we scale the
variables differently. When the steady-state values are considered the (Y K −C) term is eliminated
(see equation (4.8)).
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Table 4.2: Summary of model parameters and their dimensionless counterparts.
Dimensional Estimate Units Non-dimensional Estimate
Parameter Parameter
K1 1.0 nM — —
K2 1.0 nM K
′
2 = K2/K1 1.0
K3 1.08 nM K
′
3 = K3/(τk1b) 1.08
k1b 1.0 nM min
−1 — —
k1 9.0 nM min
−1 k′1 = k1/k1b 9.0
k2b 1.0 nM min
−1 — —
k2 3.74 nM min
−1 k′2 = k2/k2b 3.74
k3b 1.0 nM min
−1 — —
k3 4.21 nM min
−1 k′3 = k3/k3b 4.21
k4 1.0 nM
−1 min−1 k′42 = k4k2bτ
2 1.0
— — — k′43 = k4k3bτ
2 1.0
k-4 1.0 min
−1 k′-4 = k-4τ 1.0
φMyc 1.0 min
−1 — —
φCycD 1.0 min
−1 φY = φCycDτ 1.0
φCDK4 1.0 min
−1 φK = φCDK4τ 1.0
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4.2.2 Modelling Gene Knockouts
In Sansom et al.’s gene-knockout experiments both copies of a gene were removed from DNA by
Cre recombinase. As discussed in section 4.1.1 the technique Sansom et al. used has the effect of
immediately stopping mRNA transcription, although existing proteins survive (and translation of
proteins from existing mRNAs may continue) for a short time until the natural turnover eliminates
the protein from the cell. Here we address the modifications needed to equations (4.5)–(4.8) in order
to model the process of Sansom et al.’s knockout experiments.
To model this experimental process of an APC knockout we assume that β-catenin will attain
its maximum value, as discussed in section 3.2.3. We further assume that a large value of β in
effect saturates the Michaelis-Menten terms in equations (4.5) and (4.6) such that equation (4.5) is
modified to read
dM
dT
= 1 + k′1 −M, (4.9)
and equation (4.6) becomes
dY
dT
= 1 + k′2 − k
′
43(Y K − C)− φY Y. (4.10)
To model a Myc knockout we assume that there is no longer any production ofM , such that equation
(4.5) transforms to simply
dM
dT
= −M, (4.11)
the natural protein turnover eliminates Myc from the cell.
To model a double knockout of APC and Myc we use equations (4.11) and (4.10) in place of (4.5)
and (4.6) respectively.
4.3 Results
4.3.1 Time-dependent behaviour
Note that equation (4.5) decouples from the rest of the system. If β is time-independent, then
equation (4.5) can be solved to give
M(T ) = M˜ +
(
M(0)− M˜
)
e−T , (4.12)
where M(0) is the initial condition and M˜ represents the steady-state value for M(T → ∞), given
by
M˜WT = 1 + k
′
1
β
1 + β
, M˜A = 1 + k
′
1, and M˜M = M˜AM = 0
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for the wild-type, APC knockout, Myc and double knockouts respectively.
To examine the behaviour of the model as the protein knockouts take effect we have plotted equation
(4.12) and solved equations (4.6)–(4.8), or their equivalents for the knockout experiments, numer-
ically with the ODE solver routine ode45 in MatLab. The solutions can be seen in Figure 4.3.
The effect of an APC knockout is presented in Figure 4.3(a). After the knockout the production of
both Cyclin D and c-Myc is upregulated, leading to a higher rate of production of CDK4. However
the level of free CDK4 in the cell drops, as it is quickly incorporated into Cyclin D:CDK4 (due
to the high levels of Cyclin D). The increased production of CDK4 via Myc compensates for this
over time and leads eventually to higher levels of CDK4 and Cyclin D:CDK4. We propose that this
mechanism could be responsible for the hyperproliferation of the colonic epithelial cells when an
APC mutation occurs (Sellin et al., 2001).
The results of the Myc knockout are presented in Figure 4.3(b); the production of Myc is switched
off, leading to an exponential decay in the Myc level towards zero. Myc’s promotion of CDK4 falls as
a result, and CDK4 levels are reduced by the natural turnover rate of the protein. Cyclin D:CDK4
levels fall to a new steady-state value, releasing Cyclin D, which causes a small transient peak before
the Cyclin D level returns to its original steady-state value. The result of the Myc knockout is a
reduction in the concentration of Cyclin D:CDK4.
The effect of a double (APC and Myc) knockout is shown in Figure 4.3(c). The level of Myc falls
exponentially, as it did in the simulation shown in Figure 4.3(b) and as does the profile for CDK4,
which eventually reaches the same equilibrium levels as for the Myc knockout. However the level
of Cyclin D increases dramatically, as it did under the single APC knockout. This initially leads to
a peak in Cyclin D:CDK4 levels, as (for our particular choice of parameter values) Cyclin D levels
increase more rapidly than free CDK4 is degraded. After some time the levels of CDK4 become
sufficiently low to balance the increase in Cyclin D levels, such that their product (Y K, the rate of
production of Cyclin D:CDK4) is similar to that of the wild-type case. This makes the level of C,
[Cyclin D:CDK4], our input into the cell cycle, similar to that of the wild-type case; i.e. we have
qualitative agreement with Sansom et al.’s results.
4.3.2 Steady States
To analyse the behaviour of the system without resorting to simulation we examine the steady
states of the equations, which can all be found analytically. Equations (4.5)-(4.8) admit a unique
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Figure 4.3: Time-dependent simulations of the three knockout experiments. (a) APC knockout,
(b) Myc knockout and (c) APC, Myc double-knockout. The knockout experiments
are performed as discussed in section 4.2.2 on the nondimensional equations (4.5)–
(4.8) at T = 25, with the initial conditions being the steady state of the wild-type
equations. Simulations performed with β = 1
8
and the other parameter values shown
in Table 4.2.
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steady state, which can be found by setting the time derivative to zero in each equation. Denoting
steady-state values with tildes, it is straightforward to derive analytic expressions for the steady-state
solutions for the various cases or interest.
Wild-Type Steady States
At the wild-type steady state of equations (4.5)–(4.8), denoted by a subscript ‘WT’, we have:
M˜WT = 1 + k
′
1
β
1 + β
, (4.13)
Y˜WT =
1
φY
(
1 + k′2
β
K ′2 + β
)
, (4.14)
K˜WT =
1
φK
(
1 + k′3
M˜WT
K ′3 + M˜WT
)
, (4.15)
C˜WT =
1
φKφY
(
1 + k′2
β
K ′2 + β
)(
1 + k′3
M˜WT
K ′3 + M˜WT
)
. (4.16)
APC Knockout Steady States
If we denote the APC knockout steady states with a subscript ‘A’, then our steady state for equations
(4.9), (4.10), (4.7) and (4.8) becomes:
M˜A = 1 + k
′
1, (4.17)
Y˜A =
1
φY
(1 + k′2) , (4.18)
K˜A =
1
φK
(
1 + k′3
M˜A
K ′3 + M˜A
)
, (4.19)
C˜A =
1
φKφY
(
1 + k′2
)(
1 + k′3
M˜A
K ′3 + M˜A
)
. (4.20)
Comparing (4.13)–(4.16) with (4.17)–(4.20), we deduce that
M˜A > M˜WT,
Y˜A > Y˜WT,
K˜A > K˜WT,
C˜A > C˜WT.
Thus, as expected, following an APC knockout the levels of all model variables are elevated relative
to the wild-type.
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Myc Knockout Steady States
We determine this steady state by fixing M˜ = 0 in equations (4.13)–(4.16). if we denote it by a
subscript ‘M’, then our Myc knockout steady state has
M˜M = 0, (4.21)
Y˜M =
1
φY
(
1 + k′2
β
K ′2 + β
)
, (4.22)
K˜M =
1
φK
, (4.23)
C˜M =
1
φKφY
(
1 + k′2
β
K ′2 + β
)
. (4.24)
Comparing (4.13)–(4.16) and (4.21)–(4.24) we note that
M˜M < M˜WT,
Y˜M ≡ Y˜WT,
K˜M < K˜WT,
C˜M < C˜WT.
Therefore the levels of all variables are diminished following a Myc knockout, except for free Cyclin D
(Y ) whose levels remain unchanged as Myc is not a transcription factor for Cyclin D.
Double APC and Myc Knockout Steady States
A double (APC and Myc) knockout is denoted by a subscript ‘AM’. The steady states of equations
(4.11), (4.10), (4.7) and (4.8) are
M˜AM = 0, (4.25)
Y˜AM =
1
φY
(1 + k′2) , (4.26)
K˜AM =
1
φK
, (4.27)
C˜AM =
1
φKφY
(1 + k′2) , (4.28)
respectively. In this case, comparison of (4.13)–(4.16) and (4.25)–(4.28) reveals that
M˜AM < M˜WT,
Y˜AM > Y˜WT,
K˜AM < K˜WT.
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Table 4.3: Experimental results from Sansom et al. (2007, supplementary material).
Protein APC knockout
vs. Wild-Type
Myc 4.99
Cyclin D2 4.09
CDK4 2.39
Protein APC Myc knockout
vs. Wild-Type
CDK4 0.51
The Myc knockout causes a downregulation in CDK4 levels (K), yet the APC mutation causes an
increase in Cyclin D (Y ) levels. It is not possible to derive an inequality for the concentration of
Cyclin D:CDK4 (C) as it is proportional to the product of Y˜AM and K˜AM. The size of C˜AM relative
to C˜WT depends crucially upon parameter values. It is possible that under certain parameter
regimes C˜AM ≈ C˜WT, which would be consistent with Sansom et al.’s experimental observation
of approximately equal levels of proliferation. Below we will use the experimental observations of
Sansom et al. (2007) to fix some of our parameter values.
4.3.3 Parameter estimates
In this section we match the steady-states of our model with steady-state values recorded in
Sansom et al. (2007), in order to estimate parameter values. In their supplementary material
Sansom et al. (2007) record the overall protein concentrations relative to the wild-type case. These
figures provide a measure of the total amount of protein present, including protein that is complexed
with other proteins, and are shown in Table 4.3.
The values in Table 4.3 represent averages over many epithelial cells. In the wild-type case these cells
would have been exposed to a range of Wnt stimuli, and hence have different β-catenin levels. To
compare the experimental results with results from our model we first reinterpret β as representing
the fixed, ‘mean’ level of β-catenin that these cells contained, labelling this βˆ. We explain below how
the data contained in Table 4.3 may be combined with our expressions for the steady-state solutions
to deduce four independent relationships between the system parameters.
From Table 4.3 we infer that:
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1. Myc is 5 times higher for APC knockouts than for the wild type,
2. Cyclin D2 is 4.1 times higher for APC knockouts than for the wild type,
3. CDK4 is 2.4 times higher for APC knockouts than for the wild type,
4. CDK4 is 0.5 times the wild-type level in double knockouts.
Remembering that the relationships above refer to the total levels of proteins present, using the
steady-states established in section 4.3.2, experimental observations (1)–(4) become
5M˜WT = M˜A, (4.29)
4.1(Y˜WT + C˜WT ) = Y˜A + C˜A, (4.30)
2.4(K˜WT + C˜WT ) = K˜A + C˜A, (4.31)
0.5(K˜WT + C˜WT ) = K˜AM + C˜AM . (4.32)
These knockout experiment results could reflect influences from many other upstream and down-
stream targets of this, and other pathways and are not necessarily all due to the mechanism we
have proposed; however, we will show that the model outlined in Figure 4.2 is consistent with these
results when parameters are within certain ranges.
The dissociation rate of β-catenin:TCF with a Cyclin D promoter is likely to be the same as that
with a Myc promoter, so we assume that K2 = K1, which implies that K
′
2 = 1. We also assume
that the decay rate φK = φY = 1.0 i.e. that Cyclin D and CDK4 have the same decay rate as Myc.
The rates for k4 and k-4 do not affect the steady states and are assumed to be equal to one. Here
we use the relationships (4.29)–(4.32) to provide estimates for k′1, k
′
2, k
′
3 (parameters indicating the
size of targeted production relative to background production rates) and K ′3 (the Michaelis-Menten
dissociation constant for Myc on the CDK4 promoter).
Substituting from equations (4.13) and (4.17) into equation (4.29) and rearranging leads to the
following expression for k′1:
k′1 =
4
(
1 + βˆ
)
1− 4βˆ
. (4.33)
Equation (4.33) defines the fixed value of k′1 in terms of the input βˆ; for instance, taking βˆ = 0.1
we obtain k′1 = 7.33. However β is an input into our model, and may vary; here we treat βˆ as fixed,
namely the mean value experienced by the cells in the experiments. From (4.33) we deduce that β
should lie in the range 0 6 βˆ < 14 , for consistent solutions. This means that β-catenin is not close to
saturation levels for promoting genes in healthy cells. We remark further that if βˆ > 14 then it would
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not be possible for Myc levels in APC knockouts to be five times greater than those in wild-type
cells, i.e. the experimental results cannot be matched.
Substituting (4.14), (4.16), (4.18) and (4.20) into equation (4.30) provides us with a rather more
complicated expression for k′2, given by
k′2 =
4.1
(
φK + 1 + k
′
3
M˜WT
K′3+M˜WT
)
−
(
φK + 1 + k
′
3
M˜A
K′3+M˜A
)
(
φK + 1 + k′3
M˜A
K′3+M˜A
)
− 4.1 βK′2+β
(
φK + 1 + k′3
M˜WT
K′3+M˜WT
) . (4.34)
Taken together, observations (4.31) and (4.32) imply that
K˜A + C˜A = 4.8
(
K˜AM + C˜AM
)
,
which gives us a value for k′3, namely
k′3 = 3.8
K ′3 + 1 + k
′
1
1 + k′1
. (4.35)
Finally equation (4.32) can be written
K ′3 =
(
k′3(1 + φY ) + k
′
2
β
K′2+β
− φY + 1 + k
′
2
β
K′2+β
− 2(1 + k′2)
)
M˜WT
φY − 1− k′2
β
K′2+β
+ 2(1 + k′2)
. (4.36)
We now have k′1, k
′
2, k
′
3 and K
′
3 defined in terms of the other parameters by equations (4.33)–(4.36),
to satisfy the requirements of (1)–(4) above. In Figure 4.4 we show how these parameters vary
for 0 < βˆ < 14 . In Figure 4.4 we observe that k
′
1 and K
′
3 are highly sensitive to variations in βˆ,
varying by several orders of magnitude as equations (4.33) and (4.36) both have asymptotes at
βˆ = 14 . The parameters k
′
2 and k
′
3 increase with increasing β, but remain O(1) as 0 < βˆ <
1
4 . k
′
1
controls the level of production of Myc via β-catenin promotion, whilst K ′3 affects the level of Myc’s
promotion of CDK4, which suggests that the model is sensitive to these interactions. The fact that
we can establish a range of parameter values in Figure 4.4 which recreate the steady state behaviours
observed, suggests that this model is a plausible mechanism by which the Wnt/β-catenin signalling
pathway influences Cyclin D and CDK4 levels.
We fix βˆ = 18 as our ‘mean’ stimulus for the pathway, as it falls in the centre of the range of stimuli
which reproduce the observed experimental results. With βˆ = 18 in (4.33)–(4.36) we calculate the
nondimensional parameters shown in Table 4.2, suggesting combinations of dimensional parameters
which would lead to these dimensionless parameters where appropriate. Notice that all of the ‘k’
parameters are greater than one, suggesting the promotion rates are capable of being higher than
background expression rates.
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Figure 4.4: Dependence of nondimensional parameters (a) k′1, (b) k
′
2, (c) k
′
3 and (d) K
′
3 on β;
for 0 < β < 1
4
. All other parameters are set to one.
4.3.4 Steady-state variation throughout the crypt
In Figure 4.5 we present the steady states for different knockout experiments under the fixed param-
eters, defined by substituting β = βˆ = 18 into the expressions of section 4.3.2. The protein/complex
concentrations are scaled to one in the wild-type (WT) case. Note that the levels of Cyclin D:CDK4
are our model ‘output’ as this is the complex involved in stimulating the cell cycle.
Figure 4.5 shows that the APC knockout leads to high levels of β-catenin, causing an increase in
Myc and Cyclin D levels. The elevated Myc levels cause a knock-on increase in CDK4. This leads
to elevated levels of Cyclin D:CDK4, which are responsible for the increased proliferation of APC
knockout cells.
The Myc knockout removes any Myc from the system, leading to reduced levels of CDK4. Free
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Figure 4.5: Steady-states of equations (4.5)–(4.8), defined by equations (4.13)–(4.28), using the
parameter values in Table 4.2 and the mean stimulation of β = 1
8
.
Cyclin D levels remain constant and the level of Cyclin D:CDK4 is reduced as there is less CDK4
available. We would expect Myc deficient cells to display less proliferation than wild-type cells.
The APC-Myc double knockout leads to lower levels of CDK4 (as there is no Myc promotion), but
high levels of Cyclin D (as there are high levels of β-catenin). The high availability of Cyclin D and
low availability of CDK4 balance out in the formation term for Cyclin D:CDK4 (equation (4.4)); these
steady state levels are close to those of WT cells, compensating for the effects of an APC knockout.
We remark that this observation was not used when we estimated our parameters: it emerged
naturally from the model as a result of the parameters fixed by the experimental observations in
Table 4.3.
In Figure 4.6 we plot the variation of the steady states (equations (4.13)–(4.28)), since β-catenin
levels have been observed to vary along the axis of a colorectal crypt. Since the mean level, βˆ that
is experienced in all cells is here within the range 0 < βˆ < 14 it is possible that the actual range of β
which individual cells experience varies more widely. Here we have chosen the base of the crypt to
take a value of β = 12 , and the top of the crypt to take a value of β = 0.
In the wild-type case shown in Figure 4.6(a) we can see that the low values of β (representing the top
of the crypt) cause low values of all proteins. Crucially, a low value of C (Cyclin D:CDK4) allows
the cell to cease cycling, though the cell cycle can still be initiated by Cyclin D:CDK complexes
involving other Cyclin Ds or CDK6, which are not included in the model. As β increases the levels
of all proteins, including C, increase monotonically, suggesting that this increase in the level of C
99
4.3 Results Chapter 4: Wnt, c-Myc and the Cell Cycle
0 0.1 0.2 0.3 0.4 0.5
0
5
10
15
20
25
β
Le
ve
l
Wild−Type
 
 
Myc
Cyclin D
CDK4
Cyclin D:CDK4
(a)
0 0.1 0.2 0.3 0.4 0.5
0
5
10
15
20
25
β
Le
ve
l
APC Knockout
 
 
Myc
Cyclin D
CDK4
Cyclin D:CDK4
(b)
0 0.1 0.2 0.3 0.4 0.5
0
5
10
15
20
25
β
Le
ve
l
Myc Knockout
 
 
Cyclin D = Cyclin D:CDK4
CDK4
(c)
0 0.1 0.2 0.3 0.4 0.5
0
5
10
15
20
25
β
Le
ve
l
APC, Myc Knockout
 
 
Cyclin D = Cyclin D:CDK4
CDK4
(d)
Figure 4.6: Variation of the steady states of the model with β for (a) wild-type; (b) APC knock-
outs; (c) Myc knockouts and (d) APC Myc double-knockouts. In (c) and (d) the
Cyclin D:CDK4 (C) and Cyclin D (Y ) lines are coincident, since C˜ = Y˜ K˜ and
K˜M = K˜AM = 1 in this parameter regime. Generated using equations (4.13)–(4.28)
and the parameter values in Table 4.2.
forces cells to undergo proliferation at the base of the crypt.
Figure 4.6(b) shows the protein levels under an APC mutation. The values of the variables are
independent of β. The level of C is highly upregulated throughout the crypt, leading to uncontrolled
cell-cycling, as observed in experiment (Nagase & Nakamura, 1993).
In Figure 4.6(c) we see the effect of a Myc knockout. Cyclin D behaves in the same way as the
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wild-type case, but levels of CDK4 remain constant as there is no β-dependence via Myc levels. For
this reason the level of C is reduced, which we would expect to reduce the crypt’s proliferation rate.
Figure 4.6(d) shows the results for the double APC-Myc knockout. Here the level of Cyclin D follows
the APC knockout (increased relative to wild-type), and the level of CDK4 follows the Myc knockout
(reduced relative to wild-type). The product of Cyclin D (Y ) and CDK4 (K) informs the level of
Cyclin D:CDK4 (C), which can therefore attain values which are similar to that of wild-type crypts.
This is a potential mechanism for reversing the effects of the APC knockout. However, we note that
there is no control over C levels throughout the crypt. Since crypts with the double-knockout appear
to maintain a healthy architecture of proliferation at the base and differentiation towards the top
we postulate that another mechanism must be responsible for this control, possibly a non-canonical
Wnt signalling pathway (as postulated in Figure 4.2).
4.4 Therapeutic Implications
The loss of APC in the knockout experiments has the same effect upon β-catenin levels as one
of the truncating mutations which often occur in early colorectal cancer (Na¨thke, 2006). Since an
additional Myc knockout reverses the effects of the APC knockout, it is possible that a novel therapy
involving down-regulation of Myc or one of its downstream targets could be used to treat patients
carrying a truncating APC mutation. In this section we will use our model to predict which of
our parameters are most important in regulating Cyclin D:CDK4 levels and hence suggest the most
likely candidates for drug targets.
The steady-states of Cyclin D:CDK4 levels were given by equations (4.16), (4.20), (4.24) and (4.28)
for the wild-type, APC knockout, Myc knockout and double knockout cells respectively.
An ideal drug target for this pathway would be β-catenin. As the upstream input, β upregulates
all proteins in the pathway. However, this has long been known and investigated as a possible
therapeutic target. β-catenin seems to be crucial for healthy operation of cells (see Luu et al., 2004;
Galmozzi et al., 2006, for reviews); here we use our model to suggest new possibilities.
4.4.1 Myc
Downregulation of Myc, mimicking the effect of the double-knockout, is an obvious new therapy sug-
gested by Sansom et al.’s experiments. In the case of an APC knockout the level of Cyclin D:CDK4
is elevated to four times that seen in wild-type cells (see Figure 4.5). However we cannot completely
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block transcription of a gene to mimic the experimental results, without deleting it from the DNA
which could be disastrous if Myc is required in other tissues. Alternatively the introduction of spe-
cially engineered small interfering RNA (siRNA) can degrade a specific mRNA and block translation
of a protein, however this is not yet a standard medical treatment either. A feasible drug target
would be one which blocks the promoter region of a gene (or the transcription factor itself), by
binding to it and repressing transcription. In Figure 4.7(a) we see how varying the size of k′1 by up
to a factor of two affects the final level of C˜A (Cyclin D:CDK4 in a mutant cell) relative to the level
in a wild-type cell.
Figure 4.7(a) suggests that on reducing k′1 to zero, the mutant cell will still have Cyclin D:CDK4
levels which are 2.5 times higher than in wild-type cells. This suggests that even reducing k′1 to zero
— blocking all β-catenin-dependent transcription of Myc, would not reverse the effects of an APC
mutation, as the background level of Myc promotion (k1b) would provide enough Myc to maintain
an aberrant phenotype. Alternatively the degradation rate of c-Myc could be increased, although
this would seem to be more difficult to target in practice.
4.4.2 Cyclin D
Levels of Cyclin D do not change between the APC knockout and double-knockout (Figure 4.5),
although it is proposed that their upregulation is the main cause of the disregulation observed in
the APC knockout. For this reason downregulation of Cyclin D is worth investigating as a potential
therapeutic target.
The parameters which control Cyclin D levels can be seen by comparing equation (4.18) for the
steady-state level of Cyclin D in an APC knockout with equation (4.14) for the wild-type cells.
Figure 4.7(b) shows the extent to which k′2 would have to be reduced to achieve wild-type levels
of Cyclin D:CDK4. This could be achieved with a molecule which has a high affinity for the β-
catenin:TCF promoter region of Cyclin D2. Upregulation of φY would also be a valid approach, but
is again difficult to target uniquely.
In all cases it is difficult to find drugs which target only the promoter region of a single gene. As
we saw in section 1.4.2 β-catenin:TCF binds to the promoter region of around 100 genes. It may,
however, be possible to find a molecule which binds to a unique DNA sequence that includes the
β-catenin:TCF promoter region.
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Figure 4.7: Parameter sensitivity: The effect of varying a parameter on the steady-state level of
Cyclin D:CDK4 (C˜A) in a cell with an APC knockout given by equation (4.20). The
level of C˜A is given relative to that of a wild-type cell for our base-case of β =
1
8
. We
vary only the following parameters in subfigure (a) k′1, (b) k
′
2, and (c) k
′
3 all other
parameters are as shown in Table 4.2.
4.4.3 CDK4
Another possible drug target is CDK4, the only difference between the level of Cyclin D:CDK4 in
the APC knockout (equation (4.20)) and the double knockout (equation (4.28)) being the size of K˜
— the steady state level of CDK4. The aim would be to reduce the level of K˜A given by equation
(4.19) to be the same numerical value as K˜AM given by equation (4.27).
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To do this we could increase the degradation rate φK , or reduce the rate k
′
3. If k
′
3 could be reduced
to zero then the level of K˜A and C˜A would fall to their healthy or double-knockout levels, as shown
in Figure 4.7(c); we therefore propose that a healthy proliferation rate could be achieved by this
route. To reduce k′3 we would have to block Myc’s upregulation of CDK4. One way to do this
would be to find a molecule which has a higher affinity than Myc for the DNA sequence of the Myc
promotion region of the CDK4 gene. It is possible that CDK6 would fulfil the role of CDK4 in most
tissues, and so targetting CDK4 could be the least damaging approach for a viable therapy.
4.5 Discussion
In this chapter we formulated a model to explore the regulation of the cell cycle by β-catenin. We
have examined the role of c-Myc, Cyclin D and CDK4 and our results suggest that all three proteins
interact to determine the cellular level of Cyclin D:CDK4, an input into the cell cycle. The model
reproduces the results of a recent set of knockout experiments suggesting it represents a feasible
mechanism by which Wnt signalling regulates the cell cycle.
Given the overwhelming complexity of pathways involved in regulating the cell cycle, many as-
sumptions have to be made to make any progress analysing a model. In our initial collaborations
with Dr Owen Sansom at the Beatson Institute it was suggested that p21 would be an important
downstream repression target of c-Myc (Wanzel et al., 2003; Liu et al., 2006b). As we explained in
section 1.3.2, p21 plays an important role in promoting the cell cycle. Interestingly p21 is required
to activate the Cyclin D:CDK4 complex (Sherr & Roberts, 1999; Gartel & Radhakrishnan, 2005)
and yet it disables Cyclin E:CDK2 complexes. Additionally p21 can form inactive complexes with
c-Myc (p21:Myc) and E2F1 (p21:E2F1).
We incorporated these interactions into a framework based upon Figure 3.3, formulating an intricate
model, but suffered from a lack of any experimental data on which to base parameter values. Varying
the levels of p21 did not seem to affect the output of the model significantly. Recently Dr Sansom’s
group performed a treble knockout of c-Myc, APC and p21 and found this to have much the same
phenotype as the c-Myc APC double-knockout (O. Sansom, personal communication, December
2007) so this model may be worth revisiting in the future.
Wnt signalling models such as Lee et al. (2003) and Cho et al. (2006) cannot explain the knockout
experiments, as they focus on the Wnt/β-catenin pathway (upstream of Myc). We believe that the
model of chapter 3 was the first to link Wnt signalling quantitatively to the cell cycle, yet this model
did not feature c-Myc and so could not explain Sansom et al.’s (2007) results. For these reasons the
104
4.5 Discussion Chapter 4: Wnt, c-Myc and the Cell Cycle
model presented in this chapter would seem to be as simple as possible whilst retaining the desired
behaviour under the various knockout experiments.
However, we note that we cannot represent a fully healthy crypt for a double-knockout using this
model: our results in Figure 4.6(d) have lost anyWnt-dependence. Since we use the Wnt dependence
to represent a spatial location this suggests that the cells’ behaviour would be the same in all areas
of the crypt. This is not entirely consistent with the results of Sansom et al. (2007), which showed
a normal crypt phenotype for the double knockout. This leads us to postulate a separate pathway,
shown in Figure 4.2, which retains some control over the cell cycle. Such a pathway could possibly
be due to non-canonical Wnt signalling or a related signalling pathway such as Notch or Hedgehog.
Consideration of this pathway and its influence over the cell cycle is a line of future research.
Yet further experiments have shown that “over the longer term both Myc and APC Myc deficient
cells are lost from the intestinal epithelium” (O. Sansom, personal communication, September 2007).
This could be due to a reduction in cell-cycle stimulus, such that a long-term homeostasis is not
possible, which would be consistent with our model for the reduced levels of cell-cycle proteins
under the Myc knockout. Alternatively another Myc target gene could be necessary to maintain
longer-term homeostasis for a healthy crypt.
The finding that our model can replicate the levels of proteins observed in Sansom et al. (2007) for a
number of different parameter regimes (Figure 4.4) suggests that it represents a possible mechanism
by which mutations in the Wnt pathway cause hyperproliferation, which an additional Myc knockout
can reverse. We have suggested some targets for reversing the effects of an APC mutation, with the
promoter regions of CDK4 and Cyclin D being promising subjects for further investigation.
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CHASTE Scientific Computing Environment
5.1 Introduction
T
he Integrative Biology1 project is a large collaboration between mathematical modellers, bi-
ologists and computer scientists aiming to create multiscale computational models, which
exploit High Performance Computing (HPC) resources, to better understand how cancer
and heart disease occur. Over the past three years the Integrative Biology project has been de-
veloping a scientific computing environment, featuring common code which can be implemented to
solve a range of biological problems. The computing environment is known as CHASTE — Cancer,
Heart And Soft Tissue Environment.
The Integrative Biology cancer PhD students have been the core developers for the cancer side of
the project, focussing initially on creating a software package to run simulations of a basic model
of crypt dynamics developed by Meineke et al. (2001) together with various extensions. The main
development work has been done by a team of six PhD students involved with cancer modelling
(myself, Alex Fletcher, Philip Murray, Pras Pathmanathan, James Osbourne and Alex Walter)
along with support from three computer scientists (Jonathan Cooper, Lee Momtahan and Joe Pitt-
Francis). Individually, I have spent approximately half of my time over 18 months in the development
of both the cell-cycle models, cylindrical mesh and experiment-mimicking simulation areas of the
code, although, as we will see in this chapter, no one person is solely responsible for any part of the
code.
In section 5.2 we introduce the Meineke et al. (2001) model, looking at the different componenets
and how they interact. In section 5.3 we explore some of the software engineering principles that
we have adopted for the CHASTE project. In section 5.4 we explain how these principles have
1www.integrativebiology.ox.ac.uk
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influenced the design of our model for the colorectal crypts and demonstrate how it may now be
used to simulate other cell-based models. In section 5.5 we discuss some of the advantages and
disadvantages of the approach we have taken. Firstly we motivate our decision to embark upon the
CHASTE project, highlighting the need for such a code.
5.1.1 Lessons from cardiac modelling
Cardiac modelling groups are well-established, having used numerical methods for over 40 years.
They began by simulating an action potential within a single cell (Noble, 1960), and now have
whole-organ heart models which can accurately predict the onset of arrhythmia under different
intra-cellular conditions (Noble, 2007). These groups have come to understand the need for shared
code, to avoid single researchers ‘reinventing the wheel’ when, for example, solving PDEs using finite
element methods.
Problems often occur when a research contract expires or a PhD student moves on, leaving a code
which only one person understands; usually this code has to be discarded, or is, at best, used as
a ‘black-box’ with no understanding of how it performs its function. Large codes rapidly become
untidy, containing many ‘black-boxes’ and, as one part of the code is expanded or improved, no-one
knows how this will affect the performance of the rest of the code. As a result, some heart modelling
codes can no longer even replicate some of their own past results.
The Integrative Biology project has developed a new cardiac modelling environment from scratch,
using a software engineering approach designed to avoid the pitfalls discussed above. In parallel with
this activity, we have developed a cancer modelling environment, sharing, amongst other things, the
mesh structure and ODE/PDE solvers with the cardiac modellers.
5.1.2 Common themes in cancer
If our sole aim were to run simulations of a single model, then it would not be appropriate to use an
approach where components are shared and made as flexible as possible. However we have developed
a code which we hope is easy to adapt to run simulations of many different models, utilising common
code for common modelling components.
As we saw in section 1.5.2, many models of colorectal cancer operate at the cell scale, and share
common features, such as subcellular models of the cell cycle and the need to pass information to
a daughter cell upon division. It is desireable that such sub-models for the cell cycle should share
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a common format, so that the same cell-cycle model may be incorporated into different cell-based
models. Similarly, models for other cell behaviours such as cell-cell or cell-substrate adhesion and
cell death may be applicable to many different systems.
Many cancer models include PDEs to describe the production, diffusion and uptake of vital chemicals:
nutrients such as oxygen, growth factors, and drugs (Byrne & Chaplain, 1995; Jackson & Byrne,
2000; Mallet & De Pillis, 2006; Gerisch & Chaplain, 2008). Codes for solving such a PDE using a
finite element method on a mesh would be applicable to many cancer (and other) models. Before
the CHASTE project no flexible framework for incorporating such elements into different cancer
models existed. By including codes for solving these sub-problems into a software environment, we
have made it easier to develop new models that include combinations of these features. Our initial
aim was to create a software package to run simulations of the Meineke et al. (2001) crypt model,
which we introduce in section 5.2 below.
5.2 The Meineke et al. (2001) Crypt Model
Meineke et al.’s (2001) model is a distinct improvement on earlier lattice-based models for the cellular
dynamics of crypts (Loeﬄer et al., 1986, 1988). As discussed in section 1.5.2, its main advantage
lies in preventing long-distance effects from distorting local activities such as cell birth, by moving
to an off-lattice framework. It consists of a cylindrical 2D mesh, constructed using a Delaunay
triangulation (or, equivalently, a Voronoi tessellation). Each node of the mesh represents the centre
of a cell. Cells are connected by springs, defined by the Delaunay triangulation, and move in a
heavily-damped manner according to the forces exerted on them by their springs. At the base of
the cylinder are a number of fixed Paneth and ‘stem’ cells. Stem cells (generation= 0) produce
daughter ‘transit’ cells (generation= 1) at a constant rate. Transit cells divide a fixed number
of times, and then become ‘differentiated’. In this way the introduction of daughter cells drives
migration throughout the crypt and cells are removed once they reach the top of the crypt.
5.2.1 Cells represented by nodes
Meineke et al. note that cells in an in vivo crypt pack polygonally, and the inability to reproduce
this is a weakness of previous lattice-based models. A set of nodes, meshed using a Delaunay trian-
gulation, is used to describe the positions of cell centres. The Delaunay triangulation is equivalent
to a Voronoi tessellation, which here describes the area of the cell belonging to each node. A Voronoi
tessellation allocates every point in space to the node nearest it, with cell boundaries demarcating
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lines of equal distance between two nodes.
A Delaunay triangulation and its corresponding Voronoi tessellation are presented in Figure 5.1.
When a 2D spring system is allowed to relax fully it forms a regular mesh of equilateral triangles,
whose accompanying Voronoi tessellation is a ‘honeycomb’ pattern of regular hexagons; the nodes
towards the top of the crypt depicted in Figure 5.1 behave in this way; the Voronoi representation
appears to emulate naturally the shape of epithelial cells (cf. Meineke et al., 2001, Figure 1).
The mesh presented in Figure 5.1 is in fact surrounded by some invisible nodes, which we term
‘ghost nodes’. The nodes are meshed into a ‘convex hull’ which leaves very long connections (springs
in this case) on the edges of the mesh; by creating ghost nodes the long springs and large forces do
not affect the real cells. Additionally this avoids the Voronoi tessellation for cells on the edge of the
mesh becoming semi-infinite and making visualisation difficult. This effect is a direct consequence of
the definition of a Voronoi tessellation: any point in space outside our mesh is closest to one of the
nodes on the edge of the mesh, and so the Voronoi tessellation extends infinitely in all directions.
By including a layer of ‘ghost nodes’ around the cells on the edge of the mesh we introduce finite
limits to the Voronoi tessellation for all of our cells, leaving some of the ghost nodes with infinite
tessellations.
Figure 5.1: A Delaunay triangulation of a set of nodes (left) and the corresponding Voronoi
tessellation (right). The number of Delaunay triangles (mesh elements) that a node
is involved in is equivalent to the number of sides that the cell has, as defined by the
Voronoi tessellation.
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Since nodes move at every timestep (discussed in the next section), are added because of cell birth and
are removed because of cell death, a remeshing must be performed at each timestep; the remeshing
is performed as discussed in section 5.4.1.
5.2.2 Cell Mechanics
The black lines connecting the nodes in Figure 5.1 are the edges of elements in the mesh. The
Meineke et al. (2001) model places springs along each of these edges, thereby connecting each node
(or cell) to its nearest neighbours. The total force, Fi, acting on a cell, i, due to cell-cell interactions
is obtained by summing the forces associated with the deformation of the springs that connect it to
all other cells in its neighbourhood. Using the suffix j to denote cells that are adjacent to cell i we
have
Fi(t) = µ
∑
∀j(t)
rˆij(t) (sij(t)− |rij(t)|) , (5.1)
where rij is the vector from cell i to cell j, rˆij is the corresponding unit vector, sij is the resting
length of the spring connecting cells i and j, and µ is the spring stiffness constant, which models
the strength of cell-cell adhesion. By giving individual pairs of cells different values of µij we could
model differential adhesion characteristics.
For an overdamped (‘high Reynold’s number’) system, where inertial terms are considered small
compared to dissipative terms, the velocity of node i is then given by
η
dri
dt
= Fi(t), (5.2)
where ri is the position of node i, and η is the damping constant representing the strength of
cell-substrate adhesion.
The displacement of node i, in a given time interval ∆t, is then given by the following equation
derived from equation (5.2) and formed using a Forward Euler discretisation
ri(t+∆t) = ri(t) +
1
η
Fi(t)∆t. (5.3)
Unless otherwise stated we fix ∆t = 30 s, µ = 30 kg s−2 and η = 1 kg s−1 in the simulations that
follow. We find that the ratio of µ/η leads to different behaviours: if this ratio is too large then
oscillations in cell movements can occur, as there is insufficient damping; if the value is too low
then cell birth causes a build up of cell density in the crypt, cells do not leave the crypt as their
movement is too heavily damped and the crypt does not reach a steady population. Using the above
parameters no oscillations are observed and the crypt reaches a quasi-steady population.
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5.2.3 Cell Birth
Addition of new nodes
A cell is added by picking an angle θ at random, moving the parent node a small distance in the
θ direction and adding a daughter cell a small distance in the pi + θ direction. After a remesh the
nodes are inevitably joined by a new spring (as they are very close toegether). The spring’s rest
length evolves as follows
sij =

s for aij > tM ,
aijs/tM for aij < tM ,
(5.4)
where aij is the age of spring sij , tM is the length of the M phase of the cell cycle, and s is the
mature resting spring length. We have nondimensionalised space in our simulations such that s = 1
and space is measured in ‘mature spring lengths’ or equivalently ‘mature cell widths’.
Cell cycle model
In Meineke et al. (2001) the cell cycle is controlled by the generation number of a particular cell.
A stem cell is always of generation 0. After a fixed length of time it divides asymmetrically, and
produces a daughter cell of generation 1. Cells of generation 1 are called ‘transit’ cells and, after a
fixed amount of time, divide symmetrically to produce two transit cells of generation 2. When cells
reach a certain generation number (a parameter, usually set to 3 or 4) they ‘differentiate’ and no
longer progress through the cell cycle.
The duration of a cell cycle is determined at birth, by selecting the length of the G1 phase, tG1,
from a uniform distribution of U(tG1; 10, 15) hours. The duration of the other cell-cycle phases is
fixed throughout the simulation. Cells can report which phase of the cell cycle they are currently
undergoing. To use this type of cell-cycle model the stem cells must remain in the crypt indefinitely,
otherwise the loss of one or more stem cells would dramatically change the homeostasis of the crypt.
As a result stem cells must be held pinned at the base of the crypt.
5.3 The CHASTE Approach
Often MatLab or Mathematica are used to run simulations of small to medium sized models, being
easy to use and well-supported. However these are interpreted languages, which read and run the
code one line at a time. CHASTE is written in C++. As it is a compiled language, the entire
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code is read and built into an executable file of machine-code, optimised for speed on the individual
processor(s) that will run the program. Compiled languages are up to 1000 times faster than
interpreted languages when performing numerical tasks (DeRose & Padua, 1999), and hence better
suited for large problems where the run-time is a limiting factor.
The CHASTE project was initiated during a month long programming session in 2005, when we set
up the common parts of the code. This has been followed by sixteen cancer group programming
sessions, based in the Oxford ComLab and typically of three to five days duration. We have also
worked individually to develop the code in-between these group sessions.
In this section we will outline and discuss the merits of the main software engineering principles that
we have adopted for the CHASTE project.
5.3.1 Test-driven development
The fundamental principle we have used to develop CHASTE is known as test-driven development.
At a basic level ‘testing’ means that every line of code is tested to ensure it does what it was
written to do. This could take the form of a single high-level test; testing, for example, that a crypt
simulation progresses as it should. But such high-level tests do not tell you anything about precisely
what has changed when something goes wrong.
Write source−codeWrite test−code
Refactoring
Decide on interface
New function
Figure 5.2: The process of test-driven development.
Instead, test-driven development is a way of writing code. Before any source-code is written a test-
code must be made to test its function. This process is illustrated in Figure 5.2. The first task
when a new function is required is to work out the interface that the new code will use, this being
performed by writing a test code. This process often leads to changes in the interface, as the simplest
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form becomes more evident upon implementation. Once a test-code is written the source-code can
be developed until the test passes. Only once this has been achieved can more functions be added.
The process of ‘refactoring’ is also shown in Figure 5.2. This is a name for the constant revisiting
of the source-code, attempting to make the whole code base as tidy and user-friendly as possible,
avoiding repetition of code and optimising performance. Because the whole code is thoroughly
tested, refactoring is done without changing tests to ensure that the code still performs its original
function properly.
A test-code is presented in Figure 5.3. In this example we have decided that a FixedCellCycleModel
will need to return the time until the next division, and that this will vary depending on the cell
type. Once this test is in place the minimum amount of source-code necessary should be written to
make the test pass. In Figure 5.4 we see the source-code that was written to perform the functions
tested by the code in Figure 5.3. If we decide the source-code needs to do more, then the test-code
must first be extended to cover the extra functionality.
1 #ifndef TESTCELLCYCLEMODELS_HPP_
2 #define TESTCELLCYCLEMODELS_HPP_
3
4 #include <cxxtest/TestSuite.h>
5 #include "FixedCellCycleModel.hpp"
6
7 class TestCellCycleModels : public CxxTest::TestSuite
8 {
9 public:
10 void TestFixedCellCycleModel(void) throw(Exception)
11 {
12 FixedCellCycleModel our_fixed_cell;
13
14 our_fixed_cell.SetCellType(TRANSIT);
15 TS_ASSERT_DELTA(our_fixed_cell.GetInterDivisionTime(),12,1e-6);
16
17 our_fixed_cell.SetCellType(STEM);
18 TS_ASSERT_DELTA(our_fixed_cell.GetInterDivisionTime(),18,1e-6);
19
20 our_fixed_cell.SetCellType(DIFFERENTIATED);
21 TS_ASSERT_DELTA(our_fixed_cell.GetInterDivisionTime(),1e99,1e-6);
22 }
23 };
24 #endif /*TESTCELLCYCLEMODELS_HPP_*/
Figure 5.3: The test code for a FixedCellCycleModel, an example of one of the simpler CHASTE
cell-cycle models.
This style of development may appear overly complex, taking much longer than writing a piece of
source-code. However there are many advantages. Once a piece of source-code has been ‘protected’
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1 #ifndef FIXEDCELLCYCLEMODEL_HPP_
2 #define FIXEDCELLCYCLEMODEL_HPP_
3
4 #include "AbstractCellCycleModel.hpp"
5
6 class FixedCellCycleModel : public AbstractCellCycleModel
7 {
8 public:
9 double GetInterDivisionTime()
10 {
11 double inter_division_time;
12 switch(this->mCellType)
13 {
14 case STEM:
15 inter_division_time = 12;
16 break;
17 case TRANSIT:
18 inter_division_time = 18;
19 break;
20 default:
21 inter_division_time = 1e99;
22 break;
23 }
24 return inter_division_time;
25 }
26 };
27 #endif /*FIXEDCELLCYCLEMODEL_HPP_*/
Figure 5.4: The source code for a FixedCellCycleModel, an example of one of the simpler
CHASTE cell-cycle models.
by a test, nobody can accidentally change the code’s function without the test failing, and highlight-
ing the problem. If another developer changed the way SetCellType() functioned (used on lines
14, 17 and 20 of Figure 5.3), such that mCellType was not properly updated, then the test (which
uses mCellType on line 12 of the source-code in Figure 5.4) would fail and highlight a problem.
Sometimes changes are far more subtle: a change to a low-level piece of source code (e.g. the nodes
of a mesh) could adversely affect some higher-level source code (e.g. a simulation involving cells
associated with particular nodes). However the low-level source code is automatically called by the
test codes of all the relevant higher-level functions; this ensures that one developer can never break
a part of the code that they did not intend to change.
Thoroughly tested code is almost guaranteed to be bug-free, whereas in a ‘traditional’ coding setting
most effort is not expended in coding, but in hunting for bugs in the code, especially in the case of
large codes.
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5.3.2 Central code-repository
All CHASTE code is stored on a central server known as the ‘repository’. To work on a piece of
code the whole code must be ‘checked-out’ of the repository, with its relevant version number. To
upload any changes to the repository all tests must be run to ensure nothing has been broken. Any
changes are then ‘committed’ to the repository and are given a revision number.
Central Testing
As soon as a ‘commit’ has occurred, the server ‘checks-out’ the code and runs all of the tests.
This ensures that any discrepancies in software or hardware are quickly eliminated, ensuring that
CHASTE runs on any machine. These central test results are displayed on the project website at
https://chaste.ediamond.ox.ac.uk/tests.py.
Version Control
https://chaste.ediamond.ox.ac.uk gives access to a complete history of the project, all revisions
of the code being permanently recorded. The different versions are managed by SVN2 version
management which can merge together two files if more than one team has been working on the
same piece of code. This guarantees that all results can be replicated, as an older revision can be
‘checked-out’ and re-run if necessary.
Wiki pages
The website also hosts wiki-style project management software. There is a timeline showing the
history of ‘commit’s to the repository. ‘Tickets’ can be raised for: new pieces of work, defects which
have been found or ‘refactoring’. These tickets contain a description of the work to be done, an
estimate of how long it will take to complete, and effort expended to date. There are also links to
the test results webpage and the project documentation discussed below.
5.3.3 Pair-programming
One of the software engineering principles we have used is pair-programming, where two people
share a computer and keyboard. Again, this may sound an extravagant use of resources, but it
2http://subversion.tigris.org/
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has proved to be a valuable practice. Typically one person types for half an hour, whilst the other
checks for typos and thinks about how the code could be structured better; the pair then swap
roles. Individuals rotate between pairs on average twice a day with one programmer moving on to a
different task. As a result everybody in the team develops a working knowledge of the whole code.
Additionally, best practice is transferred from experienced programmers to newer ones.
The requirement for pair-programming has been relaxed to allow for single programmers to work in-
between group sessions, but all code that enters the repository is checked by a second programmer,
to maintain a high standard and reduce the risks of mistakes entering the code.
5.3.4 Agile approach
We have used an ‘agile’ software engineering approach: the cancer coding has been decomposed
into fifteen ‘iterations’ each lasting approximately a month. At the start of an iteration a list of
tickets which should be achievable by the end of the iteration is established, defining the ‘scope’
of the iteration. Programming then begins, but can only be on tickets which are ‘in-scope’, the
idea being to expand gradually the functionality of CHASTE, rather than plan for large changes or
additions. This approach inevitably leads to code being constantly revisited to change its interface
or functionality. This is only possible when it is protected by tests to ensure that function has not
changed, or changes in a controlled manner.
As an example of this process consider the following changes to the FixedCellCycleModel intro-
duced in Figures 5.3 and 5.4. We now wish to have cell-cycle models report whether they are ready
to divide or not (based upon external influences, they can no longer predict when this will be in
advance). Now our cell-cycle models cannot return a cell.GetInterDivisionTime(), but must in-
stead simply report whether cell.ReadyToDivide(). Our FixedCellCycleModelmust be updated
to this new function using the changes shown in Figures 5.5 and 5.6.
Collective code ownership
Another aspect of agile programming is the concept of ‘collective code ownership’. This ensures that
no one person ‘owns’ or takes responsibility for any part of the core code. Everybody is allowed,
and encouraged, to review the code and improve it where possible. As a test will be in place for any
desirable behaviour, this does not allow anyone to break functionality that has been added to the
code.
This agile programming requirement has been adapted to allow for ‘user projects’, branches of the
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1 void TestFixedCellCycleModel(void) throw(Exception)
2 {
3 FixedCellCycleModel our_fixed_cell;
4
5 our_fixed_cell.SetCellType(TRANSIT);
6 TS_ASSERT(!our_fixed_cell.ReadyToDivide(11.99));
7 TS_ASSERT(our_fixed_cell.ReadyToDivide(12.0));
8 TS_ASSERT(our_fixed_cell.ReadyToDivide(12.01));
9
10 our_fixed_cell.SetCellType(STEM);
11 TS_ASSERT(!our_fixed_cell.ReadyToDivide(23.99));
12 TS_ASSERT(our_fixed_cell.ReadyToDivide(24.0));
13 TS_ASSERT(our_fixed_cell.ReadyToDivide(24.01));
14
15 our_fixed_cell.SetCellType(DIFFERENTIATED);
16 TS_ASSERT(!our_fixed_cell.ReadyToDivide(1.0));
17 TS_ASSERT(!our_fixed_cell.ReadyToDivide(1e10));
18 TS_ASSERT(!our_fixed_cell.ReadyToDivide(1e100));
19 }
Figure 5.5: The new test function for a FixedCellCycleModel, compare with Figure 5.3.
1 bool FixedCellCycleModel::ReadyToDivide(double time)
2 {
3 bool ready;
4 switch(mCellType)
5 {
6 case STEM:
7 ready = (time - mBirthTime >= mStemCellCycleTime);
8 break;
9 case TRANSIT:
10 ready = (time - mBirthTime >= mTransitCellCycleTime);
11 break;
12 default:
13 ready = false;
14 break;
15 }
16 return ready;
17 }
Figure 5.6: A refactored ReadyToDivide() method for FixedCellCycleModel, compare with
GetInterDivisionTime() on line 9 of Figure 5.4.
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repository owned by a single programmer. These projects can call upon any code in the main
(‘core’) repository and allow users to do their own work. Often code from user projects is reviewed
and committed into the core if it is thought to be more widely useful.
5.3.5 Doxygen
All good code should include comments documenting its function, and giving any relevant
information about how the code should be utilised. Doxygen3 ensures that the CHASTE
code is fully documented. This is a utility which scans through the source code, read-
ing relevent comments left in the code about classes and functions. It assembles a website
(https://chaste.ediamond.ox.ac.uk/docs/) which contains all the information about the in-
teractions between different pieces of code, along with any other comments about the operation of
pieces of code and even individual functions. This website is automatically updated to keep in step
with the latest revision. An example of some Doxygen output can be seen in Figure 5.8.
5.3.6 Further testing
In addition to the continuous testing referred to above, other tests are run nightly. Memory testing
ensures that none of the tests uses up memory without freeing it; this should ensure that our code
can run indefinitely. Coverage tests ensure that all code is covered by the continuous tests. The
entire code is run on a parallel machine and under different compilers to ensure that it will work on
High Performance Computing (HPC) systems, which we utilise for running our simulations.
5.4 Cancer Models in CHASTE
In this section we outline the structure of CHASTE’s cancer code. The primary aim is to create an
environment to run simulations of the Meineke et al. (2001) model, so many of the code structures
were designed with this in mind. We describe the structure of this code in section 5.4.1. By using
the techniques described above we have generalised some sections of the code to other cancer models,
and we describe how these models use CHASTE in section 5.4.2.
3http://www.doxygen.org
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5.4.1 Implementing the Meineke et al. (2001) model
Where possible we have tried to use a code structure which is as faithful to the biology as possible,
dividing our code into separate classes to represent different biological components. A schematic
of the main classes we have created is shown in Figure 5.7. We will use the example of cell-cycle
External Influences
CellKillers
Cylindrical2dMesh
Node
Node
Node
Cell
Cell
Cell CellCycleModel
CellCycleModel
CellCycleModel
Tissue
TissueSimulation
Elements
Mechanics System
Figure 5.7: A schematic of the interactions between different classes of the CHASTE cancer
code. Solid lines with arrows denote interactions, and the direction of the influence.
A dashed line encloses objects which are members of another class, whilst dotted
lines denote a class managing the correspondence between objects.
models to illustrate how different classes inherit from one another.
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Cell-Cycle Models
In the Meineke et al. (2001) model a new node is created, in anticipation of a daughter cell, at the
beginning ofM phase, and the rest length of the spring joining the two nodes increases to its natural
rest length during M phase. So, somewhat unusually, our cell-cycle models are defined to start in
M phase rather than G1.
As we saw in section 1.3.3, many different approaches can be used to model the cell cycle. We have
constructed a framework in which simulations can use the simple FixedCellCycleModelmentioned
above, or a more complicated ODE-based model in order to decide when to progress to a new
phase. Different cell-cycle models take the form of different classes. Classes can inherit methods
and variables from other classes. For example, all cell-cycle models are responsible for reporting the
CurrentCellCyclePhase(), whether or not a cell is ReadyToDivide(), performing a Reset() upon
division, and providing a CreateDaughterCellCycleModel(). These functions are all implemented
in an AbstractCellCycleModel from which the individual cell-cycle models inherit. A schematic
showing the inheritance of the different models is presented in Figure 5.8.
Figure 5.8: A schematic of the inheritance between different classes of the CHASTE cell-
cycle models, automatically generated as part of our Doxygen documentation
(https://chaste.ediamond.ox.ac.uk/docs/inherits.html ).
The inheritance shown in Figure 5.8 follows an “is a” relationship, to avoid repeating code between
similar cell-cycle models. So that an AbstractOdeBasedCellCycleModel is an AbstractCellCycle-
Model, and WntCellCycleModel is an AbstractWntOdeBasedCellCycleModel. Some of the result-
ing classes are very simple, for example StochasticWntCellCycleModel only re-implements one
method, SetG2PhaseDuration(), changing the length of the cell cycle’s G2 duration to introduce a
stochastic element into the simulations to avoid cells cycling completely synchronously.
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Cells
A TissueCell has a CellCycleModel, and knows: whether it is ready to divide, the cell-type (stem,
transit or differentiated), its mutation state, whether it is currently undergoing apoptosis and other
cell-level properties. The TissueCell class can be asked if it is ReadyToDivide(), for this the cell
calls ReadyToDivide() on its CellCycleModel. The cell can be told to Divide() and will return a
daughter cell. The Divide() method consists of resetting its own cell-cycle model before setting up
a new cell with a cell-cycle model in the correct state, and passing on relevant information (such as
the parent’s mutation state).
Tissue
To associate our cells with a point in space, we have a Tissue class, as shown in Figure 5.7. This class
stores a list of TissueCells, and a Cylindrical2dMesh, keeping track of which cell is associated
with which Node in the mesh. Tissue handles all requests for cell locations, and the logic for
adding/removing cells and nodes to/from the simulation.
Cylindrical 2D Mesh
To implement periodic boundaries we created a Cylindrical2dMesh class which inherits all the
functions of a general Mesh<DIMENSION=2> class. The Cylindrical2dMesh class is given a crypt
width, C, and overrides some of the planar geometry methods to map the results onto a cylinder.
Nodes are moved at every time step using equation (5.3), are added when cells are born, and re-
moved when cells die; so we recalculate the Voronoi tessellation at every time step. It is possible
to construct a cylindrical Delaunay triangulation (see Okabe et al., 2000, p209–211). However to
save time we have been using the Triangle software package; a robust, efficient and optimised De-
launay triangulator (Shewchuk, 1996). Because Triangle works only in a 2D planar geometry, it was
necessary to add more functions to Cylindrical2dMesh to utilise Triangle.
Before calling Triangle’s re-meshing algorithm Cylindrical2dMesh::ReMesh() creates a horizontal
row of ‘ghost’ nodes above and below the crypt to maintain the convex-hull property of the triangu-
lation, see Figure 5.9(b). Cylindrical2dMesh then creates ‘images’ of all the nodes in 0 6 x < C/2
and places them in C 6 x < 3C/2 and also takes the nodes in C/2 6 x < C and places images
of them in −C/2 6 x < 0; this creates double the number of nodes, covering twice the area (Fig-
ure 5.9(c)). We keep a list of which ‘real’ node is associated with which ‘image’. Triangle is then
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called on this extended set of nodes and creates their Delaunay triangulation. Note that elements
which cross x = 0 or x = C are repeated on each side of the tessellation — in one case with one real
and two image nodes, and in the corresponding element with two real nodes and one image node
(Figure 5.9(d)).
(a) (b) (c)
(d) (e) (f)
Figure 5.9: The cylindrical remeshing process. (a) original set of nodes, (b) ‘ghost nodes’ added,
(c) ‘image’ nodes added, (d) Triangle meshing performed, (e) cylindrical mesh re-
constructed, (f) ‘ghost’ nodes and elements removed.
We then reconstruct the cylindrical mesh by selecting each element containing one image node, and
replacing the image node with its real counterpart in the element definition. We then delete all
elements containing two or three image-nodes, and all of the image nodes (Figure 5.9(e)). Finally
we remove the ghost nodes (and associated elements) from the top and bottom of the crypt, leaving
us with a mesh which is a Voronoi tessellation in a cylindrical geometry (Figure 5.9(f)).
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Mechanics System
The Meineke et al. (2001) spring force calculation (equation (5.1)) and node-speed calculation (equa-
tion (5.2)) are performed in a separate class Meineke2001SpringSystem which returns the speed of
each node to the simulation class. The mechanics system can be subclassed to give individual cells
different spring or damping constants, or to change the mechanics laws for the cells altogether.
Simulation Class
The simulations are run from a TissueSimulation class, whose main role is to coordinate all the
activities of the other classes. TissueSimulation does most of its work in a Solve()method, shown
in Figure 5.10.
1 while (SimulationTime::Instance()->GetTimeStepsElapsed() < num_time_steps)
2 {
3 mNumDeaths += DoCellRemoval();
4
5 mNumBirths += DoCellBirth();
6
7 mpTissue->ReMesh();
8
9 drdt = mpMechanicsSystem->rCalculateVelocitiesOfEachNode();
10
11 UpdateNodePositions(drdt);
12
13 SimulationTime::Instance()->IncrementTimeOneStep();
14
15 mrTissue.WriteResultsToFiles();
16 }
Figure 5.10: An outline of the TissueSimulation main Solve() method.
The TissueSimulation::Solve() method shown in Figure 5.10 contained much more of the
Meineke-specific spring calculations and cell birth and death in earlier revisions. As new projects
have come into scope our agile approach has factored out common code into the MechanicsSystems,
and different rules for removing cells into CellKillers, leaving a simple and easily extendible base
for all of our tissue simulations. The different class interactions are shown in Figure 5.7.
Modifications
Using our agile approach has allowed us easily to introduce new features that extend the basic
Meineke et al. (2001) model. We have introduced an external WntConcentration, which influences
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the CellCycleModels, as shown in Figure 5.7. We have also used a new WntCellCycleModel to
remove the need for pinned stem cells, with a cell’s behaviour now defined by the WntConcentration
it experiences, rather than its generation number. This allows different populations to establish in
the crypt rather than all cells being descended from a fixed number of stem cells. We have modified
the spring stiffness to depend upon the length of the cell-cell contacts, defined by the Voronoi
tessellation. Additionally we have added a new model for cell-cell adhesion, dependent on levels of
membrane-bound β-catenin, influenced by a subcellular Wnt-signalling model. We will explore the
results of these modifications in Chapter 6.
5.4.2 Extending CHASTE for other models
We have extended the CHASTE cancer code to simulate other models, using the same framework as
that shown in Figure 5.7. Here we briefly explain how this has been done for two alternative models.
Tumour spheroid simulations
The crypt modelling framework which we have been using, shown in Figure 5.7, can model tumour
monolayers or spheroids by simply replacing the Cylindrical2dMesh with a Mesh<2D> or Mesh<3D>
respectively. The group has been exploring the solving of PDEs alongside the simulation, for example
a PDE for oxygen concentration, with source and sink terms controlled by the individual cells. This
introduces feedback into the ‘External Influences’ of Figure 5.7, and allows for cell-based simulations
to be compared to classical continuum approaches for tumour spheroid growth, with the added
possibility of studying asymmetric tumour growth.
Crypt Projection model
The group has also produced a ‘crypt projection’ model by using a standard 2D monolayer simula-
tion, and adding a new CryptProjectionMechanicsSystem which projects the 2D mesh onto a 3D
parabola before performing the spring calculations. A new RadialCellKiller is used to remove
cells based on their radial position instead of height. These new classes have slotted into the existing
framework and have quickly allowed this new model to be simulated.
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5.5 Discussion
By using software-engineering design and coding principles we have developed a new C++ library
for simulating cell-based models of healthy and cancerous tissues. There are many benefits to this
style of development, discussed in the paragraphs below.
A huge benefit of test-driven development is the users’ confidence that the code is doing the task that
it was created to do, and will continue to perform this task as new functionality is added. Knowing
that a change cannot break existing code gives the team freedom to experiment with new components,
and refine existing components. As extra capabilities have been added the code has been through
some large changes, completely altering the interfaces and interactions of many components, with
complete confidence that it still performs the same tasks it was originally programmed to perform.
Without constant testing it would be impossible to change the existing code to accommodate new
components and the project would have to adhere to well-defined limits defined during an initial
design phase; instead we have a code which can adapt to new demands as necessary.
The use of classes and inheritance allows us to change a simulation very easily; for example using a
different cell-cycle model inside every cell of a tissue simulation becomes a trivial exercise of changing
one word in a test script. This is excellent for modelling processes on different scales as we can change
a single component on a single scale and observe the effect on a different scale of behaviour. The
class based structure also makes it very easy to incorporate new components, as repeated code can
be inherited from a base class, leaving only the new function to test and code.
The central code repository automatically tracks the revisions that the team makes to the code
and displays them in a timeline. This allows the whole team to keep up to date with changes and
allows them to make improvements to any part of the code. Such transparency ensures that the
code is written to a high standard. The different revisions of the code can be retrieved at any time
allowing us to replicate past results easily. If it is important for the code to be able to produce the
results at any time then a test can be written. Because the code is compiled and tested on parallel
systems, and different companies’ processors, we have been able to utilise HPC clusters to run our
simulations.
There are some disadvantages to the agile methods we have been using. Despite knowing that we
were setting out to construct a code that could simulate a Meineke-style model, the use of small
iterations (of limited ‘scope’) meant that we could not think ahead to make code easily useable in
the future. There have been instances where assumptions which had been built into the code were
hard to remove later, but would have been relatively easy to make flexible initially. This has led to
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many hours of work to refactor the code into a more extendable form, without the end requirement
changing. However the agile approach has allowed these changes to be made, whilst knowing that
the underlying code retains its function. Over the course of the project we have changed the amount
of planning that is done accordingly, to fit the requirements of scientific computing better, rather
than keeping it to a minimum as agile methods would suggest.
In chapter 6 we show how we have used the CHASTE code to simulate Meineke et al.’s (2001) model
and various extensions, discussing the results and their relevance to important scientific questions
about the mechanisms controlling cell dynamics in colorectal crypts.
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Wnt Signalling in Colorectal-Crypt Models
6.1 Introduction
A
s we saw in section 1.5.2, there are a number of different cell-based models for colon crypts
and the initiation of colorectal cancer. In this chapter we extend the model proposed
by Meineke et al. (2001), to study the impact of Wnt signalling on the behaviour of a
colorectal crypt.
All of the experiments and simulations refer to murine crypts since they are smaller than their
human counterparts and hence easier to simulate. Murine crypts are believed to operate in the same
way as human ones (Stappenbeck et al., 1998) and there is more data available on the murine crypt
(Potten & Loeﬄer, 1987).
We would like to study the impact of different cell-cycle models on the dynamics of an entire crypt:
for example, does a model in which a cell divides a certain number of times or a model in which a
cell divides under a certain Wnt signal best describe the observed dynamics? We aim to reveal what
level of modelling detail is needed to simulate the observed behaviour realistically.
Crypts have been observed to become monoclonal; all cells are descended from one original cell
(Taylor et al., 2003). By following the lineage of individual cells in our simulations we hope to provide
insight into this process. We also simulate a common cell-labelling and crypt-section experiment to
determine how accurately the results represent the true crypt dynamics.
As we discussed in chapter 5, the CHASTE software library was developed to simulate all the models
we examine in this chapter. The chapter is structured as follows: firstly we describe our extensions
to Meineke et al.’s (2001) crypt model, then we introduce some of the experimental results, before
presenting our simulation results.
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6.2 Modifications to the basic Meineke et al. (2001) model
As we saw in section 5.2, Meineke et al. (2001) developed a cell-based, lattice-free model for the
cellular dynamics in a small-intestinal crypt. It consists of a cylindrical 2D mesh, constructed using
a Delaunay triangulation (or, equivalently, a Voronoi tessellation). Each node of the mesh represents
the centre of a cell. Cells are connected by springs, defined by the Delaunay triangulation, and move
in a heavily-damped manner according to the forces exerted on them by their springs. At the base
of the cylinder are a number of fixed Paneth cells (which secrete antimicrobial enzymes) and ‘stem’
cells. Stem cells (generation= 0) produce daughter ‘transit’ cells (generation= 1). Transit cells
divide a fixed number of times, and then become ‘differentiated’. In this way the introduction of
daughter cells drives migration throughout the crypt and cells are removed once they reach the top
of the crypt.
It should be noted that the Meineke et al. (2001) model described above was designed to emulate
cell dynamics in the small-intestinal crypts, rather than the colorectal crypts. We have adapted
Meineke et al.’s model by using different dimensions, based upon measurements by Sunter et al.
(1979), and by removing the Paneth cells which are not present in the colorectal crypts (see section
1.2.1). We present a simulation of the standard Meineke et al. model in Figure 6.1: we label one of
the stem cells at t = 0 and track its progeny through further simulations, the cells produced at the
base of the crypt are swept to the top, and eventually leave the crypt.
In the rest of this section we will discuss the other extensions that we have made to Meineke et al.’s
(2001) basic model.
6.2.1 Wnt Concentration
We have imposed a fixed, spatially-varying WntConcentration, decreasing linearly from 1 at the
base to 0 at the top of the crypt. This distribution is based on the assumption that Wnt is produced
by myofibroblasts at the base of the crypt and then diffuses upward along the crypt axis. The Wnt
concentration at a particular point in space can then be used as an input into, for example, the cells’
ODE-based Wnt signalling models.
6.2.2 Cell Cycle Models
We have simulated many different cell-cycle models, the full range of models currently incorporated
into CHASTE is shown in Figure 5.8. In this section we will introduce some of the models which
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Figure 6.1: A simulation of the standard Meineke et al. model in the CHASTE environment.
Light blue cells are stem cells, yellow cells are transit cells, and red cells are dif-
ferentiated cells. Blue cells are a labelled population descended from the stem cell
labelled at t = 0. Top row: t = 0, t = 10, t = 20, t = 30; middle row: t = 40, t = 50,
t = 60, t = 70; bottom row: t = 80, t = 90, t = 100, t = 110. Time, t, is in hours.
For parameter values see Appendix A.
have been implemented in our extensions to Meineke et al.’s model.
Simple Wnt Cell Cycle Model
The simplest new model we have included is a SimpleWntCellCycleModel, which uses the
WntConcentration as an input. The duration of G1 phase for a particular cell is determined upon
birth or after division, and selected from a normal distribution of mean tG1, with a standard deviation
of 1 hour. The cell will progress through the cell cycle into a new phase if the WntConcentration at
its node’s location exceeds a threshold value. We have set the threshold value to 0.65 (dimensionless)
to match the overall rates of cell production with those of the Meineke cell-cycle model.
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Van Leeuwen Wnt Signalling and Swat Cell Cycle Model
Van Leeuwen et al. (2007) developed a model to investigate the interaction between β-catenin’s
role in adhesion and transcription. There are two main hypotheses: under hypothesis one, β-
catenin’s fate is determined by competition for binding partners; under hypothesis two, β-catenin
undergoes a conformational change which favours transcription. The authors formulate an ODE
model distinguishing between all these different pools of β-catenin. A schematic and the governing
equations of the van Leeuwen et al. (2007) Wnt signalling model can be seen in Appendix B.
−catenin levelβ
Membrane−bound
−catenin levelβ
Nuclear
Wnt−signalling model
van Leeuwen (2007)
−catenin levelβ
Cytoplasmic
Cell adhesion model
Wnt concentration
Swat et al. (2004)
Cell−cycle model
Figure 6.2: Inputs and outputs of the van Leeuwen et al. (2007) Wnt-signalling model inside a
single cell. Solid lines indicate those components that are used in the simulations
presented in this chapter; dashed lines indicate other components which have been
included in CHASTE, which are not utilised in the simulations of this chapter.
The implementation of the model for a single cell is presented in schematic form in Figure 6.2. The
WntConcentration is an input to the model, and the level of nuclear β-catenin is one of the three
outputs. Nuclear levels of β-catenin are used as an input into the Swat et al. (2004) model of the
G1/S transition of the cell cycle, as β-catenin is a transcription factor for cell-cycle proteins as we
have previously studied in chapters 3 and 4. The implementation of this link between the models
is performed as discussed in section 3.3 for a simpler Wnt-signalling model. Membrane-bound β-
catenin levels could be used as an input into a cell-cell adhesion model, this is implemented by other
developers of CHASTE. Each cell carries its own copy of these Wnt-signalling and cell-cycle models,
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as the WntConcentration varies throughout the crypt.
Interestingly the WntConcentration object has to be changed to create a quasi-steady crypt with
the same levels of proliferation as those observed using the Meineke and SimpleWntCellCycleModel.
The van Leeuwen et al. (2007) model includes time-dependent ODEs for the response of β-catenin
levels to the extra-cellular Wnt concentration; the time-dependence means it takes the cells a certain
amount of time to respond to changes in the Wnt concentration. Subsequently, a cell near the base
of the crypt under a strong Wnt stimulus will retain high β-catenin levels for some time after moving
up the crypt into a region of lower Wnt stimulus. The importance of this effect depends upon the
difference in rates of cell migration and β-catenin response.
To match proliferation rates with those of the other two models, under our parameter regime, the
WntConcentration has to be set to zero at 44% of the crypt height for Hypothesis One, and 61% of
the crypt height for Hypothesis Two. There is some evidence that many Wnt factors are only found
near the base of the crypt, and not at the top (Gregorieff et al., 2005). Notably, different Wnts
are expressed in different regions of the crypt, but as yet all mathematical models feature a single,
general Wnt factor since the differences in function are poorly understood. Our findings suggest
that a gradient in intracellular levels of β-catenin along the crypt axis could be established by Wnt
factors being expressed only around the base of the crypt.
6.2.3 Unpinned stem cells
In Meineke et al. (2001) stem cells are pinned at the crypt base. This means that the crypt is always
filled with cells descended from n ancestors, where n is the number of fixed stem cells.
After introducing new cell-cycle models, which are not reliant on asymmetric division and cells
dividing a fixed number of times, we can ‘unpin’ the stem cells at the base of the crypt. Stem cells
can then be treated simply as ‘transit’ cells, which happen to be under a strong Wnt stimulus. The
crypt is no longer restricted to having n separate clonal populations, and we have added a variable
that enables us to relate each cell to its oldest ancestor. This allows us to study which populations
of cells are washed out of the crypt and which populations persist.
6.3 Experimental Results
In this section we present some experimental results for healthy murine crypts, using the CHASTE
programming environment to replicate and explain them in section 6.4
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6.3.1 Labelling Experiments
Cell labelling is well established in experimental labs, markers such as tritiated thymidine (3HTdR)
or bromodeoxyuridine (BrdU) can be introduced into cells and incorporate themselves into the cell’s
DNA as it is synthesised (during the S phase of the cell cycle). Such markers are then passed on to
the cells’ progeny and, in a colorectal crypt, degrade on a slower timescale than the cell cycle. In
this way it is possible to identify which cells in a population are in the S phase and to track their
movement and proliferation.
We now present murine data due to Sunter et al. (1979) in Figure 6.3. Samples were taken an
hour after a 3HTdR radioactive marker was introduced. Mice are killed, crypts are dissected out
and sliced into sections along the crypt axis, allowing either one or two sections to be taken from
each crypt. The number of cells in these sections and positions of labelled cells were then recorded.
Sunter et al. (1979) performed these experiments at a range of different sites, finding considerable
variation along the length of the colon (see Figure 6.3). The data presented suggest that most
Figure 6.3: Results of Sunter et al. (1979) labelling experiments 1 hour after injection. (i), (ii),
(iii) and (iv) correspond to different sites along the mouse colon. Reproduced from
Sunter et al. (1979).
proliferation occurs at the base of the colon: with up to 40% of the cells in S phase at any one time,
the data suggest that all of the cells at the base of the crypt are actively cycling. Towards the top
of the crypt the labelling index reduces to zero, suggesting that all of the cells towards the top of
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the crypt are differentiated.
In section 6.4.1 we demonstrate how to recreate the results of Figure 6.3 by simulating these labelling
experiments, using the CHASTE environment.
6.3.2 Mitochondrial DNA Experiments
There are many hundreds of mitochondria in every cell, each with many copies of their own small
16.5kb genome (Taylor et al., 2003). Mitochondrial DNA (mtDNA) is prone to sporadic mutations,
some of which leave the cell cytochrome c oxidase-deficient. These mutations are thought to occur
randomly and relatively commonly upon replication of mtDNA. As the cells in the colon are dividing
continually from the organism’s birth onwards, this makes mutations in the mtDNA reasonably prob-
able, with the likelihood of (at least) one mutation occurring increasing with age (McDonald et al.,
2006). Cells can be labelled for cytochrome c oxidase-deficiency (see Figure 6.4). In experiments
the cells carrying the cytochrome c oxidase-deficiency are labelled blue.
Cytochrome c oxidase is involved in respiration within the cell, but the cell-cycle time, migration
and behaviour of the cell within the crypt are thought to be unaffected by this mutation. The
cells behave as normal crypt cells, and this mutation is not associated with colorectal cancer or
aberrant behaviour. Patches of clonally-identical crypts are shown in Figure 6.4 (c) and (d), and
were confirmed to carry precisely the same mutations (Taylor et al., 2003), suggesting a common cell
gave rise to the labelled population. Neighbouring crypts are thought to become part of the same
monoclonal population due to crypt fission (Greaves et al., 2006). Given that there is thought to be
more than one stem cell in a crypt, it was suprising to find that a single crypt is usually monoclonal
(Figure 6.4 (a) and (b)).
To explain this finding the concept of ‘stem-cell niche succession’ has been proposed. This hypothesis
states that the crypt has a pool of stem cells (the ‘niche’). Since the crypts become monoclonal,
stem cells must move in and out of the ‘stem-cell niche’, leading to a succession of stem cells from
which the entire population arises.
However some crypts are found which are not monoclonal: a clonal population may form a ‘ribbon’
which extends from the bottom to the top of the crypt (see Figure 6.5). The labelled ribbons of cells
from the stem-cell niche to the top of the crypt form ‘wavy columns’. The band of cells does not
maintain a constant width as one might first expect (see Figure 6.5). Other results, similar to those
in Figure 6.5, show these uneven columns beginning at a higher position in the crypt, rather than at
the base of the crypt. Professor Nicholas Wright (Queen Mary’s School of Medicine and Dentistry,
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Figure 6.4: Results of mtDNA labelling experiments from Taylor et al. (2003). Mutations occur
in a single cell, taking over a single crypt (a) and (b), then spreading to produce a
patch of clonally identical crypts (c) and (d). Reproduced from Taylor et al. (2003).
London) has postulated that these populations could be descended from a new pool of stem cells,
found higher in the crypt than previously thought (Wnt Meeting, QMC Nottingham, 29th October
2007). We investigate other possible explanations for these observations in section 6.4.2.
6.4 Simulation Results
We ran all of our simulations using the CHASTE framework described in Chapter 5, using the
parameter values shown in Appendix A. Firstly we examine how well our labelling experiments
match those in section 6.3.1, secondly we provide some insight into the mtDNA labelling results
of section 6.3.2 and finally we suggest how the multiscale nature of our model might provide new
predictions.
6.4.1 Comparison with labelling data
We saw in section 6.3.1 how experimentalists have produced crypt sections and labelling data for
over 30 years. Here we describe how we may simulate this process.
To take a virtual crypt-section we simply choose a point at the base of the crypt cylinder at random,
choose another random point along the top of the cylinder and draw a line along the 2D cylinder-
surface connecting the two. Note that this section could pass across the periodic boundary if this is
the most direct line. We then produce a list of the cells whose nodes fall within 0.5 (relaxed spring
lengths) of this line, ordered from the base to the top of the crypt. We interrogate these cells to
establish whether they are labelled or not and produce a binary vector (of the same length as the
cell section) containing this information.
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Figure 6.5: Results of mtDNA labelling experiments from Taylor et al. (2003) showing a labelled
clonal population spreading through a crypt. This is a reconstructed image of a single
crypt built up from 59 2D slices. The crypt is rotated by 45◦ about its main axis
between each of the three views above. Reproduced from Taylor et al. (2003).
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We can then simulate the labelling experiments as follows (with bracketed steps where appropriate);
• A healthy crypt simulation is run until it settles into a quasi-steady state (cell production rates
are steady), time is set to t = 0.
• At t = 0 hours all cells in S phase are labelled.
• Simulation is run to the first time-point.
• Two crypt sections are taken.
• (Simulation is run to the second time-point.)
• (Two further crypt sections are taken.)
• All cells are un-labelled.
• Results are recorded.
• Process is repeated for the same number of runs as mouse-experiments, using the end position
as a new quasi-steady starting point.
In the following graphs we display the results of 250 ‘virtual dissection’ experiments for a number of
different cell-cycle models. We display the results of taking crypt sections in scatter plots, compared
with the averaged results for all the cells in bar charts. We have used the geometry denoted (i) in the
Sunter et al. (1979) paper: a crypt width of 20 and a height of 30 (units are cells or relaxed spring
lengths); see Figure 6.3 for the experimentally observed patterns. Three different cell-cycle models
have been used to review the impact of different cell-cycle models on labelling experiment results.
In all cases the quasi-steady starting point has the same crypt cell-production rate, as described in
section 6.2.2.
Computations were performed using CHASTE executables run on the University of Nottingham’s
HPC resource ‘Jupiter’. The code runs on a single processor at approximately 300 ‘simulation hours’
per hour of computation for cell-cycle models with no ODEs, slowing down to around 100 ‘simulation
hours’ per hour of computation using cell-cycle models with over 20 ODEs.
Meineke cell-cycle model
Figure 6.6 displays the result of a set of ‘virtual dissection’ labelling experiments, and the averaged
results, in a crypt with Meineke cell-cycle models. As we might expect, the graphs show that more
of the cells towards the base of the crypt are labelled as being in S phase than the cells towards
the top. Nine hours later the label has spread some distance up the crypt, which again is consistent
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Figure 6.6: Left: Virtual dissection and Right: Averaged labelled cells by height for
Meineke et al. (2001) cells in Sunter i) Geometry. Results shown for 250 simula-
tions. For parameter values see Appendix A.
with experimental results. The labelled fraction has increased as labelled cells which were in S
phase have now divided and a greater percentage of the crypt now carries the label. Despite both
plots exhibiting these characteristics, there are differences between the scatter graph on the left of
Figure 6.6 and the bar-chart on the right: the ‘virtual dissection’ skews the results suggesting that
labelled cells reach much further up the crypt than the averaged results show.
Simple Wnt cell-cycle model
Figure 6.7 shows the same set of results, in this case for a crypt which has cells running the simple
Wnt cell-cycle model. The simple model generates a square wave in the averaged results, as the
division rule becomes effectively “divide only below a certain height”. It is interesting to observe how
this simple set of results becomes skewed by the ‘virtual dissection’ process to leave a complicated
labelling graph which is not easily distinguishable from Figure 6.6, or indeed the experimental results
presented in Figure 6.3.
Wnt ODE-based cell-cycle model
Figure 6.8 shows the labelling experiment results, in this case for a crypt which has cells running
the Wnt ODE-based cell-cycle model of chapter 3. To add stochasticity the G2 phase is allocated
from a normal distribution with the mean G2 phase given in Table A.2, and a standard deviation
of 0.9 hours. In the unlikely event that the allocated time is negative, it is rejected and resampled.
In Figure 6.8 we see a pattern which, as we might expect, falls between those seen in Figure 6.6 and
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Figure 6.7: Left: Virtual dissection and Right: Averaged labelled cells by height for SimpleWnt
cells in Sunter i) Geometry. Results shown for 250 simulations. For parameter values
see Appendix A.
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Figure 6.8: Left: Virtual dissection and Right: Averaged labelled cells by height for Wnt ODE-
based cells in Sunter i) Geometry. Results shown for 250 simulations. For parameter
values see Appendix A.
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Figure 6.9: Left: Virtual dissection and Right: Averaged labelled cells by height for
van Leeuwen et al. (2007) Hypothesis One cells in Sunter i) Geometry. Results shown
for 250 simulations. For parameter values see Appendix A.
6.7. Again we have a good agreement with the experimental data presented in Figure 6.3.
Van Leeuwen-Swat cell-cycle model
The van Leeuwen Wnt signalling/Swat cell-cycle model has also been used in these labelling exper-
iment simulations, producing Figure 6.9, when using the van Leeuwen model in its first hypothesis,
and Figure 6.10 when using the second hypothesis. Figures 6.9 and 6.10 are almost indistinguish-
able, so it seems unlikely that one could distinguish between the two hypotheses on the basis of
labelling experiments. We will see what differences are predicted by simulations including these two
hypotheses later.
We predict that the large error bars are due to a lack of stochasticity in this model, which leads to
cells cycling largely in synchrony. This in turn leads to either a large labelled population in a part of
the crypt or a lack of a labelled population, increasing the error from that seen in Figure 6.8 which
is performing a very similar task with a stochastic element.
The overestimates of the height of the labelled cells are due to an artefact of the dissection process:
cell packing means there are more ‘cell positions’ than the actual crypt height measured in cells.
Because crypt sections do not always cut directly down the crypt axis, but are usually slightly off
centre this also pushes the labelling results to higher cell positions. These effects skew the results
to give the impression that the label has reached further up the crypt than it has in reality. Taking
crypt sections also smooths any steep gradients in the underlying proliferation patterns as we saw
in Figure 6.7.
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Figure 6.10: Left: Virtual dissection and Right: Averaged labelled cells by height for
van Leeuwen et al. (2007) Hypothesis Two cells in Sunter i) Geometry. Results
shown for 250 simulations. For parameter values see Appendix A.
An interesting direction for future work would be to create PDE continuum models for the fraction of
cells in S phase at a certain height up the crypt. Studying where the progeny of these cells migrate to
over time would allow comparisons with both the data we have generated and experimental results.
We would also like to vary some of the parameters within the model, such as spring stiffness,
viscosities and cell-cycle parameters to see their effect on the labelling experiment results.
Although the ‘virtual dissection’ and averaged simulation results show some differences the main
trends are preserved between the two, and taking crypt sections remains a good method for studying
the proliferation and migration within the crypt. The artefacts that we have observed when taking
crypt sections should be noted when drawing conclusions from such experiments.
6.4.2 mtDNA Experiments
We can easily simulate mtDNA experiments by simply labelling a cell with a harmless mutation, the
label spreading to all of its progeny. Figure 6.11 shows how clonal populations develop for Meineke
simulations (first and second columns), and for a SimpleWntCellCycleModelbased simulation (third
and fourth columns); in columns one and three we represent the ancestor of each cell with a colour,
in columns two and four we follow a single labelled population (to represent a mtDNA experiment).
It is clear that the Meineke simulation produces clonal populations which extends to the top of the
crypt, and each of the stem cells maintains a quasi-steady sub-population. This is because all stem
cells are pinned and so contribute equally to the crypt.
In the SimpleWntCellCycleModel simulation we label a single cell located near the base of the crypt
140
6.4 Simulation Results Chapter 6: Wnt Signalling in the Crypt
Figure 6.11: Clonal expansion in the crypt, in columns 1 and three each colour represents a
different clonal population. Column 1: A Meineke-style simulation with pinned
stem cells. Column 2: A single clone of column 1. Column 3: A Simple-Wnt
simulation with unpinned stem cells. Column 4: A single clone of column 3. Row
1: t = 0hrs, row 2: t = 40hrs, row 3: t = 100hrs, row 4: t = 300hrs, row 5:
t = 800hrs, row 6: t = 1340hrs. For parameter values see Appendix A.
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in column four of Figure 6.11 and follow its lineage over time. We observe that this single cell is the
ancestor of the whole crypt at the end of the simulation. All of our unpinned-stem-cell simulations
have been observed to reach a monoclonal state, through random movement of cells around the base
of the crypt. The model simulations support the evidence for, and can replicate, the monoclonal
nature of the crypt.
Figure 6.12 shows how the number of distinct populations present in the simulation of columns three
and four of Figure 6.11 changes over time. Note that all the cells in the crypt are initially labelled
as distinct populations, so the number of different clones in the population reduces approximately
exponentially to around 7. This phase continues until the crypt is populated by cells descending only
from the viable long-term positions at the base of the crypt. The next losses of clonal populations
follow a slower decay, with monoclonality occurring after 1350 hours (roughly 8 weeks).
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Figure 6.12: The number of clonal populations present in the simulation shown in the third and
fourth columns of Figure 6.11. At time t = 0 all cells are labelled as separate
populations, giving 242 clonal populations. At t = 1350 hours only one population
remains and the crypt has become monoclonal.
We have performed the above experiment 500 times, recording the amount of time taken for the
crypt to become monoclonal, the results are presented in Figure 6.13. We see how the time it takes
for a crypt to become monoclonal is distributed in Figure 6.13 (a) with a median of around 40 days,
or 960 hours. The cumulative distribution is shown in Figure 6.13 (b), with a smooth transition and
all crypts becoming monoclonal after around 160 days (or 4000 hours).
To further examine the concept of ‘stem cells’ we follow the the cell which gives rise to the entire
population in simulations such as those displayed in Figure 6.13. In every simulation the original
‘ancestor’ cell drifed out of the crypt, we examine how many times each of these cells divided before
leaving the crypt in Figure 6.14. We see that the model does not support the theory that any
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Figure 6.13: Left: the distribution, and on the right the cumulative distribution, of the time it
takes for a crypt to become monoclonal. Results are from 500 simulations using
the same parameter values as those used in simulations for columns three and four
of Figure 6.11.
stem cells are ‘immortal’, rather that there is a progression in the cells which give rise to the entire
population. Since the median time taken for a crypt to become monoclonal is around 960 hours a
cell in one of the ‘stem’ positions would need to persist through around 60 generations, we see that
in 250 simulations all of these ancestor cells are lost in less than 20 generations.
Wavy Columns
Prior to leaving or dominating a crypt, a labelled population in column three of Figure 6.11 may
form a ‘wavy column’, as seen in experiments (see Figure 6.5). By visualising our simulations we
observe that the crypt is a very dynamic environment; it is highly unlikely that a column would ever
have regular sides within our simulation environment. The ‘waves’ in the sides of the columns can
also correspond with groups of cells being descended from a single cell near the base of the crypt.
Cells descending from a cell near the base of the crypt have roughly synchronised cell cycles, so a
number of cells are born at roughly the same time (or, equivalently, height up the crypt) leading to
a swell in the width of a column.
If there are n cells near the crypt base (in a ‘stem cell position’) and one is labelled at random there
is a 1/n chance that this label will take over the crypt, and a 1− 1/n chance that it will be swept
away; there is a high probability that any single clonal population in a ‘stem cell position’ will be
lost from the crypt.
In Figure 6.15 we present a visualisation of the loss of the penultimate population from the simulation
that was shown in column 3 of Figure 6.11. We postulate that the clones which have been observed
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Figure 6.14: The number of divisions that the ancestor cell (which gives rise to the entire crypt
population) performs before being swept out of the crypt. Results are from 250
simulations using the same parameter values as those used in the simulations of
columns three and four of Figure 6.11.
starting from a height above the crypt base, are not steady populations; but are clones in the process
of being swept out of the crypt (such as those in the second row of Figure 6.15). The same findings
that have led Professor Wright’s group to postulate a new population of stem-cells seem consistent
with our observations of many more populations leaving the crypt than becoming dominant. Such
stem cells occupying a higher position in the crypt also seem unlikely, given that they would have
to defend their positions against a steady flow of cells emanating from the stem cells at the base of
the crypt.
The main weakness in our findings is the limitation of the cylindrical 2D geometry we have been
using. In reality the base of a crypt does not contain 20 cells all equally likely to become the
dominant clone. There are possibly as few as four or five cells with any chance of dominating the
real crypt, and they will not do so with equal probabilities; the cell directly at the base of the crypt
probably has a far higher chance of becoming the dominant clone than any other cell. For this
reason we expect that our 8 week timeframe for the crypt to become monoclonal is an overestimate.
Conducting the same mtDNA simulations in more realistic geometries is a high priority for future
work. It is notable that we can recreate all of the findings of the mtDNA experiments without having
any cells explicitly behaving as ‘stem cells’; all of the cells in our CHASTE simulations are simply
proliferating or differentiated, the external Wnt stimulus and geometry being sufficient to drive the
patterns of proliferation.
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Figure 6.15: Loss of a clonal population from the crypt. Visualisation for regular intervals (over
1535 < t < 1635 from left to right, top to bottom) for the simulation shown in
columns three and four of Figure 6.11. The labelled cells are the penultimate clonal
population, that which remains in the crypt for the largest amount of time apart
from the dominant clone. For parameter values see Appendix A.
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6.4.3 β-catenin expression
The van Leeuwen et al. (2007) Wnt signalling model predicts the amount of β-catenin distributed to
the nucleus, membrane and the cytoplasm as presented in Figure 6.2. The nuclear level of β-catenin
acts as a transcription factor, activating the cell-cycle model. In the context of a Wnt gradient and
crypt geometry we have adapted the CHASTE visualiser to display these concentrations in the style
of a GFP labelling experiment, with the intensity of a colour label depending on the concentration
of the component. Figure 6.16 shows a (quasi-)steady-state crypt for each of the two hypotheses
that the van Leeuwen et al. (2007) model tests (given in Appendix B).
Figure 6.16: A quasi-steady simulation of van Leeuwen et al. (2007) under hypothesis one (left)
and hypothesis two (right), with cells stained for β-catenin. The CHASTE visu-
aliser displays the concentrations of nuclear and cytoplasmic levels of β-catenin
on the green scale and membrane-bound β-catenin on the grey scale, facilitating
a qualitative comparison with crypt staining or GFP-labelling experiments. For
parameter values see Appendix A.
We see from Figure 6.16 that both hypotheses predict low cytoplasmic and nuclear levels of β-catenin
towards the top of the crypt, with moderate membrane-bound concentrations there. However the
distribution near the base of the crypt is quite different in the two cases; with high levels of membrane
bound β-catenin associated with the first hypothesis, but low levels for the second hypothesis.
These predictions could be compared with GFP or other labelling experiments to establish how
well hypothesis one or two describe the observed results. At first glance it would appear that
in reality membrane-bound levels of β-catenin remain higher than cytoplasmic and nuclear levels
throughout the crypt (Shih et al., 2001), suggesting that hypothesis one is more realistic (subcellular
β-catenin binding is purely down to competition). This approach will also be useful as we extend
the work to compare the distribution of β-catenin in healthy and early colorectal cancer tissue
(Fodde & Brabletz, 2007).
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6.5 Discussion
In this chapter we have used the CHASTE framework to address a number of topics relating to the
function of the healthy colorectal crypt.
We have shown that there is a difference between the results of a virtual dissection and the underlying
proliferative activity in a crypt simulation. This suggests that a similar difference exists between the
results of crypt section experiments and the underlying proliferation in a real crypt. In particular,
the taking of crypt sections appears to exaggerate how far the label has travelled, due to the packing
of cells and the slicing a crypt section slightly off-axis. The difference between the virtual dissection
and averaged results is smallest in what we consider to be our most realistic cell-cycle model. The
process does have the unwanted effect of smoothing out all of the results; none of the cell-cycle
models leads to particularly different results after the virtual dissection process.
We have coupled an external Wnt signal to cell proliferation and investigated its impact on a crypt-
scale model. The initial results are encouraging and suggest that a Wnt signal could be responsible
for sustaining the ‘stem-cell pool’, and dictating when differentiation should occur. Furthermore,
we can predict the subcellular distribution of β-catenin, throughout the crypt, for different Wnt
signalling models and compare these with experimental results.
Our results can explain all the findings of mtDNA experiments on a single crypt, with the rich
behaviour arising simply out of the geometry and proliferative pressure of the system. Cell-cycle
models being roughly synchronised, for a cell population travelling up the crypt, can help to account
for the ‘wavy columns’. We suggest that columns which seem to begin part-way up the crypt are
actually in the process of being ‘swept-out’, rather than being sustained by a stem cell higher up
the crypt.
Intestinal stem cells have been the subject of intense debate for well over the past ten years
(Potten et al., 1997; Leedham & Wright, 2007). Yet our CHASTE simulations recreate all of this
behaviour without the need to model a separate population of ‘stem cells’. Our simulations would
suggest that cells giving rise to a population which eventually colonises the entire crypt do so simply
because they are trapped at the base of a crypt and under strong proliferative signals. To replicate
any of the experimental results seen to date a spatial model of the colorectal crypt does not need to
have a separate population of stem cells. A separate pool of stem cells is required in some non-spatial
compartmental models — this serves as a representation of the crypt geometry. We venture that
considering there to be a separate population of ‘stem cells’ in the colon crypt is at best unhelpful,
and at worst misleading, in aiding understanding of the crypt’s cell population dynamics.
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Our model represents the ‘stemness’ of cells as a continuum rather than assuming a discrete change
from a stem cell to a transit cell. Thus the notions of symmetric and asymmetric stem cell divi-
sion have no meaning, with the ‘stemness’ dependent on the external signals (in our case the Wnt
concentration). Our geometry and migration captures the way in which cells can become more
differentiated. This is similar approach to that taken by Roeder and collaborators in recent sub-
cellular models for hematapoetic stem cells and their differentiation (Kirkland et al., 2006; Roeder,
2006); interestingly our geometry captures the ‘stemness’ of the cell in much the same way, without
the need for an internal variable. Future work could include adapting some of Roeder’s models
for differentiation (Glauche et al., 2007) in order to simulate the differentiation of crypt cells into
enterocytes, goblet cells and enteroendocrine cells.
Extensions of this work should focus on refining the current cylindrical 2D geometry to more closely
resemble the ‘test-tube’ shape of a colorectal crypt. This will allow more accurate and useful pre-
dictive simulations of mtDNA clonal population experiments. By introducing mutant cells useful
contributions could be made to the “where do the two hits hit?” discussion (Komarova & Wang,
2004; Leedham & Wright, 2007), shedding some light on whether the process of top-down or bottom-
up mutant clone expansion is a more likely cause of colorectal cancer initiation. The code is already
in a position to predict β-catenin distributions throughout the crypt within healthy and aberrant
cells, which could then be tested experimentally.
148
Chapter7
Discussion
T
he Wnt signalling pathway has long been implicated in the initiation of colorectal cancer.
We have investigated some of the possible mechanisms by which Wnt signalling main-
tains healthy homeostasis in a colorectal crypt, and looked at the mechanisms by which
mutations in the Wnt pathway may cause a cell to cycle uncontrollably.
Wnt signalling was first thought to be important in controlling the cell cycle in a crypt when it was
observed that mutations in the Wnt pathway cause polyp formation (Kinzler et al., 1991). In chap-
ter 2 we performed an asymptotic analysis on the Lee et al. (2003) model, which is the most widely
used model for the Wnt signalling pathway, being well-grounded on experimental measurements of
parameter values. We exploited the fact that reaction rates and component concentrations vary by
several orders of magnitude, in order to separate out the operation of the pathway onto three distinct
timescales. Since β-catenin varied only on the slowest timescale we were able to reduce the entire
pathway model to a single ODE, without losing any of the qualitative Wnt-dependent behaviour of
β-catenin levels.
Cho et al. (2006) added an Axin2 feedback loop into the Lee et al. (2003) model, the 2006 model
being the most widely used in recent publications. We performed the same asymptotic analysis
on this variation of the model, reaching the same type of reduced model — comprising of a single
ODE for the β-catenin levels. Again, this reduced model closely matches the behaviour of the full
Cho et al. (2006) model. The process of the asymptotic analysis shed much light on the operation
of the Wnt pathway and has made computation of the Lee et al. (2003) model, and its extensions
to include feedback effects, far simpler.
Many of the components of the Wnt signalling pathway are localised to either the membrane or
the nucleus of a cell. The Lee et al. (2003) model assumes that all proteins are freely mixing in
the cytoplasm. Further work could include the construction of a compartmental ODE model for
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the Wnt signalling pathway, with compartments representing different areas of the cell. There is
much research into the control of nuclear import and export of Wnt/β-catenin pathway proteins,
and the factors controlling their recruitment to the cell membrane; this should allow such a model
to be constructed in the near future. The Lee et al. (2003) model is limited by the fact that the
parameter values were established from Xenopus eggs in vitro; we would ideally gain parameter
values from human crypt cells in vivo.
In chapter 3 we linked the simple Wnt signalling model derived in chapter 2 to an existing model
of the cell cycle (Swat et al., 2004), relating them via Cyclin D. We investigated the impact of
mutations in the Wnt pathway on the proliferative behaviour of cells under different Wnt stimuli.
This model predicted that a single APC mutation is insufficient for cancer initiation, and that a
double-hit is required; whilst a single β-catenin mutation is sufficient to significantly reduce control of
the cell cycle. The observation that double APC mutants are most commonly observed in colorectal
cancer, rather than a single β-catenin mutation, cannot be explained simply by the probability of
such a mutation occurring or their effect on the cell cycle. This suggests that the APC mutation
causes functional changes being ‘selected’ in the process of tumour formation. Modelling the impact
of APC, and its mutant forms, on some of these other effects (such as cell adhesion, migration
and the cytoskeleton) would form an interesting line of enquiry. GSK3β and other Wnt pathway
components affect a similarly wide-range of processes, for which more data is available than ever
before, opening up new avenues of subcellular modelling opportunities.
The model of chapter 3 could not explain results which were published last year by Sansom et al.
(2007). In these experiments a disregulated crypt was caused by an APC knockout, yet a double
knockout of APC and Myc restored the crypts to near normal. Our model could replicate the first
finding, but not the second as the action of Myc was not featured in the model. In chapter 4 we
constructed a new model for Wnt’s control of the cell cycle featuring Myc, CDK4 and Cyclin D,
with levels of Cyclin D:CDK4 complex as reporters for cell-cycle stimulation. Some parameters for
this model were fixed by Sansom et al.’s experiments and the results of the knockout experiments
can be replicated; this suggested a number of drug targets which could be used to reverse the effects
of an APC mutation, with the promoter regions of Cyclin D and CDK4 being the most promising
candidates. To validate our model we would like to gain some decay and dissociation rate parameters
from experimental results.
There are a number of directions for future modelling linking Wnt signalling to the cell cycle.
Feedback loops from cell-cycle proteins to our Wnt signalling pathway are known to exist, for
example E2F1 featured in the model of chapter 3 is a Myc-promoter. The importance of such
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feedback loops is not yet known and their effects could be considerable. We have also postulated
the need for a secondary level of cell-cycle control via a different pathway: there is evidence that
proliferation in the crypts is also dependent on non-canonical Wnt signalling or other pathways such
as Erk, Delta, Notch and Hedgehog signalling.
We constructed the CHASTE software environment to run cell-based simulations of a colorectal
crypt as documented in chapter 5. Working as part of a team we used principles from software-
engineering to develop a large C++ code-base, a major advantage being that components common
to many models do not need to be coded by each individual researcher for each implementation of
a model. The code-base is fully tested so that each sub-component performs exactly the function
for which it was programmed. All revisions of the code are automatically logged so that all results
are replicatable. We used an ‘agile’ approach which splits down the workload into manageable
‘iterations’, with the final code structure emerging from the iterations rather than being planned
from the beginning of the project. It was necessary to strike a balance between the agile approach
and a more traditional planned approach to best suit the requirements of scientific computing.
In chapter 6 we have used the CHASTE framework to simulate the Meineke et al. (2001) model
for crypt dynamics with a number of extensions. We took our crypt geometry and modelled the
experimental process of taking ‘crypt sections’. We then compared the results of this process with
the underlying dynamics of the crypt. We found that the experiment provides a good representation
of the true crypt dynamics, but the process overestimates the height at which processes occur due to
polygonal packing of the cells in the crypt. We have generated a number of virtual crypt sections for
different cell-cycle models, which can be compared with experimental data to reveal which cell-cycle
model provides the most realistic representation of the patterns of proliferation within a crypt.
Mitochondrial DNA experiments have recently allowed experimentalists to track the progeny of a
single cell within the crypt. They have found that a crypt is usually observed to be monoclonal, yet
some crypts have ‘wavy-columns’ of labelled cells from a single ancestor whilst the rest of the crypt
is filled with cells descended from different ancestors. The Meineke et al. (2001) model contains
a population of n pinned stem cells, and so the crypt is always populated by n separate clonal
populations.
We extended the Meineke et al. (2001) model to allow for a cell-cycle model where cells divide based
upon the Wnt concentration that they are experiencing, rather than a generation number. This also
removes the requirement for a population of pinned ‘stem cells’. We found that a labelled population
forms a ‘wavy column’ of cells prior to dominating or being swept out of the crypt. This process
can explain all of the mitochondrial DNA experiment results that have been presented to date — in
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terms of progression towards a monoclonal crypt. We suggest that cells act as ‘stem cells’ because of
their position, rather than an inherent ‘stem-cell’ property. The weakness of our estimate of the time
it takes for a crypt to become monoclonal is probably due to the artificial 2D cylindrical geometry
we have been using. We have many cells at the base of a crypt all equally likely to become the
dominant clone in the crypt. In reality the ‘test-tube’ geometry suggests that the cell directly at
the base of the crypt has a higher probability of becoming the dominant clone. A full 3D geometry
will allow far better predictions for the monoclonality timescale, as such this is a research priority.
By incorporating the van Leeuwen et al. (2007) subcellular Wnt signalling model into our crypt
simulations we have made predictions for the distribution of β-catenin, both within a single cell and
throughout the crypt, for two different hypotheses. A finding which emerged from this multiscale
model came from the time it takes for β-catenin to react to a new level of Wnt stimulation. Since
the cells in the crypt are constantly moving upwards towards the top of the crypt, a cell experiencing
a high Wnt stimulus towards the base will maintain it for some time as it is pushed up the crypt.
The model suggests that a strong Wnt stimulus around only the base of the crypt (and no Wnt
stimulus elsewhere) is enough to create a gradient of nuclear β-catenin levels along the crypt axis. By
comparing the quasi-steady-states of simulations with experimental data we will be able to suggest
which of the model’s two hypotheses is most consistent with observed distributions of β-catenin.
We are in a position to introduce cells harbouring mutations, to track the resulting populations and
their success rates in dominating the crypt. We can investigate whether the inability of cells to stop
proliferating affects their probability of becoming the dominant clone. There is a large discussion
as to “where do the two hits hit?”: for example, do both APC mutations happen in a ‘stem cell’ or
does one happen in a stem cell and the second elsewhere? By performing sets of simulations in a
realistic 3D geometry we would hope to be able to contribute a great deal to this discussion. Other
members of the group are studying the effects of changing viscosity (which represents cell-substrate
adhesion) on the probability of a mutant cell dominating the crypt.
We have formulated and analysed models linking an external Wnt stimulus to the cell cycle, and
introduced cells with such models into a crypt-scale model. The initial results are encouraging and
suggest that a Wnt stimulus is responsible for sustaining the proliferation and cell dynamics within
a crypt. We are in a position to use these models to investigate the crypt dynamics which lead to
the onset of colorectal cancer.
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CHASTE Parameter Values
Table A.1 shows the geometries and cell-cycle models used in the CHASTE simulations presented
in Chapter 6.
Table A.1: Parameters used in the CHASTE simulations of Chapter 6.
Figure 6.1 6.6 6.7 6.8 6.9 6.10 6.11:col 1 & 2, col 3 & 4. 6.15 6.16
Geometry (iii) (i) (i) (i) (i) (i) (iii) (iii) (iii) (i)
Cell-cycle model 1 1 2 5 3 4 1 2 1 3 & 4
The geometry parameters referred to in Table A.1 are shown in Table A.2, either for the sites referred
to by Sunter et al. (1979) as (i) or as (iii) (shown in Figure 6.3 of the main text). The cell-cycle
models referred to in Table A.1 are shown in Table A.3, see section 6.2.2 for details.
The mechanics parameters used in the CHASTE simulations, which we have not varied between
simulations, are shown in Table A.4. Mechanics parameters are based on Meineke et al. (2001),
however the spring stiffness/damping constant ratio has been increased from those of Meineke et al.
(2001) to sustain a colorectal crypt rather than the smaller small-intestinal crypt. Note that a
stiffness which is too large, or damping which is too small leads to oscillations in the springs, whilst
a stiffness that is too small, or damping which is too large, leads to a crypt becoming unable to
maintain a quasi-steady state, with proliferation occurring faster than sloughing.
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Table A.2: Parameters for the different geometries of CHASTE simulations in Chapter 6, all
parameters from Sunter et al. (1979), crypt length adjusted for polygonal packing.
Sunter geometry (i) Sunter geometry (iii)
Parameter value value units
G1 duration
∗ 7.0 9.4 hrs
S duration 6.2 7.4 hrs
G2 duration 1.8 1.4 hrs
M duration 0.5 0.72 hrs
Crypt width 20 14 —
Crypt length 23 15 —
∗ ignored by those cell cycle models using ODEs for G1 phase.
Table A.3: Parameters for the different cell cycle models used in Chapter 6, adjusted to provide
the same cell-turnover for a whole crypt of Sunter (i) geometry.
Model Model Maximum transit Top of linear
number description generations Wnt Concentration
1 Meineke generation-based 3 —
2 Simple Wnt-based — 1.0
3 Van Leeuwen (2007) Hypothesis One: Swat (2004) — 0.44
4 Van Leeuwen (2007) Hypothesis Two: Swat (2004) — 0.61
5 Wnt ODE-based model (chapter 3) — 0.22
Table A.4: Mechanics parameters for the CHASTE simulations of Chapter 6.
Parameter symbol value units
Spring stiffness µ = 30 kg s−2
Damping constant η = 1 kg s−1
Timestep ∆t = 30 s
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Van Leeuwen (2007) Wnt signalling model
Two different hypotheses have been suggested to explain how β-catenin ‘decides’ between taking a
role in cell adhesion (at the cell-membrane) or transcription (in the nucleus). In the first hypothesis
the destination of β-catenin depends purely on the competition for binding partners in the different
locations. In the second hypothesis, Wnt signalling causes a conformational change to the β-catenin
protein, leaving it unable to perform a role in cell-adhesion.
The van Leeuwen et al. (2007) model for Wnt signalling takes the form of a compartmental ODE
model, concentrating on the location and state of different pools of β-catenin. A schematic of the
model is shown in Figure B.1. The variables shown on Figure B.1 are listed in Table B.1. β-catenin
is labelled C, and can only participate in adhesion in its ‘open’ form, denoted by CO. The different
hypotheses are modelled by varying the rate at which β-catenin takes up its ‘closed’ form, CC ,
through the reaction r15(W ) in Figure B.1. This is implemented by changing from ξC = 0 for
hypothesis one to ξC = 5000 for hypothesis two. The rest of the parameter values can be found in
Table B.2.
The governing equations are given by the following expressions, derived from Figure B.1 using mass-
action and Michaelis-Menten terms:
• APC-mediated degradation of β-catenin:
d[D]/dt = (1− σD)sD[X ]− (d̂D + d̂DX)[D],
d[X ]/dt = sX − (1 − σD)sD[X ]− d̂X [X ] + d̂DX [D],
d[CU ]/dt =
pU [D][CF ]
[CF ] +KD
− dU [CU ].
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Variable Description
D APC destruction complex
X Axin
CU β-catenin marked for ubiquitination
CO Open form β-catenin
CC Closed form β-catenin
MO Open form mutant β-catenin
MC Closed form mutant β-catenin
A Free Adhesion molecules
CA β-catenin:Adhesion
MA Mutant β-catenin:Adhesion
T free TCF
COT Open β-catenin:TCF
CCT Closed β-catenin:TCF
MOT Open Mutant β-catenin:TCF
MCT Closed Mutant β-catenin:TCF
Y Wnt Target protein
W Wnt level
Table B.1: Dependent variables in van Leeuwen et al.’s (2007) Wnt signalling model.
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Figure B.1: Schematic of van Leeuwen et al.’s (2007) Wnt signalling model. Reproduced from
van Leeuwen et al. (2007).
• Cytoplasmic β-catenin:
d[CO]/dt = (1− σβ)sC + dCA[CA] + dCT [COT ]− (sCA[A] + sCT [T ] + dC)[CO]
−
p̂C [CO]
[CO] + [MO] +KC
−
pU [D][CO]
[CF ] +KD
,
d[CC ]/dt =
p̂C [CO]
[CO] + [MO] +KC
+ dCT [CCT ]− (sCT [T ] + dC)[CC ]−
pU [D][CC ]
[CF ] +KD
,
d[MO]/dt = σβsC + dCA[MA] + dCT [MOT ]− (sCA[A] + sCT [T ] + dC)[MO]
−
p̂C [MO]
[CO] + [MO] +KC
,
d[MC ]/dt =
p̂C [MO]
[CO] + [MO] +KC
+ dCT [MCT ]− (sCT [T ] + dC)[MC ].
• Cell–cell adhesion:
d[A]/dt = sA + dCA([CA] + [MA])− sCA([CO] + [MO])[A]− dA[A],
d[CA]/dt = sCA[CO][A]− dCA[CA],
d[MA]/dt = sCA[MO][A]− dCA[MA].
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• Induction of Wnt-target gene transcription:
d[T ]/dt = sT + dCT ([CT ] + [MT ])− sCT ([CF ] + [MF ])[T ]− dT [T ],
d[COT ]/dt = sCT [CO][T ]− dCT [COT ],
d[CCT ]/dt = sCT [CC ][T ]− dCT [CCT ],
d[MOT ]/dt = sCT [MO][T ]− dCT [MOT ],
d[MCT ]/dt = sCT [MC ][T ]− dCT [MCT ],
d[Y ]/dt =
sY ([CT ] + [MT ])
[CT ] + [MT ] +KT
− dY [Y ],
where the following substitutions have been made:
CF = CC + CO,
CT = CCT + COT ,
MF = MC +MO,
MT = MCT +MOT ,
d̂D = DD + ξDW,
d̂DX = DDX + ξDXW,
d̂X = DX + ξXW,
p̂C = pC + ξCW.
Mutations are handled as follows:
• σβ = 0⇐⇒ wild-type β-catenin;
• σβ = 0.5⇐⇒ single β-catenin mutation;
• σD = 0⇐⇒ wild-type APC;
• σD = 0.5⇐⇒ single APC mutation;
• σD = 1⇐⇒ double APC mutation.
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The initial conditions for the Wnt pathway are given by the steady-state solutions, denoted by ⋆:
[D⋆] =
(1 − σD)sDsX
(1− σD)sDd̂D + d̂X(d̂D + d̂DX)
,
[X⋆] =
sX(d̂D + d̂DX)
(1− σD)sDd̂D + d̂X(d̂D + d̂DX)
,
[C⋆F ] =
(sC − dCKD − pU [D
⋆]) +
√
(sC − dCKD − pU [D⋆])2 + 4sCdCKD
2dC
,
[C⋆O] =
sC − p̂c − θKc +
√
4sCθKc + (sC − p̂c − θKc)2
2θ
,
[C⋆c ] = [C
⋆
F ]− [C
⋆
o ],
[C⋆OT ] =
sCT sT [C
⋆
O]
dTdCT
,
[C⋆CT ] =
sCT sT [C
⋆
C ]
dT dCT
,
[C⋆T ] =
sCT sT [C
⋆
F ]
dTdCT
,
[A⋆] =
sA
dA
,
[C⋆A] =
sAsCA[C
⋆
O]
dAdCA
,
[T ⋆] =
sT
dT
,
[Y ⋆] =
sCT sT sY [C
⋆
F ]
dY (sCT sTC⋆F + dCTdTKT )
,
with θ = dC +
pu[D
⋆]
[C⋆F ]+KD
.
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sA = 20 nM/h dCT = 750 h
−1 pC = 0 h
−1
sCA = 250 (nM h)
−1 dD = 5 h
−1 pU = 100 h
−1
sC = 25 nM/h dDX = 5 h
−1 ξD = 5 h
−1
sCT = 30 (nM h)
−1 dT = 0.4 h
−1 ξDX = 5 h
−1
sD = 100 h
−1 dU = 50 h
−1 ξX = 200 h
−1
sT = 10 nM/h dX = 100 h
−1 dC = 1 h
−1
sX = 10 nM/h dY = 1 h
−1
sY = 10 h
−1 KC = 200 nM
dA = 2 h
−1 KD = 5 nM
dCA = 350 h
−1 KT = 50 nM
Table B.2: Parameter values for van Leeuwen et al.’s (2007) Wnt signalling model.
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